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Fibroblast growth factor (FGF) signalling plays many fundamentally important roles 
during the development of the mammalian embryo. However, its effects on 
pluripotent stem cells derived from mouse and human embryos appear to be markedly 
different.  FGF2 is routinely added to culture medium for propagating undifferentiated 
human (hES) cells, whereas in mouse (mES) cell cultures FGFs have been described 
as regulators of their differentiated progeny.  To assess the effect of FGF signalling on 
undifferentiated mES cells, the effects of FGF2 and 4 were analysed in the presence 
of saturating and sub-saturating levels of the inhibitor of differentiation, leukaemia 
inhibitory factor (LIF).  Mouse ES cell self-renewal was quantified by measuring the 
expression of the stem cell specific reporter Oct4-LacZ in biochemical and 
fluorometric assays.  Treatment with FGF reduced the expression of the OCT4-LacZ 
reporter, even under saturating concentrations of LIF and this was mirrored by 
decreased levels of OCT4 protein. Furthermore, treatment with FGF leads to 
upregulation of the ectodermal differentiation marker Pax6.  These results suggest that 
FGF signalling has a direct impact on undifferentiated mES cells, and actively 
promotes their differentiation.  To asses the effect of FGF signalling on hES cells 
without the influence of undefined factors, a feeder and serum free system was 
developed.  Cells growing in this conditions for >20 passages maintained expression 
of surface (SSEA3 and TRA1-60 and 81) and internal (OCT4) markers specific for 
undifferentiated hES cells.  Expression of these markers was dependant on the 
continuous presence of FGF2.  Indeed, withdrawal of FGF2 resulted in a rapid 
decrease of in hES cell growth and of the emergence of cell flattened morphology and 
of the surface marker SSEA1, changes typically associated with differentiation.  Two 
important signals activated by FGF in hES cells are the ERK/MAPK and PI3K 
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pathways.  To assess their functional relevance, hES cell cultures were treated with 
the drugs UO126 and LY294002, inhibitors of the MAPK and PI3K pathways 
respectively.  Drug mediated suppression of the phosphorylation of these pathways, 
correlated with a reduction in cell growth, flattening of the colonies and reduction in 
SSEA4 expression.  Use of SB431542, specific inhibitor of TGFβ/activin type I 
receptor kinase (Alk5) also resulted in the flattening of the colonies and the 
appearance of dispersed cells.  Therefore, inhibition of MAPK and PI3K appears to 
impair growth and self-renewal in hES cells and this may be happening in conjunction 
with TGFβ/Activin pathway.   Taken together, these results suggest that FGF 
signalling has opposite effects in mouse and human ES cells: inducing differentiation 
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Understanding the mechanisms of self-renewal in human embryonic stem (ES) cells has 
proven to be a major challenge.  Initially mouse and human ES cells were isolated and 
propagated in an identical manner, on inactivated mouse embryonic fibroblasts (MEFs) 
(Thomson et al., 1998).  However, the factors that mediate self-renewal in mouse and 
human ES cells are different.  Mouse ES (mES) cell differentiation is prevented by the 
cytokine Leukaemia Inhibitor Factor (LIF) and the Bone Morphogenetic Protein 4 
(BMP4) (Dani et al., 1998; Ying et al., 20003a).  Significantly, LIF and BMP4 not only 
are unable to support human ES (hES) cell proliferation but they promote their 
differentiation (Xu et al., 2002; Daheron et al., 2004).  By contrast, fibroblast growth 
factor 2 (FGF2) is the key component in the culture of hES cells (Levenstein et al., 
2005), despite also being highly expressed by the cells (Wei et al., 2005).  This differs 
with mES cells, which do not require the supplement of FGF or express FGF2.  Mouse 
ES cells, instead, synthesise high levels of FGF4 (Rappolee et al., 1994), although it 
does not appear to have a positive role in the propagation of mES cells (Rappolee et al., 
1994; Wilder et al., 1997).  In the murine system, paracrine FGF4 signalling is required 
for the development of the trophectoderm and the primitive endoderm in vivo (Feldman 
et al., 1995) and appears to have a role in vitro because mES cells fail to form EBs in the 
absence of FGF signal (Chen et al., 2000; Ying et al., 2003a).  FGF2 in turn, co-
regulates later stages of development, such as the patterning of mesodermal and neural 
cell lineages (Burdsal et al., 1998).  Therefore, FGF signalling pathway seems to be 
important in both species but in different ways.   
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The divergent biology between mouse and human ES cells may be reflecting a slightly 
different stage of development in the cells when they were isolated, thus perhaps 
indicating that hES cells are originated later in development.  This seems to be in line 
with hES cells requirement for FGF in culture, which is consistent with the growth 
requirements of a later epiblast stage (Camus et al., 2006).  A better understanding of the 
mechanisms in control of mouse and human ES cell self-renewal would enhance the 
knowledge in the early developmental biology of the two species, giving insight into 
conserved and divergent mechanisms.   
 
In addition to the fundamental differences in the regulation of mouse and human ES 
cells, this thesis will address more specifically the role of FGF in hES cell proliferation.  
The biology of hES cells is relatively poorly understood.  In fact the mechanisms by 
which FGF2 sustain the undifferentiated proliferation of hES cells are still unclear.  
Clarifying these mechanisms will give rise to developing improved strategies in the 
culture of hES cells, which would aid to the better understanding of the biology of hES 
cells and by association, clarifying human development and disease.   
 
The following introduction will describe the different pluripotent cells, highlighting 
mouse and human ES cells and their regulation.  FGFs, their signalling and functions 
will be also reviewed in this introduction.  The roles of FGF signalling on mouse and 
human ES cells will be studied in chapters 3 and 5 respectively.  Present problems 
associated with the development of culture systems to grow hES cells and the 
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approaches employed to tackle them will be studied in chapter 4.  The main objectives 
of this project will be outlined at the end of this chapter.     
 
1.2 Pluripotent embryonic cells 
Pluripotency is defined as the capacity to give rise to all the three embryonic cell 
lineages.  Pluripotent stem cells exist briefly during embryonic development in the inner 
cell mass (ICM) of the blastocyst of preimplantation embryos and in foetal gonads, as 
primordial germ cells (PGCs).  These transitory cells can be maintained as established 
cell lines in culture and in the last few years several cell lines of murine and of human 
origin have been characterised.  Embryonic stem (ES) cells are derived from the ICM of 
blastocysts (Martin, 1981; Evans and Kaufman, 1981; Thomson et al., 1998).  Cells 
derived from primordial germ (PGC) cells are designated embryonic germ (EG) cells 
(Martin, 1981; Evans and Kaufman, 1981; Matsui et al., 1992; Resnick et al., 1992; 
Resnick et al., 1998; Shamblott et al., 1998).  In addition to this, pluripotent lines have 
been derived from tumorigenic derivatives of germinal tissues, which are designated 
embryonic carcinoma (EC) cells (Kleinsmith and Pierce, 1964; Andrews et al., 1984).  
Recently, a new type of pluripotent cell line has been derived from the epiblast of early 
post implantation mouse and rat embryos designed epiblast stem (EpiSCs) cells (Brons 
et al., 2007; Tesar et al., 2007). 
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The derivation of these cell lines has been a gradual process, which started with the 
isolation of EC cells from mouse testicular teratocarcinomas (Kleinsmith and Pierce, 
1964).  This early report led to the first derivation of murine ES cells (Evans and 
Kaufman, 1981; Martin, 1981), followed by human EC cells (Andrews et al.,1984), 
murine EG cells (Andrews et al., 1984; Matsui et al., 1992) primate ES cells (Thomson 
et al., 1995) human ES cells (Thomson et al.,1998) and murine and rat EpiES cells 
(Brons et al., 2007; Tesar et al., 2007). 
 
Although these cell lines have similar properties such as immortality, their different 
origins are reflected in their development potential.  EC and EpiES cells have a more 
restricted potential and it is unlikely to be transmitted through the germ line of chimeric 
animals (Brons et al., 2007; Tesar et al., 2007).  EG cells normally undergo spontaneous 
differentiation but may be unable to support normal development due to epigenetic 
modifications, which have occurred during the formation of PGCs (Tada et al., 1997).  
Thus, ES cells were shown to have the greatest developmental potential by 
differentiating into the widest range of cell types reviewed in (Smith, 2001). 
 
1.2.1 Embryonic Carcinoma (EC) cells  
 
Germ cell tumours are derived from the primordial germ cells (PGCs), the embryonic 
precursors of the gametes in the adult animal (Gardner, 1978),  which also give rise to 
embryonic germ (EG) cells when cultured in the right conditions.  Germ cell tumours 
can be broadly grouped into two types: benign teratomas, which are composed of a wide 
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variety of differentiated tissue types and malignant teratocarcinomas, which contain an 
additional undifferentiated cell population.  This undifferentiated population can be 
isolated and propagated indefinitely in culture as EC cell lines (Kleinsmith and Pierce, 
1964).  Teratocarcinomas can also be induced by grafting early embryos into ectopic 
locations of immune-compromised mice (Finch and Ephrussi, 1967). 
 
EC cells retain the ability to differentiate and can form teratocarcinomas when 
transplanted back into an appropriate mouse host (Damjanov et al., 1982).  The 
developmental potential of murine EC cell lines has also been demonstrated by injecting 
them into the blastocyst.  The ECs incorporated into the developing embryo, contributed 
to a range of cell lineages, but were never transmitted through the germline (Brinster, 
1974; Rappolee et al., 1994).  This may occur because typically EC cells have an 
abnormal karyotype, which is possible to prevent progression through meiosis to 
produce mature, functional gametes (Bradley et al., 1984).  The behaviour of EC cells in 
culture is not standardised, some EC cell lines remain undifferentiated if they are 
maintained in sub-confluent cultures, but differentiate spontaneously when grown to 
confluence.  However, other EC cell lines require culture on feeder layers to prevent 
differentiation (Rosenthal et al., 1970), which suggests that feeder cells produce factors 
with a positive effect on their pluripotency.  In this case, differentiation could be induced 
by removing the EC cells from the feeder cells and then grown in suspension to form 
embryoid bodies (Martin and Evans, 1975). 
 
 12
Human EC cells have been isolated from spontaneously occurring human germ cell 
tumours (testicular teratocarcinomas) and maintained in culture (Andrews, 1988).  Like 
mEC cells, hEC cells retain the capacity to differentiate in vitro into tissues 
representative of all three germ layers (Pera et al., 1989) and express OCT4 (Yeom et 
al., 1996).  Furthermore, they share similar morphology and growth patterns, and both 
express high levels of alkaline phosphatase.  Characteristically, hEC cells do not require 
special culture conditions such as addition of extrinsic factors.  This could be due to the 
fact that hEC are always aneuploid and usually have a limited capacity for spontaneous 
differentiation.  Furthermore, and in contrast with many mouse EC lines, hEC cells need 
to grow at high density and differentiate when grown as single cells (Andrews, 2002), 
which may indicate an autocrine mechanism to maintain self-renewal.   
 
1.2.2 Embryonic Germ (EG) cells 
 
The isolation of EC cells from teratocarcinomas (Kleinsmith and Pierce, 1964) 
suggested that undifferentiated cells could be derived directly from PGCs.  Murine 
PGCs obtained before midgestation and grown on feeder cell layers in medium 
supplemented with FGF2, LIF and stem cell factor (SCF) could be induced to proliferate 
in culture (Matsui et al., 1992; Resnick et al., 1992).  These cells were termed EG cells 
and had many similarities to murine EC and ES cells such as SSEA1 expression (Matsui 
et al., 1992; Resnick et al., 1992).  EG cells retain the capacity to differentiate in vitro 
via EBs and in vivo by forming tumours in immunodeficient mice and by contributing to 
chimaeras following blastocyst injection (Matsui et al., 1992). 
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(Matsui et al., 1992; Shamblott et al., 1998) isolated human EG cells from genital ridges 
after five to nine weeks of embryonic development.  Human EG cells express similar 
antigens to human ES cells but they also express SSEA1.  SSEA1 is the marker 
associated with mouse but not with human ES cells.  Human EG cells retain the capacity 
to differentiate into the three germ layers in vitro via EB intermediates as well as 
maintaining a normal karyotype through prolonged periods of culture (Matsui et al., 
1992; Shamblott et al., 2001). 
 
1.2.3 Embryonic Stem (ES) cells  
 
Since teratocarcinomas can also be formed by grafting blastocysts at ectopic sites, it was 
thought that pluripotent cell lines might be derived directly from blastocysts rather than 
from tumours.  In the blastocyst, ICM and trophectoderm are formed at embryonic day 
3.5 in the mouse and day 5 in human.  The trophectoderm will form the trophoblast 
layers of the placenta while the ICM gives rise to the embryo proper (Rossant and Nagy, 
1995).  Pluripotent embryonic stem (ES) cells derive from the inner cell mass (ICM) of 
the pre-implanted blastocyst and retain the differentiation potential of cells in the ICM.   
Furthermore, ES cells have the capacity for unlimited self-renewal in an undifferentiated 
state when maintained under the appropriate culture conditions (Smith, 2001). 
 
In 1981, two groups, Evans and Kaufman and Martin derived for the first time murine 
ES cells and, in 1998 Thomson and colleagues reported the isolation of hES cells.  These 
 14
cells, unlike EC cells were karyotypically normal and expressed the classical markers of 
pluripotency: the transcription factors OCT4, SOX2, NANOG and REX1 and the 
enzyme alkaline phosphatase.  However, the expression of surface markers was different 
between mouse and human ES cells.  Undifferentiated human and primate ES cells 
shared many markers, and these markers are also expressed in the ICM of human 
blastocysts (Henderson et al., 2002).  This includes the expression of stage-specific 
embryonic antigen 3 (SSEA3) and SSEA4, tumour rejection antigen 1-60 (TRAl-60) and 
TRA1-81.  Interestingly, hES cells only express SSEA1 after differentiation (Andrews, 
1984; Thomson, 1998).  In contrast, differentiation of mES is typically characterised by 
the loss of SSEA1 and could be accompanied by the appearance of SSEA3 and 4 (Solter 
and Knowles, 1979).  Murine ES cell expression of surface markers is shared by cells of 
the ICM and primitive ectoderm (Henderson et al., 2002).  An illustration of the 
different expression of surface antigens in human and mouse at different stages of the 
embryonic development is shown in Table 1.1. 
 
Mouse (Evans and Kaufman, 1981; Martin, 1981) and human ES cells (Itskovitz-Eldor 
et al., 2000) can differentiate spontaneously into multiple cell types representative of all 
three embryonic germ layers.  Both cell types can form teratomas after grafting into 
mice or in vitro through differentiation in EBs under appropriate conditions.  However, 
only mouse ES or EG cells have been shown to contribute to the germ line when 
reintegrated into the normal embryonic development (Bradley et al., 1984).  In addition 
to pluripotency, another key defining characteristic of ES cells is their ability to undergo 
unlimited self-renewal in an undifferentiated state.  The appropriate conditions to 
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maintain self-renewal differ between mouse and human ES cells and this will be 
discussed in section 1.3 of this introduction. 
 
Antigens 2-8 cell Morula ICM Trophoblast 
 Mouse Human Mouse Human Mouse Human Mouse Human 
SSEA1 + - + + ++ - + + 
SSEA3 + - + - - ++ - - 
SSEA4 + - ++ - - ++ - - 
TRA1-60 - - - - - +++ - - 
TRA1-81 - - - - - ++ - - 
 
Table 1.1. Cell surface antigen expression by pre implantation stages of human and 
mouse embryos (adapted from Henderson et al., 2002).  These results reported by 
Henderson et al., 2002 were obtained by immune fluorescence staining of embryos and 
ES cells for the expression of SSEA1, SSEA3, SSEA4, TRA1-60, and TRA1-81.  All 
the antigens except SSEA1 were localized mainly on the ICM in human blastocysts 
whereas these markers (except TRA1-60 and 81) were absent from mouse embryos at 
the same stage but present at earlier cleavage stages.  Conversely, SSEA1 was expressed 



















1.2.4 Epiblast stem cells (EpiSC) 
 
Recently two independent groups, Brons et al, (2007) and Tesar et al, (2007) reported 
the isolation of a new type of rodent pluripotent embryonic stem cell.  These cells were 
termed epiblast stem cells (EpiSCs) because of their origin in the post implantation 
epiblast (5.75 d.p.c).  EpiSCs were derived and propagated using chemically defined 
media containing Activin and FGF2 (CDM/AF), the same culture conditions required 
for growing hES cells.  The use of identical culture conditions might be the cause of the 
similar morphology observed in EpiSCs and hES cells.  Both cell types produce large, 
flat colonies that grow in monolayers differing from the compact colonies of mES cells.  
In addition to requiring the same growth factors, a similar pattern of gene expression is 
observed in EpiES cells and hES cells (Brons et al., 2007 and Tesar et al., 2007), and 
this differs from the gene expression found in mES cells (Cai et al., 2006).  For example, 
gene targets of OCT4 in human ES cells and EpiSCs overlap seven times more (Tesar et 
al., 2007) than between human and mouse ES (Boyer et al., 2005).  This gene 
expression in EpiSCs (Brons et al and Tesar et al., 2007) and a dependency on FGF and 
Activin signalling is characteristic of the cells in the epiblast (Camus et al., 2006).  
Mouse ES cells, on the other hand, express genes of the pre-implantation embryo, 
suggesting that mES and EpiSCs cells are at two distinct pluripotent states.  
Interestingly, a shared gene expression and activation of equivalent signalling pathways 
may also imply a similar origin of epiblast between EpiSCs and hES cells.  Another 
shared feature between EpiSCs and hES cells is their striking capacity to differentiate 
into cells expressing markers of primitive endoderm and trophectoderm when exposed to 
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BMP4 (Brons et al., 2007; Xu et al., 2002).  Conversely, mES cells have little or no 
capacity for contribution to either primitive endoderm or trophectoderm lineages in 
chimaeric embryos (Beddington and Robertson, 1989) and only differentiate into 
trophectoderm by the mutation of the Oct4 gene (Niwa et al., 2000).  It is logical to 
think that if cells in the ICM of the blastocyst cannot differentiate into primitive 
endoderm and trophectoderm cells, then EpiSCs which represent later stages of 
development should have a more restricted differentiation potential.   
 
EpiSCs express the universal markers of pluripotency OCT4, SOX2 and NANOG, and 
the murine specific marker SSEA1.  The pluripotency of EpiSCs was confirmed in vitro 
by the wide variety of cell types formed in EB differentiation and in vivo by injecting 
cells in the testis and formation of teratomas containing several types of tissues.  
However, when EpiSCs were injected into the blastocysts they did not integrate 
successfully with the endogenous cells and subsequently, were not transmitted into the 
germ line.  Both groups agreed in hypothesising that the difficulty to form chimeras was 
a consequence of developmental asynchrony (Brons et al and Tesar et al., 2007).  This 
may indicate that although pluripotent, EpiSCs may represent an intermediate stage of 
development between mouse ES cells and committed cells.   
 
In conclusion, the finding of EpiSCs has signified a change in the views of ES cells, 
since many differences between mouse and human ES cells that were previously 
attributed to species divergence could instead be reflecting a difference in the pluripotent 
state of the cells of origin.  This links with the culture requirements and gene expression, 
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which may indicate a similar epiblast origin in hES cells and EpiSCs.   However, a 
similar pluripotent state is not consistent with EpiSCs expression of the mES cell marker 
SSEA1, which is expressed on the human morula.  Furthermore and as expected, the 
ICM marker Rex1 is not found in EpiSCs but REX1 is expressed by hES cells.  In 
addition to this, clarification is still needed of the developmental incongruence, which is 
the differentiation into trophoblast of EpiSCs and hES cells.  A summary of the reported 
differences between the profile of mES cells and EpiSCs and those of hES cells are 
shown in Table 1.2. 
 Culture media Marker expression Other 
characteristics 
 LIF/BMP4 FGF/Activin OCT4/SOX2 
NANOG 




+ - + + + - 
Rodent 
EpiSCs 
- + + - + + 
Human ES 
cells 
- + + + - + 
 
Table 1.2. Differences in culture media requirement and marker expression 
between mouse ES, EpiSCs and hES cells.  Whilst mES cells are dependent on LIF 
and BMP4, EpiSCs and hES cells are dependent on FGF and Activin to maintain self-
renewal, pluripotency and prevent differentiation.  The three cell types are pluripotent as 









1.3 Regulation of Embryonic Stem cells 
Although much of mammalian development biology is based on studies of the mouse, 
there are significant differences between early mouse and human development.    
Differences in embryonic development could also be reflected in the ES cells, for 
example, in the different pattern of surface markers expressed and in the ability to 
differentiate into trophectoderm.  Substantial differences also exist in a number of key 
signalling pathways that regulate mouse and human ES cell proliferation and 
differentiation.  The LIF/STAT3 and BMP4 are the essential signalling pathways in the 
maintenance of mES pluripotency.  Conversely, LIF and BMP4 cannot maintain hES 
cells and it is the FGF and Activin/TGFβ signalling pathways that have been related to 
hES cell self-renewal. 
 
1.3.1 Intrinsic factors in embryonic stem cell regulation  
 
OCT4, SOX2 and NANOG are master regulators of pluripotency by antagonising pro-
differentiating signals.  The traditional belief was that together, these transcription 
factors activated key genes in self-renewal and repressed inducer genes of differentiation 
(Boyer et al., 2005).  However, new evidence indicates that different genes may be the 
targets of NANOG, since ES cells deficient in NANOG express many genes involved in 
pluripotency (Chambers et al., 2007).  The findings in the report by Chambers et al, 
(2007) also question the conventional mechanisms of regulation in Oct4, Sox2 and 
Nanog.  Against the suggested reciprocal regulation supposedly occurred in mES 
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(Catena et al., 2004; Rodda et al., 2005) and hES cells (Boyer et al., 2005), it was 
demonstrated that ES cells deficient in Nanog, highly express Oct4 and Sox2 (Chambers 
et al., 2007).  Furthermore, it was shown that NANOG and OCT4 act independently 
from each other.  Their over-expression cannot activate each other or be able to reverse 





OCT4, encoded by Pou5f1 belongs to the POU (Pit-Oct-Unc) family transcriptional 
regulator.  OCT4 usually heterodimerize with the transcription factor SOX2 and both 
bind to adjacent domains when regulating gene expression.  OCT4-SOX2 sites have 
been found contiguous to each other in regulatory regions of Sox2, Rex1, Fgf4, Nanog, 
etc (Yuan et al., 1995; Nishimoto et al., 1999; Tomioka et al., 2002). 
 
OCT4 is expressed throughout oogenesis and pre-implantation development.  During the 
blastocysts stage, OCT4 becomes restricted to the ICM and later in the development it is 
expressed throughout the early epiblast, before being limited to the developing germ 
cells (Palmieri et al., 1994; Yuan et al., 1995; Nishimoto et al., 1999).  Targeting gene 
deletion has shown that Oct4 deficient embryos develop only to the blastocyst stage due 
to the inability for normal differentiation of the ICM cells.  These cells can only generate 
trophoblast cells and as a consequence are absorbed shortly after implantation (Yuan et 
al., 1995; Nichols et al., 1998).  OCT4 expression is also exclusive and essential for 
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maintaining the pluripotency in undifferentiated mouse and human EC, EG and ES cells 
(Yuan et al., 1995; Reubinoff et al., 2000).  To sustain ES cell self-renewal, OCT4 
levels need to be on a narrow range.  Mouse ES cells differentiate into trophectoderm 
when the levels of OCT4 are reduced to less than 50%. On the other hand, a less than 2-
fold increase triggers differentiation into endoderm and mesoderm, which are the 
lineages produced by LIF withdrawal (Niwa et al., 2000) or Nanog deletion (Chambers 
et al., 2003; Mitsui et al., 2003).  This might suggest that although OCT4 and NANOG 
control lineage commitment, they may use different mechanisms. Experiments using 
RNAi induced depletion of OCT4 confirmed trophoblast differentiation in both mouse 




NANOG is a homeobox transcription factor isolated by Chambers et al and Mitsui et al 
in 2003.  These groups established that NANOG was expressed in the ICM and PGC 
cells, in mouse ES, EG and EC and in human EC cell lines.  Both groups demonstrated 
that over-expression of NANOG was sufficient to maintain the self-renewal of mES 
cells whilst its deletion seemed to trigger differentiation into primitive endoderm in ES 
cells.  Recently it has been shown that other types of differentiation can also occur in 
Nanog null cells, but this differentiation is more restricted to the endoderm lineage 
(Chambers et al., 2007).  However, it has been also demonstrated that ES cells with both 
alleles of Nanog deleted could still proliferate undifferentiated and retain pluripotency 
(Chambers et al., 2007).  ES cells expressing different levels of NANOG also occur 
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naturally in ES cell cultures.  These cells are in a transient state in which they can re-
express NANOG and remain undifferentiated, but due to the loss of the buffering effect 
of NANOG against differentiating signals, they also have a major tendency to 
differentiate (Chambers et al., 2007). 
 
During mouse development the expression of NANOG in pluripotent cells is also 
dynamic.  NANOG is expressed in the morula in an opposite pattern to the expression of 
Gata6 and Cdx2 (Hyslop et al., 2005), which may indicate that Nanog maintains 
pluripotency by repressing these transcription factors associated with extraembryonic 
lineages (Hyslop et al., 2005).  NANOG expression continues in the blastocyst and it is 
down-regulated at the time of implantation (Chambers et al., 2003) and expressed again 
in the egg cylinder (Hart et al., 2004).  NANOG re-expression in the egg cylinder was 
believed to be necessary in preventing an early commitment during gastrulation 
(Chambers et al., 2007).   
 
NANOG is also expressed in the ICM and the nucleus of human ES cells and its knock-
down induces hES cell differentiation into extra-embryonic lineages (Hyslop et al., 
2005).  Hyslop et al, (2005) reported the down regulation of OCT4 and differentiation of 
hES and EC cells as a consequence of NANOG silencing by small interfering (si) RNA.  
However, its function in hES cells is not clear since NANOG was not found among the 
532 genes up-regulated in undifferentiated hES cells (Brandenberger et al., 2004). 
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1.3.2 Extrinsic factors on mouse embryonic stem cell regulation  
 
Murine ES cells can be maintained undifferentiated in culture indefinitely by the 
administration of leukaemia inhibitor factor (LIF) (Smith et al., 1988) and bone 
morphogenetic protein 4 (BMP4) (Ying et al., 2003a).  A simplified diagram of the 
regulation of mES cells is shown in Figure 1.1.  A recent publication also attributes 
heparan sulphates (HSs) a significant role in the maintenance of mES cell self-renewal 
(Sasaki et al., 2008).  Sasaki et al, (2008) reported that autocrine/paracrine Wnt/β 
catenin signalling through heparin sulphate (HS) chains is required for the regulation of 
Nanog expression.  Therefore, in addition to LIF plus BMP4 or serum HS might be part 




































Figure 1.1.  Mouse ES cells regulation.  LIFR and GP130 receptor subunits exist as 
monomers that dimerise by LIF binding and subsequent phosphorylation of receptor-
associated JAKs.  JAKs phosphorylate tyrosine residues on the cytoplasmic domain of 
GP130, which recruits STAT3 via the SH2 domain which subsequently becomes 
phosphorylated.  STAT3 becomes tyrosine phosphorylated and disengages from the 
receptor before dimerising in the cytoplasm.  STAT3 dimers translocate to the nucleus 
where they act as transcription factors. Activated JAKs also activate SHP2, leading to 
activation of RAS via GRB2 or GAB1.  Active Ras initiates a cascade of signals which 
leads to activation of ERK.  LIF acts in conjunction with BMP4 to enhance mES cell 
self-renewal.  BMP4 induces phosphorylation of the serine/threonine kinase receptors 
(BMPR1) and subsequent activation of the SMAD1/5 transcription factors.  SMAD1/5 
proteins bind to a co-transcription factor SMAD4 and together translocate into the 
nucleus where they induce the expression of the inhibitor of differentiation (Id) genes.   
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1.3.2.1 Leukaemia Inhibitor Factor (LIF) 
 
Independent culture of mES cells from primary mouse embryo fibroblast (MEF) feeder 
cells is possible since the discovery that LIF is the factor released by the MEFs that 
prevented mES cell differentiation (Smith and Hooper, 1987).  In vivo, Lif mRNA is 
expressed by the trophoblast cells whilst the pluripotent cells of the ICM express the 
specific receptors, LIFR and GP130 (Nichols et al., 1996).  LIF signalling is necessary 
for the survival of the cells in the ICM during the delay in embryo implantation or 
diapause (Nichols et al., 2001) .  This could suggest a role of LIF in promotion of the 
survival and propagation of undifferentiated ES cells rather than suppressing ES cell 
differentiation.  However, Smith et al, (1988) showed that besides the selective 
proliferation and replating advantage over differentiated cells, LIF also inhibits ES cell 
differentiation.  Therefore, LIF seems to have two major effects in mES cells: self-
renewal of the undifferentiated cells (including cell proliferation and inhibition of 
differentiation) and survival of the undifferentiated cells (Viswanathan et al., 2003).   By 
contrast hES cell self-renewal is independent from LIF (Humphrey et al., 2004).  This is 
congruent with the low expression of the receptors LIF and GP30 in hES cells, whilst 
LIFR is readily detected in mouse ES cell cultures (Brandenberger et al., 2004; Ginis et 
al., 2004).   
 
Important signal transduction molecules activated by the GP130 and LIF receptors are 
the signal transducer and activator of transcription (STAT), mitogen-activated protein 
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kinase (MAPK/ERK) and phosphoinositide-3 kinases (PI-3 kinase) (Yin and Yang, 
1994; Boulton et al., 1994; Ernst et al., 1996). 
 
1.3.2.1.1 Signal transducer and activator of transcription (STAT)  
The signalling of LIF or the related cytokines through the GP130 receptor is critical for 
mES cells self-renewal (Niwa et al., 1998).  LIF induces GP30 hetero-dimerisation with 
LIFR, triggering the activation of associated Janus kinases (JAKs) by cross-
phosphorylation (Yin and Yang, 1994; Ernst et al., 1996; Heinrich et al., 1998).  JAK 
activation leads to the phosphorylation of the cytoplasmatic tyrosines of gp130, creating 
binding sites for proteins with the binding motif Src-homology 2 (SH2) domain.  The 
principal proteins activated by the receptor are the signal transducer and activator of 
transcription (STAT) 1, 3, and 5 transcription factors.  Following activation, the STATs 
dissociate from the receptor and hetero/homo dimerise through their SH2 domain (Ihle, 
1996).  The most abundant STAT factor in murine ES cells is STAT3, which in the main 
form homodimers (Burdon et al., 1999a).  Once the dimer is formed, the STATS 
translocate to the nucleus and bind to the specific enhancer sequences of their target 
genes.  STAT3 activity is required for mES cell self-renewal (Niwa et al., 1998) 
possibly in association with the transcription factor MYC (Cartwright et al., 2005) since 
it is a key effector of the LIF/STAT3 pathway.  MYC has also been shown to be 
involved in cell immortalisation (Cartwright et al., 2005) possibly through the activation 




1.3.2.1.2 Mitogen-activated protein kinase (MAPK) pathway 
LIF stimulation of GP130 also activates the MAPK/ERK signalling pathway in mES 
cells when GP130 recruits and phosphorylates the tyrosine phosphatase SHP2.  SHP2 
phosphorylation results in the binding of growth factor receptor bound protein 2 
(GRB2).  GRB2 recruits son of sevenless homologue (SOS) and thereby activates the 
oncogene RAS.  Activation of RAS initiates a signalling cascade, which culminates in 
ERK activation.  The MAPK pathway can also be activated through GP130 by the 
GRB2 associated protein 1 (GAB1) activation of RAS.  
 
Unlike STAT3 activation, MAPK stimulation is not required for ES cell self-renewal; in 
fact it is likely to be important in ES cell differentiation. ES cells over-expressing a 
catalytically inactive SHP2 are compromised in their ability to activate MAPK and to 
differentiate (Burdon et al., 1999b).  This was demonstrated by the stable introduction of 
a mutated Gp130 receptor that was unable to engage SHP2 into D027 ES cells.  In D027 
ES cells, the endogenous activity of both copies of the Lif gene had previously been 
ablated (Dani et al., 1998).  D027 ES cells containing the mutant receptor, prolonged 
STAT3 activation and enhanced self-renewal, indicating a negative role for MAPK 
activation in ES cell self-renewal.  ES cells also showed an enhanced self-renewal and 
reduced dependency on LIF when cultured in the presence of the MAPK pathway 
inhibitor PD98059 (Burdon et al.,1999b).  This supports a role for MAPK activity in ES 




1.3.2.1.3 Phosphatidylinositol-3-OH kinase (PI3K) pathway 
Phosphatidylinositol-3-OH kinases (PI3Ks) are heterodimers composed of a regulatory 
subunit p85 constitutively bond to the p110 catalytic subunit.  The subunit p85 contains 
two SH2 and one SH3 domain, by which PI3K is connected with many active tyrosine 
kinases and with tyrosine phosphorylated docking proteins such as FRS2/IRS1 and the 
scaffold protein GRB2-associated binder protein1 (GAB1).  Stimulation SHP2 by 
GP130 leads to PI3K signalling.  Phosphorylated SHP2 can bind to Grb2 and Gab1.  
Gab1 recruits the lipid kinase PI3K to the complex formed between SHP2 and GRB2, 
which results in PI3K mediated phosphorylation of phospholipids in the membrane and 
the amplification of the signal (Takahashi-Tezuka et al., 1998). 
 
PI3Ks catalyse the phosphorylation of inositol-containing lipids, known as 
phosphatidylinositols (PtdIns).  Activated PI3K phosphorylates PtdInsP2 or PIP2 to 
generate the second messenger PtdInsP3 or PIP3.  The activity of PIP3 can be negatively 
regulated by PTEN and SHIP, two phosphoinositide specific phosphatases that convert 
PIP3 back to PIP2 (Bolland et al., 1998).  PIP3 mediates translocation to the membrane of 
a variety of signalling proteins such as the Ser/Thr kinases PKB or AKT and PDK1, 
GAB1 and PLCγ1, among many others (Bellacosa et al., 1998).  For example, 
PKB/AKT is phosphorylated by 3-phosphoinositide-dependent protein kinase-1 (PDK1) 
when translocates to the plasma membrane (Stokoe et al., 1997). 
 
PI3K has been implicated in mES cell proliferation and survival by regulating cyclin D1 
levels (Jirmanova et al., 2002).  Cyclin D1 is present at low levels in mES cells, 
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compared to differentiating cells and may not be required for G1/S transition in mES 
cells (Savatier et al., 2002).  The role of PI3K in proliferation and survival is related to 
the oncogene ES cell-expressed Ras (ERAS).   ERAS binds and activates PI3K and have 
been shown that in its absence, ES cell proliferation rates decrease considerably 
However, ERAS is not essential to maintain pluripotency in ES cells, since ERAS null 
ES cells form fertile chimaeric mice (Takahashi et al., 2003). 
 
In addition to proliferation, PI3K has a role in regulation of self-renewal of mES cells in 
the presence of LIF (Paling et al., 2004).  Inhibition of PI3K signalling was associated 
with an increase in ERK phosphorylation resulting in a reduction of mES cell self- 
renewal (Paling et al., 2004).  Upon PI3K inhibition the important balance between 
STAT3 and ERK signals in determining cell fate (Burdon et al., 2002) seems to be 
altered in favour of the pro-differentiation effects of ERK.  Nevertheless, inhibition of 
ERK reversed the effects of PI3K inhibition on self-renewal independently of STAT3 
activation (Paling et al., 2004).   
 
1.3.2.2 Bone Morphogenetic Protein 4 (BMP4) 
 
LIF is only effective in medium containing serum; however LIF in combination with the 
Bone Morphogenetic Protein 4 (BMP4) alone are sufficient to maintain mES cells in a 
pluripotent state in the absence of serum (Ying et al., 2003a).  The TGFβ superfamily of 
ligands signal through two branches: the SMAD1/5 branch, which transduces BMP and 
GDF (growth differentiation factor) ligands and the TGFβ/Activin/Nodal branch, which 
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activate SMAD2/3.  Murine ES cells only use the BMPs/Smads1/5 pathway since they 
do not express the specific receptors for TGFβ (Goumans et al., 1998).  BMP4, through 
specific serine/threonine kinase receptors (BMPR1) activates an independent pathway to 
the LIF/STAT3 for ES self-renewal.  Subsequent to the receptor phosphorylation, the 
SMAD1/5 transcription factors are activated and in turn induce the expression of the 
inhibitor of differentiation (Id) genes.  Id genes sequester the neurogenic basic/helix-
loop-helix (bHLH) transcription factors, preventing their differentiating activity in mES 
cells.  In fact, over expression of Id genes can bypass BMP signals in the presence of 
LIF and in the absence of serum (Ying et al., 2003a). 
 
1.3.3 Extrinsic factors on human embryonic stem cell regulation  
 
Traditionally, the proliferation of undifferentiated hES cells has relied on the presence of 
mouse (Thomson et al.,1998) or human (Amit et al., 2003; Richards et al., 2003) 
fibroblast feeder layers.  The feeder cells secrete factors that produce a matrix required 
to allow adherence and to maintain self-renewal and pluripotency of the hES cells 
(Thomson et al., 1998).  Alternatively, the feeder cells can be replaced with Matrigel, an 
extracellular matrix (ECM) preparation, and conditioned medium (CM) from the feeder 
cells (Xu et al., 2001).  CM provides numerous factors produced by the feeder cells to 
sustain the undifferentiated growth of hES cells.  Among those factors, FGF2 and 
several members of the TGFβ family have been implicated in hES cells self-renewal.  A 
simplified diagram of the regulation of hES cells is shown in Figure 1.2. 
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Figure 1.2.  Human ES cell regulation.  FGFR monomer dimerises by FGF binding 
resulting in receptor activation.   Activated receptors recruit signalling proteins with the 
culmination of regulation of hES cell self-renewal.  TGFβ/Activin/Nodal signalling 

















1.3.3.1 Fibroblast growth factor 2 (FGF2) 
 
FGF2 is the central point of study in this thesis, thus an overview of the functions, 
structure and signal transduction of FGFs will be discussed in the following sections.  
FGF2 is a mitogenic, angiogenic and neurothrophic factor that plays key roles in the 
development, remodelling and tumour growth in almost every organ system reviewed by 
Bikfalve et al, (1997).  In hES cells, the requirement for exogenous FGF2 signalling to 
sustain self-renewal and retain their pluripotency is currently accepted (Levenstein et al., 
2005).  Fgf2 and its receptors are highly expressed in undifferentiated hES cells 
(Brandernberger et al., 2004) suggesting the activity of autocrine, paracrine and possibly 
an intracrine FGF signalling on these cells.   In transient hES cells, on the other hand, 
FGF2 has been shown to induce development of ectodermal and mesodermal cells 
(Schuldiner et al., 2000) and to support hES cell differentiation into neural lineages 
(Carpenter et al., 2001; Reubinoff et al., 2001).  By contrast, studies in mES cells have 
indicated that autrocrine FGF signalling is preferred for neural specification (Ying et al., 
2003b).  Fgf2 is not detected in mES cells (Reubinoff et al., 2001; Wei et al., 2005) and 
neither is it required for their culture.  Fgf2 knock-out mice are viable, although with 
neuronal and cerebral cortex defects at birth (Ortega et al., 1998; Reubinoff et al., 2001).  
This indicates that although FGF2 is not essential for embryonic development, its 
specific role in neurogenesis is not compensated by other FGF family members.   
 
MAPK, PI3K and NFκβ transcripts have been found to be enriched in hES cells 
(Armstrong et al., 2006), which suggests that there may be some of the effector 
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signalling pathways of FGF in hES cell self-renewal.  In addition to these pathways, 
some reports point towards TGFβ and Wnt signalling as being responsible for 
undifferentiated hES cells (Sato et al., 2003).  However, recent reports indicate that it is 
FGF2 and TGFβ/Activin/Nodal factors, which may be involved in maintaining the self-
renewal and pluripotency of hES cells (Reubinoff et al., 2001; Amit et al., 2004; Vallier 
et al., 2005; Levenstein et al., 2005; Greber et al., 2006).  Nevertheless, the signalling 
pathways downstream of FGF2 which are responsible for hES cell self-renewal have not 
been described.  Furthermore, the possible collaboration of FGF with other signaling 
pathways needs to be clarified. 
 
1.3.3.2 Transforming growth factor β/Activin/Nodal 
 
Several members of the branch of the TGFβ/Activin/Nodal in the TGFβ family have 
been implicated in maintaining hES cells undifferentiated state (Reubinoff et al., 2001; 
Vallier et al., 2004; Beattie et al., 2005; James et al., 2005).  Conversely, BMP/GDF, 
which activates the Smad1,5,8 branch induces hES cell differentiation (Xu et al., 2002; 
Vallier et al., 2004; Pera et al., 2004; James et al., 2005).  Indeed, inhibition of BMP 
signalling promotes the undifferentiated growth of human ES cells (Pera et al., 2004; 
James et al., 2005; Xu et al., 2005a).  Like FGFRs, most of the TGFβ receptors are 
expressed in hES cells (Wei et al., 2005).  However, a difference in the reduction in 
FGFRs expression upon differentiation on hES cells, (Brandernberger et al., 2004) 
TGFβ1 and its receptors TGFR1 and TGFR2 are all expressed throughout human EB 
formation (Poon et al., 2006).  This contrasts with the low levels or absence of TGFRs 
 34
on mES cells suggesting fundamental differences regarding the importance of FGF and 
TGFβ1 signalling in early development.  
 
1.4 Fibroblast growth factors (FGFs)  
FGFs are small (from 17 to 34KDa) signalling polypeptide growth factors with functions 
of crucial importance in all the stages of development and in the physiology and 
pathology of adult tissue.   The times and the patterns of FGF expression differ in the 
distinct tissues; some FGFs are only expressed during embryonic development whereas 
others are expressed in embryonic and adult tissue (Ornitz and Itoh, 2001).  To date 22 
homologue members of the Fgf family have been identified in a variety of organisms 
from nematodes and flies to mice and humans (Zhang et al., 2006).  FGFs have in 
common a central core of 120 aminoacids and a high affinity for the transmembrane 
receptor tyrosine kinase, fibroblast growth factor receptor (FGFR) (Ornitz and Itoh, 
2001).  FGFs also interact with membrane-bound heparan sulfate proteoglycans 
(HSPGs) or their soluble fragments, such as heparin.  Binding of FGFR to these proteins 
is necessary for the stable activation of the receptors and for modulation of FGF activity.  
Although most FGFs produce their effect in target cells by signalling through FGFRs, 
some members can interact with intracellular proteins by internalisation in complex with 
the receptor.  Furthermore, internal activation can occur because some FGFs are sited in 
the cytoplasm or nucleus of the producing cells due to poor or no classical secretion 
signal motifs reviewed by Goldfarb, (2001).  The high expression of FGF2 and FGF4 in 
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human and mouse ES cells respectively, make them a focus of study in this project.  The 
functions of these FGFs in ES cells as well as in development will be more thoroughly 
discussed in chapters 3 and 5 but their general features are outlined below. 
 
1.4.1 Fibroblast growth factor 2 (FGF2; basic FGF, bFGF)  
 
FGF2 was identified based on its mitogenic activity on the Bal/c3T3 cell line 
(Gospodarowicz et al., 1975).  FGF2 is the prototypic FGF since it is the most 
extensively studied FGF and has a high (>90%) sequence homology across a wide range 
of species.  FGF2 contains four cysteine residues with intramolecular disulfide bonds, a 
large number of basic residues and two sites that can be phosphorylated by protein 
kinases A and C (Bikfalvi et al., 1998).  FGF2 is encoded by a single copy gene that is 
alternatively translated to produce one low (18KDa) and four high (22-34KDa) 
molecular mass isoforms (Abraham et al., 1986).  The 18KDa low molecular mass 
FGF2 lacks the secretion signal sequence and it is released associated with other 
molecules by an exocytotic mechanism independent of the endoplasmatic 
reticulum/Golgi pathway (Piotrowicz et al., 1999).  It has also been reported that FGF2 
is released as a result of cell damage, such as membrane disruptions and death (Conrad 
et al., 1998).  Subsequently in a paracrine or autocrine manner FGF2 binds and activates 
its specific FGFRs.  Cytosolic 18KDa and all the high molecular mass isoforms of FGF2 
containing a nuclear localisation sequence (NLS) are targeted to the nucleus (Sheng et 
al., 2004).  This form of FGF2 produces receptor independent intracrine activities, for 
 36
example activation of MAPK, by induction of the PLC/PKC signalling pathways 
(Gaubert et al., 2001). 
 
1.4.2 Fibroblast growth factor 4 (FGF4; hst-1/kFGF) 
 
FGF4 was described as a human stomach cancer transforming factor by (Taira et al., 
1987).  The role of FGF4 as oncogene has been established by finding that FGF4 is 
expressed in human teratoma cell lines and in surgically removed human testicular germ 
cell tumours including seminomas and embryonal carcinomas (Yoshida and Morii, 
1998).  In addition to this, FGF4 is found in stomach and breast cancer and in Kaposi 
sarcoma (Adnane et al., 1991).  This expression indicates that FGF4 expression in adult 
organisms seems to be associated with malignancies.  By contrast, in murine early 
development stages, FGF4 is an essential factor expressed as early as the 1 cell stage 
(Rappolee et al., 1994) and its deletion results in early embryonic death (Feldman et al., 
1995).  Crucially, FGF4 is also highly expressed in mES cells (Wei et al., 2005) under 
the regulation of OCT4 and SOX2 (Yuan et al., 1995).   This may suggest a role of 
FGF4 in mES cell self-renewal but it has been demonstrated that mES cells do not 
require FGF4 (Wilder et al., 1997).  Indeed, a recent report appoints FGF4 as inducer of 
neuroectoderm differentiation in mES cells (Kunath et al., 2007).  FGF4 unlike FGF2 
contains a secretion signal sequence indicating that FGF4 acts predominantly through 
cell surface receptors.  Contrasting with the high expression of Fgf4 in mES cells, 
mRNA expression in human ES cells appears to be approximately 30-fold lower (Ginis 
et al., 2004; Brandernberger et al., 2004).   
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1.4.3 Biological functions of FGFs 
 
FGFRs activate numerous downstream signalling proteins with a wide range of roles at 
the cellular level, such as migration, survival, death, proliferation, self-renewal, 
differentiation, adhesion, and alterations in the cell cytoeskeleton.  As a result of some of 
these functions, FGFs are essential in all the stages of development as well as having a 
role in inflammation, haematopoiesis and the repair process of the adult tissue.  All 
functions need to be tightly regulated otherwise they can contribute to disease and 
cancer (Ornitz and Itoh, 2001).    
 
1.4.3.1 FGF functions in cells 
 
FGFs have a wide range of roles in cell behaviour.  The same FGF can generate different 
responses on the same cell when they are at different stages of differentiation.  For 
example, components of the FGF/FGFR signalling pathway (including FGFR1, 2, 3 and 
4 as well as FGF2, 11 and 13) are found at significantly higher levels in undifferentiated 
hES cells than in their differentiated progeny and mES cells (Sato et al., 2003; Sperger 
et al., 2003) In addition to this, the same stimulus can produce a different response in 
different cell types.  For instance, FGFR1 stimulation in fibroblasts leads to cell 
proliferation whilst in neuronal cells it induces cell survival and differentiation.  The 
different responses are likely to be the consequence of the expression of cell type-
specific effector proteins and transcription factors in different cells (Schlessinger, 2000).  
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FGFs can also stimulate a range of cellular responses even in the same cell type.  For 
example, FGF2 induce both proliferation and differentiation in cerebelar granule 
neurons, chondrocytes, and osteoblasts (Bikfalvi et al., 1997).  A reason for the different 
responses in the same cell has been shown to be related to differences in FGF 
concentration.  Low and high concentrations of FGF2 rescue cells from apoptosis 
induced by serum starvation.  Conversely, in the same conditions, intermediate 
concentrations of FGF2 increase apoptosis (Garcia-Maya et al., 2006).  In addition to 
FGF concentration, different FGFR activation, the effector pathway used and the 
strength and duration of signalling are other factors responsible for the divergent 
responses to the same FGF (Schlessinger, 2000).  The level of FGFR activation would 
depend on its binding capacity.  This would be reflected on the rate of FGF binding to 
the cell and in turn may result in different cell response to FGF (Richardson et al., 
1999). The cell cycle phase or the level of confluency of the cell population may also be 
factors influencing the cell choice in transduction pathway (Schlessinger, 2000).  
Furthermore, different duration and strength of signal can activate diverse transduction 
pathways with, consequently, different outcomes.  For example, transient FGF 
stimulation can activate the SRC pathway leading to a migratory phenotype, whilst 
sustained stimulation appears to correlate with cell proliferation through MAP kinase 
activation (LaVallee et al., 1998).  However, the opposite can also occur and the signal 
duration and strength can generate different outcomes through the same pathway.  For 
instance, a transient stimulation of MAPK stimulates PC12 cell proliferation whilst a 
sustained and robust MAPK response results in cell differentiation of the same cells 
(Marshall, 1995). 
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1.4.3.2 FGF functions in development 
 
Fgf knock-out studies together with studies of the expression patterns of Fgfs in different 
tissues and cells demonstrate that these factors are critical during most stages of mouse 
development.  Significantly, their functions at cellular level, which include proliferation, 
differentiation, survival, apoptosis and migration, indicate a critical role in early 
development.   
 
Some FGFs have a much specialised biological role resulting in a highly specific 
phenotype whilst the loss of other FGFs can be compensated by related members of the 
FGF family, resulting in no obvious phenotypes.  For example, Fgf4 -/- and Fgf8-/- cause 
embryonic lethality, whereas Fgf2-/-, Fgf1-/- and Fgf6-/- have apparently a normal 
phenotype (Powers et al., 2000).  Furthermore, targeted disruption of the four Fgfrs 
shows a wide range of phenotypes.  Firstly, Fgfr1 knock-out causes embryonic lethality 
before or during gastrulation (E9.5-E12) as a result of defects in cell migration (Deng et 
al., 1994).  Fgfr2-/- mice die after implantation of blastocyst (E10.5) due to defects in 
endoderm differentiation from the ICM (Arman et al., 1998).  Furthermore, disruption of 
the Fgfr3 gene results in bone overgrowth whereas no evident pheonotype was observed 
in Fgfr4-/- mice (Eswarakumar et al., 2005) suggesting that Fgfr3 and 4 operate at later 
stages of embryonic development.  
  
FGF4 is required from the earliest stages of development possibly by regulating cell 
division (Chai et al., 1998).  FGF4 and its specific receptor FGFR2 are expressed in the 
 40
blastocyst: Fgf4 in the ICM and Fgfr2 in the trophectoderm (Rappolee et al., 1994; 
Haffner-Krausz et al., 1999).  After implantation, Fgf4 is expressed throughout the 
epiblast (Niswander and Martin, 1992) whilst Fgfr2 is restricted to the extraembryonic 
ectoderm (Orr-Urtreger et al., 1991).  This pattern of expression is consistent with the 
role of paracrine FGF4 signal in the proliferation of trophectoderm (Nichols et al.,1998) 
and extraembryonic endoderm (ExEn) (Wilder et al., 1997).  This is shown by the 
absence of extraembryonic endoderm in Fgf4 and Fgfr2 mutant embryos and null ES 
cells (Wilder et al., 1997).  Consequently, the null embryos do not survive after 
implantation and null blastocysts do not survive in culture (Feldman et al., 1995; Arman 
et al., 1998).  The effect of dominant negative FGFR (dnFGFR) was the blockage of 
embryo division before implantation (Chai et al., 1998), rather than the generation of the 
Fgf4 null embryo after implantation (Feldman et al., 1995).  The phenotypes of dnFGFR 
embryos come into view earlier than those of Fgf4 null mutant (Chai et al., 1998), 
possibly due to maternal FGF4 (Rappolee et al., 1994) or other FGFs.  
 
FGF2 is also involved in early mouse development, and Fgf2 together with its specific 
receptor Fgfr1 (Ornitz et al., 1996) are expressed in mouse blastocyst (Campbell et al., 
1992).  Fgf2 is expressed in the primitive ectoderm and is detected in pregnant mouse 
uterus (Jirmanova et al., 1999).  FGF2 signalling has a role in regulating the patterning 
of mesodermal and neural cell lineages (Burdsal et al., 1998).  This has been confirmed 
by the failure of differentiation into visceral endoderm and primitive ectoderm found in 
EBs derived from ES cells with a targeted disruption of Fgfr1 (Esner et al., 2002).  A 
more extreme outcome was observed by the effects of a dnFGFR in ES cells in which  
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FGF repression of signalling completely inhibited the differentiation of EBs (Chen et al., 
2000).   
 
In humans, developmental disorders normally occur when a copy of the Fgf gene is lost 
or by altered activity of the FGFR rather than null mutations, which are rare.  
Developmental defects due to mutations in FGFR genes involve achondroplasia or short 
limb dwarfism, craniosynostosis or premature fusion of the skull bone, Apert Syndrome 
or fusion of digits and many other types and degrees of malformations (Burke et al., 
1998). 
 
1.4.3.3 FGF functions in adult tissue 
 
FGFs have essential roles in the control of the nervous system, in hematopoiesis, in 
angiogenesis and wound healing.  In wound repair FGFs play a role in inflammation by 
inducing the migration of inflammatory cells.  FGFs also have significant roles in repair 
and regeneration due to their proliferative effects on other cells reviewed by Powers et 
al, (2000).   
 
1.4.3.4 FGF functions in cancer 
 
FGFs and their receptors can contribute to cancer when their functional regulation is 
impaired.  Neoplastic transformations, especially haematological malignancies, are often 
related to abnormal activation of FGFRs.  For example, in multiple myeloma (MM), a 
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translocation results in the constitutive activation of FGFR3 causing MM cell 
proliferation and survival (Chesi et al., 2002).  Other types of cancer are characterised 
by the over-expression of FGFRs, such as breast cancer in which FGFR1 is over-
expressed.  In pancreatic adenocarcinoma, an abnormal expression of FGFR1 and 
FGFR4 is also found, in thyroid carcinoma there is an over expression of FGFR3, etc.  
Over-expression of secreted FGFs is another mechanism by which FGFs can promote 
cancer progression.  This is due to the mitogenic, angiogenic and migratory effects of 
FGFs on tumour and endothelial cells, which result in tumour metastasis (Powers et al., 
2000). 
 
An example that links cancer, stem cells and FGFs is the non-seminomatous testicular 
cancer, which has been associated with FGF4 and 2.  For example, the Fgf2 gene is 
highly expressed in human testicular carcinomas.  FGF produces tumour proliferation or 
migration at low and high concentrations respectively (Granerus et al., 1993).  FGF4 is 
also over-expressed in different human types of germ cell tumours and in murine EC 
cells.  FGF4 and FGFR1 are associated with the most aggressive types of testicular germ 
cell tumours (Suzuki et al., 2001).  Moreover, FGF2 and FGF4 are expressed in the 
undifferentiated human EC cells and both genes are down regulated during their 




1.5 Fibroblast growth factor receptors (FGFRs) 
1.5.1 Structure and isoforms of FGFRs  
 
Like all receptor tyrosine kinases, FGFRs are composed of an extracellular ligand 
binding domain, a transmembrane domain and a cytoplasmic domain containing the 
catalytic protein tyrosine kinase core as well as additional regulatory sequences 
(Schlessinger, 2000).  There are four mammalian Fgfr genes (Fgfr1-4), which by 
alternative mRNA splicing, produce a variety of isoforms (Plotnikov et al., 1999).  The 
four receptor types are present in hES, principally FGFR1, which is the main target of 
exogenous FGF2 and whose expression decreases as the ES cells differentiate 
(Brandernberger et al., 2004).  By contrast, undifferentiated mES cells weakly express 
FGFRs 1, 2 and 4 and their expression increases upon differentiation (Esner et al., 
2002). 
 
The different Fgfr splicing, results in insoluble secreted FGFRs as well as variants with 
missing fragments.  In the full length FGFR, the extracellular ligand binding domain is 
composed of three immunoglobulin-like domains that are designated D1-D3.  They are 
linked by short segments; a stretch of acidic residues in the linker connection D1 and 
D2, designated the “acid box” and a positively charged region in D2 that serves as a 
binding site for heparin (Schlessinger et al., 2000) (Figure 1.3).  Alternative splicing of 
the D3 domain confers binding specificity to the receptor (Johnson et al., 1991).  In 
other splice variants the receptors are either missing the first D1 domain or missing both 
D1 and the acid box region (Burke et al., 1998).  This does not affect FGFR function 
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because neither D1 nor the acid box are required for FGF binding to the FGFR.  In fact, 
their deletion enhances binding of the receptor to FGF and heparin (Wang et al., 1995).  
D1 and the acid box have an auto-inhibitory function by competing with FGF and 
heparin respectively (Plotnikov et al., 1999).  This occurs when FGFRs are in 
equilibrium and display a close configuration, which opens when they are ready to 
dimerise.  FGF and heparin will bind to the open configuration and will shift the 
equilibrium towards the dimeric form of FGFR (Olsen et al., 2004). 
 
The cytoplasmic catalytic domain contains a protein tyrosine kinase (PTK) core and 
additional regulatory sequences that are subjected to autophosphorylation and 
phosphorylation by heterologous protein kinases (Hunter, 1998).  Crystal structures of 
the PTK domain of FGFR in an inactive or low activity state shows a kinase residue 
interfering with the substrate binding site in the activation loop.   In order to maintain the 
catalytic domain in an active state, two tyrosine residues in the activation loop must be 
autophosphorylated (Mohammadi et al., 1996) (Figure 1.3). 
 
1.5.2 FGFR dimerisation and activation  
 
The key event in transmembrane signalling is the ligand-induced dimerisation of FGFR 
monomers in the cell membrane.  Dimerisation triggers the activation of the receptors 
and consequently, activation of downstream signalling proteins (Ullrich and 
Schlessinger, 1990).  FGFRs can form heterodimers and thus exhibit heterologous 
transphosphorylation (Bellot et al., 1991).  For this reason over-expression of any type 
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of receptor with a non-functional tyrosine kinase domain inhibits FGF signalling via all 
FGFRs (Chen et al., 2000).  Crystal structures of activated receptors have shown FGFs 
interacting with D2, D3 and the linker connecting between these two domains in the 
FGFR.  The FGFRs/FGF/HS complex is stabilised by interactions between FGF and D2 
domain in the second receptor, receptor:receptor interactions and by binding of heparin 
to the D2 domains of the two FGFRs in the dimmer and the bound FGF molecules 
(Plotnikov et al., 2000).  Receptor dimerisation produces an increase in the 
concentration of protein tyrosine kinases (PTK), which leads to the phosphorylation of 
specific tyrosine residues on their own and each others cytoplasmic region (Lemmon 
and Schlessinger, 1994).  The activation of the tyrosines induces a conformational 
change in the activation loop of the catalytic PTK domain, which adopts an open 
configuration permitting access to ATP and substrates.  This enables the phosphotransfer 
from ATP to tyrosines on the receptor and on cellular proteins involved in signal 
transmission (Hubbard et al., 1998) (See Figure 1.3).   
 
In addition to the autophosphorylation sites within the catalytic domain, there are other 
autophosphorylation sites in the noncatalytic regions of the cytoplasmic domain.  These 
sites are involved in the recruitment of proteins by creating docking sites for molecules 
containing Src-homology 2 (SH2) or phosphotyrosine binding (PTB) domains (Pawson 
and Schlessinger, 1993).  Many of the recruited molecules are signalling proteins 
containing intrinsic enzymatic activities, in addition to protein modules, which are able 
to interact with other proteins, with phospholipids or with nucleic acids (Schlessinger, 






























Figure 1.3. FGFR activation.  Monomers of FGFR in equilibrium display a close 
configuration with D1 and the acid box occupying the binding sites of FGF and heparin 
in the receptor (Olsen et al., 2004).  In the cytoplasmatic domain during the equilibrium 
state of FGFR, the inactive catalytic A-loop, adopts a conformation (red line) that 
interferes with the protein substrate and ATP binding.  FGFR monomer dimerises by 
ligand-heparin (FGF-HS) binding resulting in the phosphotyrosine autoactivation of the 
receptor (Plotnikov et al., 1999).  By ligand binding of the extracellular domain, the 
local concentration of kinases increases leading to the transphosphorylation of the kinase 
residues of the A-loop.  This produces a change in conformation of the loop, allowing 
the binding of proteins and their consequent activation.  Autophosphorylation of 
additional tyrosines of the receptor serves as binding sites for downstream signalling 
proteins (Schlessinger, 2000).  
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1.5.2.1 The role of FGF-heparin interaction  
 
Heparin, heparan sulphate (HS) or heparan sulphate proteoglycans (HSPGs) are 
heterogeneously sulphated linear polymers, which contain repeating disaccharide 
subunits. The saccharide sequence and sulfatation pattern are variable, providing high 
specificity in binding to the ligands (Ornitz, 2000).  The principal function of these 
sugars in FGFR activation is the stabilisation and enhancement of the half-life of 
FGF/FGFR dimmers (Plotnikov et al., 1999).  In addition to this, HSs have an earlier 
role protecting FGF from denaturation and proteolysis (Gospodarowicz and Cheng, 
1986) by binding free FGFs.  This would also induce FGF oligomerisation and 
subsequent FGF/HS binding to FGFRs (Ornitz et al., 1992).  Furthermore, FGF binding 
by HSs facilitates activation of the receptors by increasing FGF concentration on cell 











1.6 Signal transduction from FGFRs 
Signalling pathways downstream of FGFRs form a complex network with multiple 
positive and negative feedback mechanisms.  The principal pathways activated by FGF 
are going to be reviewed in this section and a schematic representation is shown in 
Figure 1.4.  The pathways are going to be divided into those activated by the docking 
protein FRS2 and those directly recruited and activated by FGFRs.  Docking and 
signalling proteins bind specific phosphotyrosine residues on the activated receptor by 
their Src-homology 2 (SH2) or phosphotyrosine binding (PTB) domains (Pawson and 
Schlessingert, 1993; Pawson et al., 1993).  The role of docking proteins such as FRS2, 
GRB2, CRK and SHC is recruiting signalling proteins to the FGFRs and the membrane 
when they become tyrosine phosphorylated in response to FGF stimulation (Pawson, 
1995).  The most important docking protein in FGFR signalling is FGF receptor 
substrate2 (FRS2) and in particular FRS2α (Hadari et al., 2001).  Conversely, signalling 
proteins such as the tyrosine kinase activity containing SRC or tyrosine phsosphatase 


































Figure 1.4.  Principal signalling pathways activated by FGFR.  FRS2α activates both 
the RAS/MAPkinase and PI3Kinase pathways.  In addition to this, the SRC, CRK and 












1.6.1 Role of the docking protein FRS2α  
 
FRS2 (α and β) are part of the family of docking or adaptor proteins, which also 
includes IRS1,2,3 and 4 and GAB1 and 2.  The function of docking proteins is to recruit 
signalling proteins to the receptor when they become activated (Schlessinger, 2000).   
For this purpose docking proteins contain multiple tyrosine phosphorylation sites for the 
SH2 domains of signalling proteins and a phosphotyrosine binding (PTB) domain to 
connect with specific RTKs (Kouhara et al., 1997).  In addition to this, docking proteins 
are linked to the cell membrane by transmembrane domains such as is myristyl achor in 
FRS2 (Kouhara et al., 1997) and the pleckstrin homology domain (PH) in GAB1 
(Rocchi et al., 1998). 
 
The critical role of FRS2α in early embryo development was established by the lethality 
(E7-7.5) caused by the targeted disruption of Frs2α (Hadari et al., 2001).  Since FRS2β 
is expressed exclusively in the embryo beyond E10-10.5 time point in development, this 
member of the family is unable to compensate for the loss of FRS2α earlier than E10 
(Gotoh et al., 2004).  Interestingly, FRS2 is expressed in hES cells but could not be 
detected in mES (Wei et al., 2005).  This suggests that human and mouse ES cells may 
use different signalling pathways downstream of FGFR and this might account for the 
different roles of FGF in these two cell types.  
 
Tyrosine phosphorylated FRS2α forms a complex with the adaptor protein GRB2, which 
in turn binds to SOS, linking FGFR with MAPK signalling pathway (Kouhara et al., 
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1997).   Furthermore, because GRB2 binds constitutively to GAB1, this protein can be 
phosphorylated by the GRB2/FRS2α complex.  GAB1 phosphorylation is followed by 
recruitment of SH2 domain containing signalling proteins including PI3K (Hadari et al., 
2001).  Experiments with embryonic fibroblasts from Frs2α -/- mice have confirmed the 
critical role of FRS2α in FGF induced MAP and PI3 kinase activation, with the 
consequences of cell motility and proliferation (Hadary et al., 2001).   
 
1.6.1.1 RAS/MAP kinase pathway 
 
Hadari et al, (2001) demonstrated that FRS2α is required for MAPK sustained 
activation, whereas in the absence of FRS2α, only a transient activation of MAP kinase 
was achieved, even at high concentrations of FGF.  Furthermore, a sustained activation 
of MAPK was associated with cell proliferation even at low concentrations of FGF.  
Therefore, the duration and strength of MAP kinase activation determined the biological 
response in ES cells (Hadari et al., 2001).  This indicated that FGF induced stimulation 
of MAPK is mediated by FRS2α-dependent and FRS2α-independent mechanisms. 
 
FGFR activation of MAPK is always mediated through the phosphorylation of the 
oncogene RAS (Kouhara et al., 1997; Schlessinger, 2000)  RAS is activated by SOS in 
complex with the adaptor protein GRB2.  GRB2/SOS complex are activated by FGFR 
through the SH3 domain in GRB2, in association with the protein SHC linked to the 
FGFR (Klint et al., 1995) or in association with FRS2 (Kouhara et al., 1997).  Once it is 
phosphorylated, RAS activates several effector proteins such as the serine/threonine 
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kinase RAF.  RAF activation triggers a cascade of transphosphorylation involving the 
mitogen-activated protein kinase-kinase (MAPKK, MEK) and ending in the activation 
of the extracellular signal regulated protein kinase (ERK) (Kosako et al., 1993).  
Activated ERK can activate diverse transcription factors by translocating to the nucleus.   
In addition to this, ERK can phosphorylate various cytoplasmatic and membrane linked 
substrates (Karin and Hunter, 1995). 
 
FGF activation of MAPK pathway stimulates many intracellular processes in ES and 
somatic cells, predominantly MAPK controls metabolic processes, cell cycle, cell 
migration and cell shape (Schlessinger, 2000)  as well as proliferation and differentiation 
(Marshall, 1995; Armstrong et al., 2006).  In order to regulate the wide range of 
functions of MAPK, positive and negative feedback loops operate in this pathway.  Spry 
and Sef are target genes of FGF and both are negative regulators of MAPK.  Sprouty 
(Spry) proteins antagonise the MAP kinase pathway by interfering at GRB2 or RAF 
levels (Yusoff et al., 2002; Sasaki et al., 2003).  On the other hand, SEF acts at receptor 
level, since ectopic SEF expression blocks the phosporlation of FRS2 (Kovalenko et al., 
2003). 
 
1.6.1.2 Phosphoinositide 3- Kinase (PI3K) /AKT pathway 
 
Downstream of the FGFR, PI3K is indirectly phosphorylated by activated docking 
proteins FRS2α, SHC or SHP2.  FRS2α and GAB1 combine via GRB2 resulting in the 
 53
tyrosine phosphorylation of GAB1 which in turn activates the PI3K/AKT pathway (Ong 
et al., 2001). 
 
AKT or protein kinase B (PKB) functions as an anti-apoptotic enzyme by inhibiting 
different pro-death proteins such as caspase-9, BAD and FAS ligand.  In addition to this, 
AKT has a positive role in proliferation by influencing the balance of the cell cycle by 
the inhibition of cyclin D1 kinase glycogen synthase kinase-3beta (GSK3β).  This 
prevents cyclin D1 degradation, resulting in a more rapid G1/S transition.  AKT can also 
negatively regulate the expression of cyclin inhibitors with similar results.  
Dysregulation of any of these functions is the cause of many human cancers (Vivanco 
and Sawyers, 2002).   
 
Components of the PI3K pathways have been shown to be enriched in hES cells, 
indicating a connection of this pathway with proliferation and maintenance of 
pluripotency in hES cells (Armstrong et al., 2006) and monkey cells (Watanabe et al., 
2006).  This was also confirmed by the down regulation of AKT and PDK1 
phosphorylated in the differentiation of hES cell to EBs (Armstrong et al., 2006).  
Armstrong et al., (2006) proposed that MAPK and NFκβ were down stream of PI3K, 
collaborating in hES cells self-renewal.  In contrast with hES cells, FGF activation of 
PI3K/AKT pathway is required for early epithelial differentiation of mES cells (Chen et 
al., 2000).  Conversely, activation of PI3K by gp130, in the presence of LIF is required 
for mES cell self-renewal (Paling et al., 2004). 
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1.6.2 Direct activation of SRC, PLCγ, and CRK 
 
Primary embryonic cells lacking the FRS2 binding site on the FGFR1 are still able to 
activate MAPK in response to FGF, indicating the presence of other effectors for 
FGFR1 signal (Hoch and Soriano, 2006). 
 
1.6.2.1 SRC pathway 
 
The SRC family of non-receptor tyrosine kinases are proteins broadly expressed which 
includes SRC, FYN and YES.  SRC proteins contain a myristyl anchor to the membrane, 
followed by a specific sequence that differs between SRC family members, SH3 and 
SH2 domains and a catalytic protein tyrosine kinase (PTK) domain (Thomas and 
Brugge, 1997).  SRC kinases are activated by growth factor receptor stimulation of cell 
surface receptors and by integrins (Schlessinger, 2000).  Once activated, Src initiates a 
signal transduction cascade involving the adaptor protein SHC, which culminates in the 
transcriptional activation of the transcription factor MYC (Courtneidge, 2002).  It has 
been shown that activation of SRC kinases by FGFs is involved in migration and 
proliferation of fibroblasts (Kilkenny et al., 2003).  In addition to this, SRC has been 
connected to FGF regulated adhesion, survival and the production of autocrine growth 
factors (Courtneidge, 2002).  Interestingly, it has been reported that this family of 
kinases and in particular cYES, could be a common pathway for human and mouse ES 




1.6.2.2 Phosphoinositide-specific phospholipase C gamma (PLCγ) pathway 
 
Phosphoinositide-specific phospholipase C gamma (PLCγ) is a phosphoprotein found 
associated through the SH2 domain to a specific phosphotyrosine (766) of the FGFR 
(Mohammadi et al., 1991).  Once activated, PLCγ is recruited to the cell membrane by 
the binding of its Pleckstrin homology (PH) domain to the phosphoinositide 4,5 
biphophate (PtdIns4, 5) (PIP2), which is a product of PI-3 kinase activation.   Hydrolysis 
of PIP2 by PLCγ generates inositol triphosphate (IP3) and diacylglycerol (DAG).  IP3 
binds to specific intracellular receptors that result in a calcium release from intracellular 
stores.  Calcium then binds to calmodulin, which in turn activates a family of 
calcium/calmodulin-dependent kinases.  Moreover, both, DAG and calcium activate 
protein kinase C (PKC), stimulating a variety of intracellular responses.  Activation of 
PLCγ could be connected to cytoskeletal alteration, although it seems that it is not 
involved in FGF-induced proliferation, differentiation or cell mortality (Schlessinger, 
2000). 
 
1.6.2.3 CRK-mediated signalling 
 
CRK is an SH2/SH3 containing adaptor protein able to form stable complexes with 
FGFR1 by tyrosine phosphorylation (463).  CRK is critical for propagating FGF2 
induced endothelial cell proliferation possibly by CRK activation of MAP kinase 
(Larsson et al., 1999).  However, this could be a cell specific effect as tyrosine 463 has 
not an effect in mitogenesis of fibroblasts (Mohammadi et al., 1996). 
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1.7 Project objectives 
The aim of this thesis was to determine and compare the role of FGF signalling in the 
regulation of human and mouse ES cells. The specific objectives were: 
1. To establish FGF activation of mouse ES cells 
2. To determine the effect of FGF signalling on mES cell self-renewal 
3. To develop a serum and feeder free culture system in which to study the effects 
of specific factors  
4. To characterise the effect of FGF2 on hES cell self-renewal and proliferation 
5. To clarify the role of the principal signalling pathways downstream of FGFR, on 
hES cell self-renewal 























































2.1 Cell Culture  
2.1.1 General Materials 
 
All cells were maintained under sterile conditions in a humidified incubator in a 5% CO2 
atmosphere at 37oC.  Centrifugation of the tubes was performed in a BIOFUGE primo 
R, Heraeus.  Plates were from Costar Corning, centrifuge tubes from Fisher, filter units 
from Millipore, Pipettes from Merck, aspirating pipettes from Becton Dickinson, filter 
cap flasks (human) from Nunc and flasks for mouse ES and fibroblast culture from 
Corning.  All the cells were viewed and the photos taken at x10 and x4 magnification. 
 
2.1.2 Culture of Murine Embryonic Stem (mES) Cells 
 
2.1.2.1 Solutions and Media 
 
Phosphate Buffered Saline PBS (Oxoid/Unipath) 
0.16M NaCl, 0.003M KCl, 0.008M disodium hydrogen orthophosphate (Na2HPO4), 
0.001M potassium dihydrogen orthophosphate (KH2PO4)).  Supplied in tablet form, it 
was reconstituted in distilled water (dH2O) and autoclaved prior use. 
 
L-Glutamine solution (GibcoBRL/Invitrogen; 200mM) 
2mM.   Aliquoted and stored at -20oC 
 
Non essential aminoacids (NEAA; GibcoBRL/Invitrogen; 10mM) 
0.1mM.   Aliquoted and stored at 4oC 
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TVP (Trypsin Verene Phosphate) 
1 ml Trypsin (2.5%) (Invitrogen), 0.0037g Na2EDTA (Sigma), 1ml Chicken serum 
(Invitrogen) made up to 10 ml with PBS (Dulbecco).  Filtered and stored at -20oC. 
 
Murine ES cell medium 
Components Concentration Supplier 
Glasgow’s Minimum Essential 
Medium (GMEM) 95% Sigma 
Foetal Calf Serum  (FCS) 5% Globepharm 
L-glutamine 2mM Invitrogen (Gibco) 
Sodium piruvate 1mM Invitrogen (Gibco) 
Non essential aminoacids 0.1mM Invitrogen (Gibco) 
β-mercaptoethanol 0.1mM Invitrogen (Gibco) 
Leukaemia Inhibitory Factor (LIF) 100U/ml ESGRO; Chemicon 
 
To the Glasgow’s Minimum Essential Medium (GMEM; Sigma) was added the 
components specified above by filtering then with a 50ml syringe through a sterile 
Minisart 0.20µM filter unit (Sartorius).  The final media was stored at 4oC for a 
maximum period of 4 weeks since L-glutamine is converted to glutamic acid after 4 





Cryopresevation medium  
Cryopreservation medium was prepared by filtering through a syringe, 60% mES cell 
medium, 20% FCS, 20% dimethyl sulfoxide (DMSO). 
 
2.1.2.2 Cell lines 
 
IOUD2 C2 cells (Dani et al.,1998) derived from E14TG2a, (Hooper et al., 1987) carried 
an Oct4 βgeo stem cell reporter.  Y118F (Burdon et al.,1999b) cell line was a subclass 
of the cell line D027, which have both copies of the Lif gene inactivated by homologous 
recombination and additionally carry an IREs-βgeo reporter gene inserted within one 
allele of the Oct4 gene (Dani et al.,1998).  The HPRT deficient cell line, HM1 was 
provided by J.McWhir (Roslin Institute, Scotland).  All the cell lines had been derived 
from strain 129 mouse blastocysts.  The passage number of IOUD2, Y118F and HM1 
cells ranged from 16 to 40. 
 
2.1.2.3 Murine ES cell maintenance 
  
All plastic ware was coated with gelatine (Sigma) at least 5 minutes before use.   Culture 
medium was replaced daily and cells were passaged when they reached 80-90% 
confluency, usually every 2 days.  The vented caps were left loose to ensure good 
circulation of CO2 in the flask. 
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2.1.2.4 Passage of mES Cells 
 
A medium change was carried out 1-2 hours prior to passaging to prime the cells for the 
procedure.  The cells were washed with sterile PBS, before adding the TVP solution 
(2ml to a 25cm2 flask).  The flask was placed in an incubator 37oC for 2 minutes for the 
trypsin to break intercellular protein bonds between the cells.  To loosen cells and break 
the cell aggregates to a single cell suspension, the flask was tapped.  The TVP was 
inactivated by the addition of 5ml of ES cell medium to the flask.  The cells were 
collected from the flask to a 15ml tube and centrifuged at 166g (1000rpm) for 5 minutes.  
The medium with the TVP was removed from the pellet, followed by the re-suspension 
and mixed by pipetting of the cells in fresh medium.  
 
2.1.2.5 Count of mES Cells 
 
When cell numbers needed to be calculated, a haemocytometer (Assisten) was used.  
Cells were processed as above and mixed well in 10ml of medium.  10µl of the cell 
suspension were dropped under either side of the haemocytometer coverslip.  2 of the 
square grids, consisting of 25 squares and whose area is 1cm3 each were counted and the 
mean taken of the 2 counts.  This count multiplied by 104 represented the number of 





2.1.2.6 Freeze of mES Cells 
 
To freeze flasks of cells in vials, a medium change was carried out on the flask 1-2 hours 
prior to freezing to induce growth in the cells.  The cells were trypsinised in the 
conventional manner and centrifuged to form a pellet.  The cells were re-suspended in 
50% mES cell medium and 50% freezing mix and placed in pre-chilled cryovials.  From 
a 25cm2 flask, 4 cryovials were obtained (1ml per tube).  The vials were placed at -80oC 
overnight and then transferred to -150oC for long-term storage.   
 
2.1.2.7 Thaw of mES Cells 
 
ES cells kept frozen require rapid thawing as they are sensitive once thawed to the 
cryopreservant DMSO, present in the freezing mix.  A vial was removed from a -150oC 
freezer and rapidly immersed at 37oC water.  Once thawed the content of the vial was 
mixed with medium in a 15ml tube and centrifuged at 166g (1000rpm) for 5 minutes.   
The medium was aspirated off the tube and 5ml of fresh medium added in order to re-








2.1.3 Culture of Human ES cells 
 
2.1.3.1 Solutions and Media 
 
PBS/EDTA EDTA 0.5mM EDTA (Ethylenediamine-N,N,N',N'-tetraacetic acid) in 
Ca2+/Mg+ free phosphate-buffered saline (PBS)  
 
Collagenase IV solution (GibcoBRL/Invitrogen; 200units/ml=1mg/ml).   
This dissociation solution was prepared by dissolving 20,000 units of collagenase IV in 
100ml Knockout TM DMEM. All the components were added to a 250 ml filter unit 
(0.22µM, Corning, cellulose acetate, low protein-binding) and filtered.  This was 
aliquoted and stored at -20oC until used.  
 
Growth factor-reduced Matrigel ® (Becton Dickinson)   
Matrigel was required to be thawed at 4oC for at least 2 hours to avoid polymerisation, 
and then diluted 1:2 in cold KO-DMEM .  Whilst keeping the mixture on ice it was 
mixed and aliquoted into pre-chilled tubes for storage at -20oC. 
 
Human basic fibroblast growth factor, recombinant (FGF2) (GibcoBRL/Invitrogen; 
10µg/ml)  
10 µg of FGF2 were dissolved in 1ml PBS with 0.2% BSA (Fraction V, Sigma).  The 
solution was filtered using a 0.22µM, Corning, cellulose acetate, low protein-binding 




Components Concentration Supplier 
Dulbecco’s modified 
Eagle’s medium (DMEM) 90% Invitrogen (Gibco) 
Foetal Calf Serum  (FCS) 10% Globepharm 
L-glutamine 2mM Invitrogen (Gibco) 
Non essential aminoacids 0.1mM Invitrogen (Gibco) 
 
MEF medium was prepared by filtering in a 500 ml filter unit (0.22 μm, Corning, 
cellulose acetate, low protein binding) the components above described.  The medium 
was then stored at 4º C for up to one month. 
 
Human ES medium 
Components Concentration Supplier 
Knockout TM Dulbecco’s modified Eagle’s 
medium (KO-DMEM) 80% Invitrogen (Gibco) 
Knockout TM Serum Replacement (KO-SR) 20% Invitrogen (Gibco) 
β-mercaptoethanol  0.1mM Invitrogen (Gibco) 
L-glutamine 2mM Invitrogen (Gibco) 
Non essential aminoacids 0.1mM Invitrogen (Gibco) 
 
Human ES cells was prepared by filtering in a 500 ml filter unit (0.22 μm, Corning, 




Conditioned Medium  
Conditioned medium (CM) was collected from the feeder flasks the day after human ES 
medium, supplemented with 4ng/ml FGF2 was added to flasks of MEFs.  For an 
illustration see Figure 2.1.  Collected CM was either stored at –20º C or filtered and 
supplemented with 8 ng/ml of FGF2 to be used for daily maintenance of human ES 




Figure 2.1 Production of Conditioned medium by mouse embryonic fibroblasts 








After 24h incubation with 
feeders, media was transferred 






Serum free Medium 
Components DMEM/F12-N2 medium Concentration Supplier 
DMEM/F12 100% Invitrogen (Gibco) 
Insulin 25μg/ml Sigma 
Transferrin  100µg/ml Sigma 
Progesterone 6ng/ml Sigma 
Putrescine 16µg/ml Sigma 
Sodium Selenite 30nM Sigma 
Bovine Serum Albumin (BSA) 50µg/ml Invitrogen (Gibco) 
 
Components Neurobasal/B27 medium Concentration Supplier 
NeurobasalTMMedium 98% Invitrogen (Gibco) 
B27 2% Invitrogen (Gibco) 
L-Glutamine 2mM Invitrogen (Gibco) 
 
The DMEM/F12-N2 medium was 50:50 mixed with Neurobasal/B27 medium by 
filtration producing the serum free N2B27 medium. 
 
Cryopresevation medium  
Human cryopreservation medium was prepared by filtering in a 500 ml filter unit (0.22 
μm, Corning, cellulose acetate, low protein binding), 3 parts of KO-Serum replacement, 
1 part of DMSO and 1 part of medium (CM or N2B27). 
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Differentiation medium 
Human differentiation medium was prepared by filtering in a 500 ml filter unit (0.22 
μm, Corning, cellulose acetate, low protein binding) 400ml KO-DMEM and 20% FCS. 
 
2.1.3.2 Cell lines 
 
H1 and H9 cell lines were obtained from Geron (San Francisco, USA).  T5 (Gerrard et 
al., 2006) was an OCT4-EGFP transgenic cell line whereby a plasmid containing a 
selectable marker and the EGFP reporter under control of the OCT4 promoter was 
introduced into H1 cell line to generate clonal cells lines and was obtained from Dr Wei 
Cui (Roslin Institute, Scotland).  The passage number of H1 and T5 cells used in this 
thesis ranged between 41 and 65.  Mouse Embryonic fibroblasts (MEFs) were generated 
in the lab from 13 days post coitum mouse embryos following a protocol from Geron. 
 
2.1.3.3 Isolation of primary MEFs  
 
Pregnant female mice were killed on the 13-14 day of pregnancy.  The abdomens were 
swabbed with 70% ethanol and the abdominal cavities were dissected to expose the 
uterine horns.  Uterine horns were then placed into a 10cm bacteriological Petri dish 
containing 10ml PBS supplemented with 0.25ml penicillin (5000 U/ml) / streptomycin 
(5000 μg/ml; Gibco-BRL); (PBS+ P/S).  The embryos were released into the saline 
while placenta, heads, membrane and soft tissues removed from the embryos and these 
passed to a fresh dish containing PBS.  The embryos were washed in two further 
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changes of PBS P/S and placed individually into bijou tubes containing 2ml of TVP.  
Tubes were incubated for 10 minutes at 37ºC and the content was vortexed, incubated 
for a further 10 minutes at 37ºC and vortexed one more time.  3 ml of MEF medium was 
added to inactivate the trypsin, the tubes were vortexed for a few seconds and individual 
supernatants containing the cells were transferred into 75 cm2 flasks containing 12 ml 
MEF medium.  Flasks were incubated at 37ºC and the medium was changed the 
following day to remove the cellular debris.  The cells were split at 1:2 when cells were 
80-85% confluent and when this confluency was reached again the MEFs were used as 
feeders.  MEFs could be expanded for up to 5 passages before being discarded.  
 
2.1.3.4 Irradiation of MEFs  
 
MEFs were harvested in a similar way to mES cells and placed as a single cell 
suspension in a 50ml tube.  The cell containing tubes were irradiated at 40-80 Gy in a 
Gamma cell irradiator, in order to stop the MESs cell division whilst still alive.   The 
cells were centrifuged, re-supended and plated in a previously gelatinised flask at 
56,000cells/cm2 for cultures to be used for CM.  Irradiated MEFs were used up to 7 days 
for CM. 
 
2.1.3.5 Matrigel Coating for Human ES Cultures 
 
Matrigel was thawed at 4ºC for at least 2 hours to avoid polymerisation, and then diluted 
1:15 of 1:50 in cold KO-DMEM using a chilled pipette to obtain a final dilution of 1:30 
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or 1:100 depending on the use with CM or N2B27 respectively.  Typically 25 cm2 flasks 
were coated with 3ml of the solution.  Flasks were either incubated at RT for 1-2 hours 
before use or stored at 4ºC for no longer than 2 weeks.  The Matrigel solution was 
removed from the flasks before use. 
 
2.1.3.6 Passage of hES cells 
 
For both conditions CM or N2B27 the cells were passaged when they reached 80-90 % 
confluence.   
 
CM was removed and cells were washed once with KO-DMEM.  Typically, 1ml of 200 
units/ml collagenase IV per well of 6 well plate was added to incubate at 37 ºC for 5-10 
minutes.  The collagenase was aspirated and gently the cells were washed with KO-
DMEM.  The cells were detached from the surface by scraping and dissociated into 
clusters (50-500 cells) by gentle pipetting.  The Matrigel (1:30) was removed from the 
plates and the cells in CM supplemented with 8 ng/ml FGF2 seeded into the Matrigel 
coated wells.  In this system, the hES cells were maintained in a high density with an 
optimal split ratio of 1:3.  
 
N2B27 was removed and cells were washed once with PBS.  Typically, 2ml of 
PBS/EDTA per well of 6 well plates was added to incubate at 37 ºC for 2-3 minutes.  
The PBS/EDTA was aspirated and gently the plate was tapped and fresh medium poured 
in order to loosen the cells.  In this system, the hES cells were able to be seeded at low 
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densities in small clusters of less than 50 cells, with a typical split ratio of 1:6.  The 
Matrigel (1:100) was removed from the plates and the cells in N2B27 supplemented 
with 8 ng/ml of FGF2 seeded onto the Matrigel coated wells. 
 
2.1.3.7 Freeze of hES cells 
 
The cells were harvested as above with the only variation being leaving larger clusters of 
cells, when mixed with the medium, to facilitate their thaw.  The cells were centrifuged 
and the pellet gently re-suspended in 50% of their usual medium of growth and 50% 
freezing mix and placed in pre-chilled cryovials.  The vials were placed at -80oC 
overnight and then transferred to -150oC for long-term storage. 
   
2.1.3.7 Thaw of hES cells 
 
The procedure was comparable to the mES thaw. In the case of hES cells the gentleness 
should be increased.  In the case of thawing cells in CM, two weeks in culture were 
needed before cells could be expanded. 
 
2.1.3.8 Cell count 
 
Human ES cells harvested in PBS/EDTA were counted in a NucleocounterTM 
(Chemometec).  In order to count the total number of cells in a suspension, a sample of 
the suspension (100µl) was first treated with lysis buffer (100µl) and then stabilising 
buffer (100µl).  The lysis buffer disaggregated the clusters of cells and permeated the 
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plasma membrane allowing the nuclei to be stained with propidium iodide, which is 
coated on the inside of the NucleoCassetteTM.   The stabilising buffer increases the 
efficiency of nuclear staining by raising the pH of the mixture.  A sample of the mixture 
was loaded into the NucleoCassetteTM and this placed into the Nucleocounter that would 
give the number of viable cells in an optimal range of 105-2x106 cells/ml, which should 
be multiplied by the multiplication factor (x3) to obtain the number of cells/ml. 
 
2.1.3.9 Formation of Embyroid Bodies 
 
The cells were harvested using collagenase as the cells should be collected in clumps.  2 
ml per well (into 6 well plate) of differentiation medium was added.  The cells were 
















2.2 RNA Methods 
2.2.1 Extraction and Analysis of RNA 
 
2.2.1.1 RNA Isolation from cells 
 
All equipment was autoclaved twice or thoroughly cleaned with RNase Erase (Q 
Biogen) before use.  Cells grown in monolayer were lysed directly in the culture dish by 
the addition of RN-Bee (ams biotechnology) (1ml of reagent for 10cm2) passing the cell 
lysate several times through a pipette.  200µl of chloroform were added to the 
homogenised material, shaked vigorously for 15-30 seconds and incubated on ice for 5 
minutes.  The samples were centrifuged at 12000g for 15 minutes at 4oC.  After 
centrifugation the upper aqueous phase, containing the RNA was transferred to a new 
tube, being careful to avoid protein and DNA contamination by accidental carry over of 
the interphase.  For RNA precipitation, 500µl of cold isopropanol was added to the 
sample, which was well mixed and incubated for 5-10 minutes at room temperature.  
The sample was then centrifuged (12000g; 5 minutes; 4oC), the supernatant removed and 
the pellet washed with 75% ethanol.  The washed pellet was centrifuged (7500g; 
5minutes; 4oC) and dried by incubating in a heat block for 2 minutes at 45oC.  To 
improve the solubilisation, the pellet was mixed in nuclease free water (Ambion) and 
incubated for 10-15 minutes at 55-60oC.  To avoid degradation in long-term storage, 
RNA was stored as an ethanol precipitate.  To solubilised RNA 1/10 volumes of 3M 
sodium acetate (NaOAc) were added to two and a half volumes of absolute ethanol 
before mixing and storage at -20oC.  
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2.2.1.2 Quantitation and assessment of RNA quality 
 
To assess the quality of RNA it was used electrophoresis of total RNA and then 
ethidium bromide staining.  This relies on the fact that ribosomal RNA (rRNA) quality 
and quantity reflect that of the underlying messenger RNA (mRNA).   rRNA makes 
>80% of total RNA samples with the majority of that comprised by the 28S and 18S 
rRNA species. Therefore, two bands 5 and 2Kb corresponding to 28S and 18S are 
indicative of intact RNA.  The spectophotometric measurement of the amount of 
ultraviolet irradiation absorbed by the bases was used to measure the amount of RNA 
present in the samples.  In addition to this, the more sensitive method Agilent bioanlyser 
was used in combination with the RNA 6000 Nano LabChip®kit (Agilent Technologies).  
This system uses a combination of microfluidics, capillary electrophoresis and 
fluorescence to evaluate both RNA concentration and integrity.   
 
2.2.1.3 Complementary DNA (cDNA) Synthesis 
 
Reverse transcriptase is a RNA-dependent DNA polymerase, which is encoded by 
retrovirus.  Their viral function is to copy the viral RNA genome into DNA prior to its 
integration into host cells.  This can be exploited to allow production of DNA (cDNA) 
from any RNA template and is known as reverse transcription PCR.  After RNA was 
precipitated, quantitated and diluted in nuclease free water to a final concentration of 
5µg of RNA in 8µl, the RNA was denatured (65oC; 10 minutes).  Two systems were 
used to synthesising DNA from RNA and the cDNA synthesised was used as a template 
in the Polymerase Chain Reaction (PCR). 
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MMLV Reverse Transcriptase (Epicentre Biotechnologies) 
MMLV (Moloney Murine Leukemia Virus) is an RNA-dependent DNA polymerase that 
synthesises the complementary DNA (cDNA) first strand from a single-stranded RNA 
template to which a prime has been hybridised.  MLV-RT will also extend primers 
hybridised to single stranded DNA.  Second strand cDNA synthesis can be achieved 
from some mRNA templates without an additional DNA polymerase. 
The following reagents were added to a microcentrifuge tube at room temperature 
containing 25µl of 2.5 µg of RNA. 
- 12 µl RNase free H2O 
- 5 µl 10x MMLV RT buffer 
- 5 µl 0.1 M DTT 
- 1 µl dNTP mix (2.5 µM each) 
- 1 µl Oligo (dT; 10pM)  
- 1 µl (10 U) MMLV RT (added the last) 
The reaction was incubated at 37oC for 60 minutes 
 
First Strand cDNA Synthesis kit (Amersham)   
The cDNA synthesis was also catalysed by the M-MuLV reverse transcriptase.   The 
preassembled bulk firs-strand cDNA reaction mixes required only the addition of DTT, 
RNA and the primer Not I-d(T)18.  The RNA sample was placed in a microcentrifuge 
tube and RNAse-free water added to bring the RNA to the appropriate volume, 5μg in 
5μl.   The RNA solutions were heated at 65oC for 10 minutes, and then chilled on ice.  
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Gently pipette the bulk first-strand cDNA reaction mix to obtain a uniform suspension.  
The appropriate volume of the bulk first-strand cDNA reaction mix (5μl) was added to a 
sterile 0.5ml microcentrifuge tube.  To this tube was added 1 μl of DTT solution, 1 μl of 
the primer at 1:25 dilution and the heat denatured RNA.  After mixing, the tubes were 
incubated at 37oC for 1 hour followed by 10 minutes at 90oC in order to inactivate the 
enzyme.   The cDNA was aliquoted and stored at -20oC. 
 
2.3 DNA Methods 
2.3.1 Solutions 
 
10x TBE buffer 
0.89M Tris-HCL, 0.89M borate and 0.02M EDTA, pH 8.0 
 
Genomic DNA resuspension solution 
400mM Tris-HCL (pH 8.0), 60mM EDTA, 150mM NaCl 
 
Type III loading buffer (6x) 
0.25% bromophenol blue, 0.25% xylene cyanol FF, 30% glycerol 
 
2.3.2 Polymerase Chain Reaction (PCR) 
 
PCR was performed on the cDNA produced from the reverse transcription of mRNA.  
This method allowed the enzymatic synthesis of specific segments of DNA using two 
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oligonucleotide primers that hybridise to opposite strands and flank the region of interest 
in the target DNA.  All the primers (Table 2.1) were kindly supplied by Dr Lesley 
Forrester from the Queens Medical Research Institute, University of Edinburgh.  The 
primers were design spanning an intron to avoid co-amplification of genomic DNA.  A 
repetitive series of cycles, involving template denaturation, primer annealing, and the 
extension of the annealed primers by DNA polymerase results in the exponential 
accumulation of a specific fragment whose termini are defined by the 5’ ends of the 
primers.  Because the primer extension products synthesised in one cycle serve as a 
template in the next, the number of target DNA copies approximately doubles at every 
cycle (Erlich, 1989).   
 
The system used in this report was the HotStarTaq Master Mix Kit (Qiagen).  HotStart 
DNA polymerase is activated by a 15 minute 95oC incubation step, which was 
incorporated into the routine thermal cycling programs.  The HotStartTaq Master Mix 
contains HotStarTaq DNA Polymerase, PCR Buffer (with 4mM MgCl2), and 400 μM 
each dNTP.  The PCR reaction mix was prepared by adding 10μl HotStartTaq master 
mix, 1 μl of each primer (at a final concentration 0.2 μM) and 6 μl of RNAse free H2O 
to 2 μl of the DNA template.  The PCR products were then run on an agarose gel, as 




2.3.3 Agarose Gel Electrophoresis 
 
Agarose gels were prepared by dissolving agarose (Sigma) at 0.8-1.5% in 1xTBE by 
boiling in a microwave and allowed to cool down.  Ethidium bromide (Sigma) was 
added to a final concentration of 0.5 µg/ml before pouring the gel into a horizontal 
electrophoresis gel kit (RunOneTM System, Embi Tec) and inserting the gel combs.  
Once set, the gel was submerged in 1X TBE buffer in a gel tank and the DNA samples, 
containing 20% DNA loading buffer, were loaded into the wells.  One well was reserved 
for loading molecular weight markers (1 Kb plus DNA ladder; Invitrogen).  
Electrophoresis was carried out either for 2 hours (80-120 Volts) or overnight (15-30 
Volts).  DNA was visualised by illumination on a long wave UV light box and 
photographed.  The size of the DNA fragments were examined by a comparison of their 
mobility to that of restriction fragments of known size, typically DNA Hyperladder 100 
lanes (Bioline).  
 
2.3.4 Reverse Transcription (RT-PCR) Analysis 
 
RT-PCR reactions were carried out as the PCR reactions.  To ensure no contamination 
with genomic DNA, a "no-RT" control was always included.  To normalise the 
concentration of template used in subsequent PCR reactions, a PCR reaction of a 
housekeeping gene, typically Clathrin was also included.  A band of the correct size was 
expected whe the cDNA was synthesised with RT, whereas a pure cDNA sample shoul 
not show any bands in absence of RT.   
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Oct4 5'-GGCGTTCTCTTTGGAAAGGTGTTC-3'  5'-CTCGAACCACATCCTTCTCT-3’ 58 320 20 
Nanog 5'-ATGCCTGCAGTTTTTCATCC-3'  5'-GAGGCAGGTCTTCAGAGGAA-3' 58 110 30 
Rex1 5'-TGGCTTCCCTGACAGATACC-3'  5'-CCTTCGAACGTGCACTGATA-3' 58 490 30 
Akp 5'-GCACCTGCCTTACCAACTCT-3'  5'-TTTCAGGGCATTTTTCAAGG-3'    57 110 28 
Gata6 5'-GCAATGCATGCGGTCTCTAC-3'  5'-CTCTTGGTAGCACCAGCTCA-3'  59 570 35 




5'-ATGGGGGCTTCATTCAC-3' 60 610 30 
Pax6 5'-TGCCCTTCCATCTTTGCTTG-3'  5'-TCTGCCCGTTCAACATCCTTAG-3 55 190 30 
Brachyury 5'-TGCTGCCTGTGAGTCATAAC-3'  5'-TCCAGGTGCTATATATTGCC-3' 57 120 28 
Fgf5 5’-ACCCTTTGAGCTTTCTACCC-3’ 5’-CCGTCTGTGGTTTCTGTTGAGG-3’ 58 188 32 
 
Table 2.1.  PCR primers used and their conditions. 
 
 
2.4 Protein methods 
2.4.1 Solutions 
 
SDS loading buffer 
10% Glycerol, 3% SDS, 62.5mM TrisHCL pH 6.8, 0.005% Bromophenol blue, 3% β-
mercaptoethanol 
 
4x lysis buffer 
To make 100ml: 40ml glycerol, 12gr SDS, 25ml 1MTris-HCl (pH 6.8), 0.04% 
bromophenol blue, 20ml β-mercaptoethanol.  
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RIPA lysis buffer  
10mM Tri-HCl at pH 7.4, 1mM EDTA, 150 mM NaCl, 1% NP40, 0.1% SDS, 0.1% 
Sodium Deoxycholate 
 
Wash buffer Tris-buffered saline-Tween (TBS-T)  
140mM NaCl, 20mMTris-HCL at pH 7.6, 0.1% Tween20 
 
Running buffer (5x) 
30grTris, 188gGlycine, 10gSDS (sodium dodecyl sulphate) to make 2 litres with dH2O 
 
Transfer buffer (10x)  
 
29.3g Glycine, 58g Tris, 18.8 ml 20% SDS to make 1 litre.  To prepare 1X solution used 
100ml of 10x, 700ml dH2O and 200ml Ethanol 98% 
 
Stripping buffer  
62.5 mM Tris-HCl  at pH 6.8, 2% SDS, and 100 mM β-mercaptoethanol 
 
2.4.2 Western Blotting 
 
Western Blotting or Immunoblot is a sensitive technique for detecting specific protein 
molecules in a given sample of tissue homogenate or extract.  It uses gel electrophoresis 
to separate denatured proteins by mass.  These proteins are then transferred (blotted) out 
of the gel onto a membrane (nitrocellulose or nylon sheet), where they are “probed” 
using antibodies specific to the protein of interest.  The membrane is then incubated with 
the specific antibody for the particular protein, followed by the washing away of any 
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unbound antibody.  Those proteins in the gel that bind the antibody are detected either 
by autoradiography (if the specific antibody was radiolabeled) or by using a second 
labelled antibody that binds to the primary antibody (Hames and Hooper, 2000).  
 
2.4.2.1 Cell lysis, protein isolation and gel electrophoresis 
 
Following the pertinent treatment, the cells were washed once with ice-cold PBS and 
lysed in 100 μl (per 100mm dish) 1x SDS sample buffer.  The samples were 
homogenised by sonication and before being used, they were boiled for 5 minutes in 
order to unfold the proteins completely.  5-10μl aliquots of the lysate were taken and 
fractionated on a 10% SDS-polyacrylamide.  The reducing agent β-mercaptoethanol 
breaks all the disulfide bonds and the strong anionic detergent SDS disrupts nearly all 
the non-covalent interactions in the protein, thereby unfolding the polypeptide chain.  
SDS binds to the amino acid residues, which gives the denatured protein a large net 
negative charge that is proportional to its mass (Hames and Hooper, 2000).  The 
electrophoresis was carried out at 100V for about 3 hours, which ended with a gel of 
separated proteins on the basis of their mass. 
 
2.4.2.2 Determination of protein concentration 
 
When normalisation of the protein content was required, the RIPA lysis buffer was used 
because it is compatible with the colorimetric Pierce BCA (bicinchoninic acid) Protein 
Assay.  The RIPA buffer enables the extraction of cytoplasmic, membrane and 
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particularly nuclear proteins.  This buffer used in conjunction with the BCA assay 
permitted an accurate measurement of protein concentration in the samples. 
 
Protease and phosphatase inhibitor cocktails (Sigma) were added to the RIPA Buffer 
before lysing of the cells.  The cells were washed with cold PBS and scraped off in 
100µl of RIPA buffer (per 100mm dish), whilst always maintaining the samples in ice.  
The samples were spun at 14,000 rpm for 5 minutes at 4oC and the supernatant 
containing the solubilised proteins was transferred to a plate to determine the 
concentration of the protein.  The BCA (bicinchronic acid) assay (see Figure 2.2) was 
carried out following Pierce indications: 10μl of lysate were mixed with 190μl of 
reagent B+A (BCA quit), incubated at 37oC for 10-15 minutes and read at 562nm. Once 
the protein concentration was determined, all the different concentrations were adjusted 
using the RIPA buffer.  Equal volumes of the SDS sample buffer were added to each 










                                             
  
              Cu +2                                                        Cu+1 (purple) measured at 562nm 
 
 
            Protein       BCA     BCA 
               
 
Figure 2.2. Protein estimation by BCA (bicinchoninic acid) protein assay.  Proteins 
reduced Cu2+ to Cu1+ in an alkaline medium.  Two molecules of BCA reagent were 
chelated by one cuprous cation (Cu1+) producing a purple product that exhibits a strong 
absorbance at 562nm that is nearly linear at increasing concentrations of protein (BCA 
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2.4.2.3 Electrophoretic Transfer  
 
In order to make the proteins accessible to antibody detection, they are passed from the 
gel onto a nitrocellulose membrane.   Firstly the nitrocellulose membrane(s) were soaked 
in dH2O for 5 minutes and equilibrated in transfer buffer for at least 10 minutes.  For 
each gel, two fibre pads and two pre-cut Whatman 3MM filter papers saturated in 
transfer buffer were assembled on a cassette in the order shown in Figure 2.3.  The 
cassette was inserted into the electrode module along with a stir bar and a Bio-Ice 
cooling unit (stored at -20°C) placed in the buffer tank and filled with transfer buffer.  
The buffer tank was placed on a magnetic stir plate and stirred at medium speed. The 
electrodes were attached and electrophoresed at 100 V for 90 minutes.  When the 
transfer was finished the membrane was washed and incubated for 1 hour at room 
temperature with a blocking buffer (5% non-fat dried milk in TBS-T).  The incubation 
with the protein (in this case casein) was carried out to prevent interactions between the 
membrane and the antibody used for detection of the target protein, since the membrane 
has a high ability to bind protein.  This reduced "noise" and eliminated false positives. 
 
2.4.2.4 Antibody detection of protein 
 
The membranes were then rinsed with TBST and probed with the primary antibody, 
diluted in TBS-T, for 1 hour at room temperature on an orbital shaker.  The membrane 
was washed with TBS-T, 3x15 minutes.  This was followed by the incubation of the 
membrane with a secondary antibody at room temperature for 1 hour.  This was a 
Hoseradish peroxidise (HRP) conjugated antibody with the capacity of recognising and 
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binding to the primary antibody.  An illustration of the antibodies used during this thesis 
is shown in Table 2.2. 
Antibody  Isotype Working 
dilution 
Supplier 
Phospho-p44/42 Map Kinase 
(Thr202/Tyr204)  Rabbit IgG 1:1000 Cell Signalling  
Phospho Stat3 (Tyr705) Rabbit IgG 1:1000 Cell Signalling 
Phospho-AKT (Thr308) Rabbit IgG 1:1000 Cell Signalling 
ERK2 Mouse IgG1 1:1000 BD Transduction  
STAT3 Mouse IgG1 1:2500 BD Biosciences 
SMAD2/3  Mouse IgG1 1:500 BD Biosciences 
OCT4 Mouse IgG1 1:1000 Santa Cruz 
SH-PTP2, SHP2 Rabbit IgG 1:500 Santa Cruz 
 
Table 2.2. Antibodies used in Western Blotting.  Rabbit IgG and Mouse IgG1 were 
purchased from Amersham Biosciences.  Both secondary antibodies were used at 1:5000 
dilutions.   
 
2.4.2.5 Enzymatic Chemiluminescence (ECL) detection 
 
Chemiluminescence is the emission of light as the result of a chemical reaction.   The 
HRP catalyzes the conversion of Luminol into an excited intermediate, which emits light 
when it decays to ground label and can be detected by a short exposure to blue-light 
sensitive auto-radiography.  
 
Following the incubation of the blots with HRP-coupled anti-rabbit IgG or anti mouse 
IgG1, the membranes were washed and the reaction prepared using Amersham ECL 
reagents used according to the directions provided by the supplier.  After 1 minute of 
incubation with the reagents, the membranes were placed in an X-ray film cassette in a 
suitable detection pocket.  A sheet of auto-radiography film (Hyperfilm ECL) was 
placed on top of the membrane and exposed for times varying from 30 seconds to 1 hour 
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to get an optimuml exposure.  The light produced by this chemiluminescent reaction 
peaks after 5-20 minutes and decays slowly thereafter with a half life of approximately 
60 minutes.  The exposed film was developed in a Konica SRX-101A X-ograph 
machine. 
 
2.4.2.6 Reprobing membranes 
 
Membranes were washed with TBS-T and blocked in 5% non-fat dried milk in TBS-T 
for 1 hour at room temperature.  The removal of primary and secondary antibodies from 
the membrane is possible by submerging the membrane in stiripping buffer for 30 
minutes at 50oC with occasional agitation. After washing of the membrane, the 
immunodetection protocol was repeated.   
 
2.4.2.7 Quantification of Protein Concentration 
 
To quantify the concentration of protein in relation to the total protein loaded, the 
Quantity One densitometry programme was used on the developed X-ray films of the 





2.5 Other Analytical Methods 
2.5.1  Flow Cytometry 
 
Flow cytometry is a method of quantitation of components or structural features of cells, 
by optical means.  The cells may be alive or fixed at the time of measurement, but must 
be in single cell suspension as they are passed through a laser beam by continuous flow.  
Each cell scatters some of the laser light, and also emits fluorescent light excited by the 
laser.  The cytometre measures up to five parameters for each cell: forward light scatter 
intensity (approximately proportional to cell diameter), side light scatter (which is 
approximately proportional to the quantity of granular structures within the cell) and 
three fluorescence intensities at several wavelengths (FL1 (emissions wavelength 515-
545 nm), FL2 (564-606 nm), FL3 (650nm)) and the pulse height and width of each 
fluorescence parameter. 
 
Forward size and side scatter plots were used to exclude dead cells and debris from the 
fluorescence data.  At least 10,000 “live” cells were acquired from each sample.  
Fluorescent antibodies were used to report the densities of specific surface markers and 
intracellular components, thus distinguishing populations of differentiated cell types.  
Flow cytometry was performed on a 488 nm laser FACScan (Becton Dickinson).  A 
530/30nm band pass filter was used to measure EGFP fluorescent intensity or FITC-
conjugated antibodies.  A 585/42 nm band pass filter was used to measure 
phycoerythrin-conjugated antibodies.  For cell surface marker analysis, detector settings 
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were adjusted with both untreated and isotype controls.  Analysis of the data was 
performed on CellQuesPro software (BD Biosciences).   
 
2.5.1.1 Evaluation of Cell-Surface Markers 
 
Flow cytometry was used to determine the expression of protein on the surface of a cell 
as a marker of the self-renewal status of the cells.  An antibody was incubated with the 
cells and a secondary carrying a fluorescent dye was attached to the first antibody.  The 
amount of cell surface marker was proportional to the level of fluorescence.   
 
After harvesting, the clumps of cells were dissociated by pipetting or using TVP.  They 
were washed with FACS PBS (PBS, 0.1% BSA fraction V, 0.1% NaN3).    5x106-2x107 
cells/ml was re-suspended in FACS-PBS and 50µl aliquoted per sample tube.  The 
primary or isotype control antibody was added to the FACS tubes (Greiner) and 
incubated for 30-40 minutes at 4oC in the dark.  The primary antibody was washed on 
FACS PBS by spinning at 250g for 5 minutes and discarding the supernatant.    The 
pellet was re-suspended in 50µl, and the secondary antibody added to a final dilution of 
1:100.  After 20-30 minutes incubation at 4oC in the dark the antibody was washed.  
300-500µl FACS PBS was added for the acquisition of the data by flow cytometry.  A 







Supplier Isotype Working 
dilution 
Supplier 
SSEA1 1:50 Santa Cruz Mouse IgM 1/100 Jackson 
SSEA3 1:50 Santa Cruz Rat IgM 1/100 Sigma 
SSEA4 1:100 Santa Cruz Mouse IgG3 1/100 Sigma 
TRA1-81 1:25 Chemicon MouseIgM 1/100 Jackson 
 
Table 2.3. Antibodies used in Flow cytometry.   
 
2.5.1.2 Cell Cycle Analysis by Propidium Iodide (PI) Staining 
 
Propidium Iodide is a typical cell cycle stain, because it can pass through a 
permeabilised membrane and intercalate into cellular DNA.  The intensity of the PI 
signal is then directly proportional to DNA content.  One important aspect of the DNA 
analysis is the ability of exclusion of dead/apoptotic cells and cell clumps.  The 
histogram pulse width versus pulse area was used to exclude cell clumps and dead cells.  
The selection of live cells and the cell cycle analysis was done with FlowJo software 
from Treestar.  Once the single cell population was identified, the percentage of cells in 
G1, S phase and G2/M can be estimated by the software.  Quiescent and G1 cells will 
have one copy of DNA and will therefore have 1X fluorescence intensity.  Cells in 
G2/M phase of the cell cycle will have two copies of DNA and accordingly will have 2X 
intensity. Since the cells in S phase are synthesising DNA, they will have fluorescent 
values between the 1X and 2X populations.  Histograms of the PI staining of the whole 
population is shown in figure 2.3 A, and a histogram produced after exclusion of dead 
and the agregates is shown in figure 2.3 B. 
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The samples containing 0.5 to 1x106 were centrifuged at 400g for 5 minutes and the 
supernatant discarded.  The pellet was fixed overnight in 0.3ml 50% FCS in FACS PBS 
and 0.9 ml cold 70% ethanol.  The fix was washed off and the pellet re-suspended in 0.3 
ml PI solution (50μg/ml PI + 100 μg/ml RNAse in FACS PBS).  The cells were stained 
for 1 hour at room temperature in the dark and stored in ice until analysis.  To avoid cell 
aggregates that could lead to a mistake in the analysis, the cells were harvested using 

















Figure 2.3. PI staining for cell cycle.  A: PI staining profile of the whole population. B: 
PI profile of single live cells.  A dot plot was used to exclude the dead cells and 
aggregates from the analysis.  The cell cycle analysis was done with FlowJo software 






























































2.5.2 Induction experiments 
 
In experiments where cells were induced with growth factor, 1x106 cells per 100-mm 
dishes were plated.   The following day the medium was changed to serum and LIF free 
GMEM medium in the case of the mES cells, and N2 without insulin or B27 in the hES 
cells, for 3 hours prior to stimulation with the cytokines or growth factors of interest.  
Inductions were carried out with 50μl at 25ng/ml of FGF, (in the case of FGF4 also was 
added 1µg/ml of heparin) and 10ng/ml of LIF.  Subsequent induction, the reaction was 
stopped simultaneously in all the samples by removing the stimulus; washing with PBS 
and placing the samples in ice.  The biochemical analysis of the effect of the induction 
was carried out by western blotting assays. 
 
2.5.3 Inhibition experiments 
 
The inhibitors were titrated before being used in the biological assay.  106 cells/well 
were plated on N2B27 containing FGF2.  After 24 hours the medium was changed to a 
control medium (N2 without B27, insulin and FGF2).  Following 4 hours of incubation 
the medium was changed to the control medium with the different concentrations of the 
inhibitor.  After incubating for 1 hour the cells were stimulated with 25ng/ml of FGF2 or 
10ng/ml of TGFβ.  Subsequent inductions followed the procedure as described above.  A 





Inhibitor Pathway Working 
concentration 
Supplier 
LY294002 PI3K/AKT 2.5 μM Calbiochem 
UO126 MAPK/ERK 5 μM Promega 
SU5402 FGF 20 μM Calbiochem 
SB 431542 TGFβ 20 μM Tocris 
 
Table 2.4. List of inhibitors used in this thesis. 
 
2.5.4 Proliferation assay 
 
This assay is based on the incorporation of the radioactive3H (tritium) into the Hydrogen 
of the Thymidine during DNA replication.  Therefore, the amount of 3H-Thymidine 
incorporated into the DNA relates to cell proliferation.  Cells were plated at different cell 
densities (2.42x104-3x103) in the presence of FGF2.  Once the cells were attached to the 
matrix (4-5hours) the medium was changed to + or - FGF2 and after 24 hours of 
incubation in these conditions the thymidine assay was performed.  Each well was 
labelled with 1µCi (0.037MBq) 3H-Thymidine at a dilution 1:20 in PBS.  After 6 hours 
of incubation of the plates with the label, the samples were harvested.  Once the plates 
have been harvested the filters were incubated for 1 hour at 65oC.  The dry filter was 
placed in a cassette, which was inserted to be analysed in a β-counter.   
 
2.5.5 Self-renewal assays in ES cells 
 
ES cells are defined by their ability of self-replicating whilst maintaining their 
undifferentiated state.  The self-renewal of the ES cells is directly correlated to the 
amount of the transcription factor OCT4, whose levels can be detected and quantified by 
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different methods.   The cell line IOUD2 (Dani et al.,1998) used in this project, carries 
an E. coli lacZ gene encoding β-galactosidase (β-gal) reporter gene (Beckwith, 1980), 
inserted within one allele of the Oct4 gene.  Therefore, β-galactosidase, serves as a very 
useful and sensitive reporting tool for the Oct4 gene expression and consequently for the 
self-renewal status of the cell population.  The quantitation β-galactosidase activity was 
carried out using Chromogenic assays such as the X-gal staining and the ONPG assay 
and Fluorometric assays such as fluorescein di-β-D-galactopyranoside (FDG). 
 
2.5.5.1 Chromogenic assays 
 
2.5.5.1.1   X-Gal staining 
The β-galactosidase reporter can be detected using a variety of substrates, all of which 
have a galactose link through a β-D-glycosidic linkage to a moiety whose properties 
change upon liberation from galactose.  The most common substrate used is an indole 
derivative, 5-bromo-4-chloro-3-indolyl-β-D-galactoside (X-gal) (Holt and Sadler, 1958).  
When β-gal cleaves the glycosidic linkage in X-gal, a soluble, colourless indoxyl 
monomer is produced.  Subsequently, 2 of the liberated indoxyl moieties form a dimmer 
which is oxidized and whose resultant halogenated indigo is a very stable and insoluble 
blue compound, which is easily detected (Holt and Sadler, 1958).  
 
The cells were washed with PBS and fixed (0.2ml 50% Glutaraldehyde and 0.5ml 0.5M 
EGTA (Ethylene Glycol Bis (2-aminoethyl ether) –N’N’N’N’ Tetraacetic acid) in 50ml 
of wash buffer (84mM Na2HPO4, 16mM NaH2PO4, 0.091.3mM MgCL12 6H2O) for 5 
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minutes at room temperature).  The cells were washed 3 times with the wash buffer and 
then stained (6.4mM K3Fe(CN)6, 4.45mM K4Fe(CN)6 50mg/ml X-Gal (Promega) in 
dithyl formamide).  The stained cells were incubated for 1 hour to overnight depending 
on the intensity of the expression of the lacZ.  After staining the cells were washed and 
stored at 4oC.   
 
2.5.5.1.2  Orto-nitrophenyl-β-D galactopyranoside (ONPG)  
Stem cell specific expression of β-galactosidase from the Oct4 locus was quantified by 
ONPG assay.  This assay provides a quantitative estimate of lacZ expression by 
measuring enzyme activity directly.  ONPG is the artificial colourless chromogenic 
substrate that when cleaved released a yellow product, orthonitrophenol (ONP).   
Therefore activity of the enzyme can be measured by the rate of appearance of yellow 
colour using a spectrophotometer (λmax = 420nm).  Duplicate assays were performed 
on triplicate samples for each treatment.  On day 6 of the treatment, the cells were 
washed once with PBS and lysed in 0.4ml of 0.25 M Tris, pH 7.5, 0.5 mM DTT, 0.5% 
NP40.  40 μl of the lysate were mixed with 100μl of ONPG buffer (60mM Na2HPO4, 
40mM NaH2PO4, 10mM MgCl2, 50mM 2-mercaptoethanol, 1.2 mM ONPG) in a 
microlitre plate and incubated at 37°C for 2-4 hours.  The absorbance was read at 420 
nm at every hour to get readings of the different points of the reaction.   The results 
obtained for β-gal were adjusted for the protein values.  The quantification of protein 
was obtained with the BCA kit that was prepared as indicated by the manufacturer 
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(Pierce) and measured at 562nm.  Once the concentration of protein was determined the 
values of the ONPG absorbances were normalised with the protein values. 
 
2.5.5.2 Fluorogenic assay 
 
2.5.5.2.1  Fluorescein di-β-D-galactopyranoside (FDG) assay 
In this method the β-galactoside analogue FDG was used to carefully distinguish LacZ 
positive cells from the negative ones, allowing time-dependent fluorescence activated 
cell analysis.  FDG is cleaved by β-galactosidase in LacZ positive cells to yield 
fluorescein (Nolan et al.,1988) along with galactose.  Fluorescein emits light at a 
maximum of 514 nm when excited with light at 491 nm, whereas the precursor molecule 
FDG does not.  Therefore, the activity of the enzyme is directly proportional to the rate 
of fluorescent accumulation at these wavelengths and can be detected and measured by 
fluorescence activated cell sorter (FACS) (Nolan et al., 1988).  Compared to the ONPG, 
this assay had the advantages of not requiring to kill, fix or to lyse the cells to allow 
product formation.  Further advantages were shorter incubation times, smaller sample 
volume and the possibility of including propidium iodide for the identification of 
damaged cells.   
 
The cells were harvested as protocol, collected and centrifuged.  The pellet was re-
suspended in PBS supplemented with 10% FCS, giving a total volume of 100µl.  The 
cells were carefully mixed and 40µl taken into a FACS tube for the FDG staining.  In 
order to accelerate the pass of the fluorescein through the cell membrane, the cell 
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solution was placed into a water bath at 37oC.  After 5 minutes the tubes were taken 
from the water and 0.5 mM FDG (prepared in H2O, which is pre-warmed at 37oC, at 
50% of the isotonic concentration) was loaded into the tubes, mixed gently and rapidly 
placed back into the 37oC water bath.  After 1 minute, the hypotonic shock was 
terminated by placing the cells in ice and adding 1:9 dilution of ice-cold isotonic 
medium and placed at 4oC to allow fluochrome generation and prevention of FDG 
leakage.  After 60 minutes LacZ positive cells generated a peak of fluorescence that was 
measured by flow cytometry.  
 
2.5.6 Statistical Analysis 
 
Analysis of the variance (ANOVA) was performed to determine the significance of a 
given result.  For the FDG assay, the data was log transformed to equalise variances. 
Then, the data was subjected to a 2-way ANOVA to investigate the effects of the 
treatment.  All data are expressed as the mean ± SD of observations within each 
experiment and usually of three independent experiments.  Statistical analysis was 
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FGF signalling is a conserved coordinator of neural development (Yamaguchi et al., 
1992; Wilson et al., 2000; Delaune et al., 2005; Zhang et al., 2006; Willems and Leyns, 
2008).  Among the 22 members of the FGF family (Zhang et al., 2006), FGF2, and 
particularly FGF4 are essential factors during the development of the mouse embryo.   
 
Ffg2 is expressed in the primitive ectoderm, which suggests a possible role in the 
formation of the ICM.  However, FGF2 is not expressed in undifferentiated mES cells, 
and it is only after 5 days in the absence of LIF that FGF2 is expressed (Jirmanova et al., 
1999).  Nevertheless, mES cells (Esner et al., 2002) and the mouse blastocyst (Campbell 
et al., 1992) display FGFR1 and FGFR2, the specific binding receptors for FGF2.  Esner 
et al, (2002) found that FGFR1 expression was necessary for the maturation into visceral 
endoderm of EBs.  This established the critical role of FGF2 in the regulation of EBs 
and led them to the conclusion that FGF2 did not have an effect in mES cell 
proliferation.  Studies in vivo showed that FGF2 deficient mice, although viable, 
suffered severe defects in the formation of the cerebral cortex due to a delayed 
differentiation (Dono et al., 1998).  Taken together, these studies indicate that FGF2 is a 
decisive factor in the process of embryonic mouse differentiation and may suggest a role 
of FGF2 as inducer of differentiation in mES cells.  This role in differentiation would be 
the counter effect that FGF2 produces on the human system.  Indeed, FGF2 is a critical 
factor in derivation and propagation of hES cells.  Opposing effects of FGF2 in these 
two species could be associated with the different levels of FGF2 expression: high in 
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hES cells and low in mES cells.  For this reason, it was chosen to asses the effect of 
FGF2 on mES cells and in later chapters this is compared to the effect of FGF2 in hES 
cells.   
 
Fgf4, on the other hand,  is expressed at multiple stages of mouse development; at the 
RNA level it has been detected as early as the 1 cell stage and its expression increases 
during the period of blastocyst growth (Rappolee et al., 1994).  In the pre-implantation 
blastocyst, Fgf4 expression is restricted to the cells of the ICM and coincides with Oct4 
expression (Niswander and Martin, 1992).   In the post implantation embryos Fgf4 
expression becomes restricted to the primitive streak and in later development, Fgf4 
remains in only a few cell types (Niswander and Martin, 1992).  Mouse ES and EC cells 
express Fgf4 and its receptors at the RNA and protein levels, whereas this expression is 
repressed when they differentiate (Rizzino et al., 1988).  This is a consequence of Fgf4 
gene expression in ES and EC cells being controlled by the pluripotency-associated 
transcription factors OCT4 and SOX2 (Curatola and Basilico, 1990).  OCT4 binding and 
activation of the Fgf4 has also been confirmed in mouse embryos, in which deletion of 
Oct4 resulted in a reduced or absent expression of Fgf4 (Nichols et al., 1998). 
 
As mentioned above, FGF4 is expressed in the ICM in early epiblast (Niswander and 
Martin, 1992; Rappolee et al., 1994) and FGF receptors are up-regulated in the 
trophectoderm and extraembryonic ectoderm (Rappolee et al, 1994; Arman et al., 1998).  
Nichols et al, (1998) suggested that OCT4 directed the secretion of FGF4 from the 
ICM/epiblast and FGF4 promoted the expansion of trophectoderm.  FGF4 in 
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conjunction with heparin is also required for the proliferation of trophoblast stem (TS) 
cells (Tanaka et al., 1998).  TS cells are derived from blastocysts or early post-
implantation trophoblast and can contribute to the trophoblast lineages of the placenta 
when re-introduced into the early embryo (Tanaka et al., 1998).  Therefore, FGF4 plays 
a key role in the growth and survival of extra embryonic tissues (Wilder et al., 1997; 
Nichols et al., 1998; Tanaka et al., 1998).  The essential role of FGF/FGFRs during 
development was demonstrated when mES cells expressing a dominant negative (dn) 
FGFR2 failed to form EBs (Chen et al., 2000).  Furthermore, mouse embryos with both 
Fgf4 alleles inactivated (Fgf4-/-), died soon after implantation, confirming in vivo the 
critical role of FGF4 during embryogenesis (Feldman et al., 1995).   
 
Nevertheless, in culture, the addition of FGF4 does not seem to affect the proliferation 
of the mES cells (Rizzino et al., 1988; Wilder et al., 1997).  Wilder et al, (1997) 
demonstrated that both, wild type (Fgf4+/+) and knockout (Fgf4-/-) mES cells gave rise to 
a similar mixture of differentiated tissues in teratomas.  However, they found that 
inactivation of the Fgf gene severely compromised survival and proliferation of 
differentiated cells in vitro.  This observation led them to propose that FGF produced by 
ES cells operated in a paracrine manner on the differentiated progeny, which form 
spontaneously at low density.  This conclusion is consistent with other studies which 
demonstrated an increase in extraembryonic endoderm cells derived from the ICM when 
FGF4 was added to in vitro blastocysts (Rappolee et al., 1994).   These reports 
appointed FGF4 as a survival factor and a promoter of their proliferation for the 
differentiating progeny of the mES cells. 
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However, it is also possible that FGF4 directly promoted the differentiation of ES cells, 
as in its absence mES cells were not capable of differentiation.  In the report by Wilder 
et al, (1997) the addition of FGF4 to Fgf-/- cells seemed to induce more differentiated 
cells than when the wild type mES cells spontaneously differentiated.  Moreover, when 
FGF4 was supplemented to Fgf-/- cells, the size of the undifferentiated colony appeared 
smaller than when the wild type cells were maintained in absence of this factor (Wilder 
et al., 1997).  Taken together, these observations could support a pro-differentiative role 
of FGF4 on mES cells. In addition to this, results presented by Rappolee and colleagues, 
(1994) could also be interpreted to support this hypothesis.  They demonstrated that the 
addition of FGF4 to cells derived from the ICM cells (small sized nuclei) resulted in an 
increase in the number of cells with medium sized nuclei.  These cells had the 
morphology and markers of parietal and/or primitive endoderm and were negative for 
SSEA1 (Rappolee et al., 1994).  Therefore, if small and medium/large nuclei are 
associated with undifferentiated and differentiated cells respectively, FGF4 seemed to 
increase the amount of differentiation in culture and the differentiated cells could have 
developed from the ES cells.  This was supported by the lack of mitogenic responses to 
the reduction of endogenous FGF4 in embryos (Rappolee et al., 1994).   
 
In conclusion, previous work has suggested that the proliferation of mES cells is not 
influenced by FGF4 and FGF2 signalling (Rappolee et al., 1994; Wilder et al., 1997).  
However, this lack of response in the growth of mES cells does not exclude the 
possibility of an effect of FGF on the self-renewal of these cells.  Murine ES cells 
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express the appropriate receptors for both FGF2 and FGF4, and FGF4 is highly 
expressed in mouse ES and EC cells.   
 
3.2 Hypothesis 
That FGF signalling promotes differentiation of mES cells, growing in presence of LIF, 
as well as sustains the growth of already differentiated cells.  A diagram of the 




Figure 3.1. Schematic representation of the hypothesis proposed in this chapter.   
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I. To establish the biochemical activation of mES cells treated with FGF2        and 
FGF4 
II.   To characterise the effects of FGFs on undifferentiated mES cells  
III.  To characterise the phenotype induced by FGF 
 
3.4 Results 
3.4.1 FGF activation of Mouse ES cells  
 
It has been shown that FGFs induce a strong stimulation of the mitogen-activated protein 
kinase pathway (MAPK) in different cell types and species as for example, in mouse 
endothelial cells (Pintucci et al., 2002), in vivo mouse embryo (Marshall, 1995), mouse 
fibroblasts (Hadari et al., 2001) etc.  Therefore, the analysis of the phosphorylation in 
the key downstream effectors of FGFRs, extracellular signal-regulated kinase 1 and 2 
(ERK1/2) (Ornitz and Itoh, 2001) is an effective readout of the activation of the MAPK 
pathway.  
  
To determine whether mES cells are activated by FGF, the phosphorylation of ERK was 
evaluated by western blotting after stimulating the cells with 25ng/ml of FGF2 or FGF4.  
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In addition to the FGFs, mES cells were stimulated with 10ng/ml of LIF, which has been 
shown to significantly activate ERK (Burdon et al., 1999b).   
 
ERK was phosphorylated when mES cells were treated with LIF and to a lesser degree 
with FGF4 and FGF2 (Figure 3.2).  This was confirmed by densitometric quantification 
of the immunoblots, which also showed a higher level of activation in FGF4 than in 
FGF2 (Figure 3.3).  ERK phosphorylation in FGF2 treated cells was slightly higher over 
the basal level when loading was taken into account.  LIF strongly activated STAT3 in 
mES, which is consistent with previous reports (Burdon et al., 1999a).  Neither FGF2 







Figure 3.2. Western blotting of ERK and STAT3 activation on mES cells.  Cells 
were induced with FGF or LIF and their stimulation was analysed by examining the 
activation of ERK protein or the STAT3 protein. Cell lysates from cells that have been 
starved of signal were used as controls.  The immunoblots of the cell lysates were 
probed with an antibody specific for the active phosphorylated forms of ERK1/2-P or 
STAT3-P.  After stripping, the membranes were reprobed with antibodies that recognise 




































Figure 3.3. Quantification and Normalisation of the adjusted volume of ERK-P to 
ERK levels.  The immunoblots ERK-P and ERK were scanned, quantified by 
densitometry and normalised.  Results confirmed the increased induction of ERK by 
FGF4.  The results shown here are mean values of two independent wells.   
 ERK2 
         No Factor              FGF2                        FGF4                          LIF 
STAT3 
STAT3-P 
   ERK-P 
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3.4.2 Effect of FGFs on mES cell self-renewal  
 
To determine whether the addition of FGF to mES cells affects their self-renewal or 
differentiation, two cell lines (IOUD2 and Y118F) with a lacZ insertion within the stem 
cell specific gene Oct4 were used (see section 2.1.2.2 for details).  The β-galactosidase 
activity resultant was monitored in situ by X-gal staining and quantified biochemically 
using the ONPG or FDG assays.  β-galactosidase expression is restricted to 
undifferentiated cells expressing the reporter from within the Oct4 locus, thus the level 
of activity of this enzyme relates to the potential for self-renewal in the ES cells (Figure 







Figure 3.4. Schematic representation of the experimental system used to measure 
the biological response of mES cells to the different growth factors.  The self-
renewal assays make use of lac Z insertion within the stem cell specific gene Oct4 in 
IOUD2 and Y118F cell lines.  Expression of this Oct4 reporter is restricted to 
undifferentiated mES cells. The resulting β-galactosidase activity (shown as blue), 
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3.4.2.1 LIF titration  
 
The biochemical quantification of the β-galactosidase product of the LacZ–Oct4 reporter 
was determined using the ONPG assay.  ONPG is the colourless chromogenic substrate 
that when cleaved by β-galactosidase releases a yellow product - orthonitrophenol 
(ONP), the absorbance of which can be measured on spectrophotometre.  Therefore, the 
activity of the enzyme is reflected by the intensity of the absorbance, which in turn 
represents the levels of OCT4 and the state of the self renewal of the mES cells. 
 
Previous studies into the effects of FGF on mES cells from other groups have utilised a 
single standard concentration of LIF (10ng/ml in the case of Wilder et al., 1997 and 
1000 U/ml in Esner et al., 2002).   In order to establish if there is any interaction 
between LIF and the FGF, different concentrations of LIF were assessed.  To establish a 
range of concentrations of LIF to apply in the self-renewal assays, ONPG assays were 
performed.  To carry out the selection, seven different concentrations of LIF were 
titrated covering a range from 0 to 500 Units/ml.  The resultant absorbances were 
normalised against the protein content and the results for IOUD2 and Y118F cell lines 
are shown in Figure 3.5.  β-galactosidase activity peaked at 100Units/ml and 
progressively decreased proportionally to the concentration of LIF.   
 
On the basis of these results (Figure 3.5) the concentrations: 0, 4, 100 and 500 Units/ml 
of LIF were selected to be used in conjunction with the titration of FGFs.  These 
concentrations represented specific points in the distribution of β-galactosidase activity 
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at which to identify any interactive effect with the FGFs in the self-renewal experiment.  
500U/ml of LIF was chosen as a near saturating concentration, 100U/ml was used as a 
control, because it is the concentration of LIF at which mES cells are routinely grown in 
the laboratory.  4U/ml of LIF was selected because this concentration corresponded to 
approximately half-maximal self-renewal.  It was hypothesised that at this sub-optimal 
concentration of LIF the mES cells should be more susceptible to any effects of FGF on 





















































































Figure 3.5 Effect of different LIF concentrations on self-renewal and growth of 
mES cells.  Six days after plating on the different concentrations of LIF, the cells were 
lysed and the β-galactosidase activity measured by ONPG assay.  The resultant 
absorbance values were normalised against protein concentration in cell lysates.  Values 
of the mean of triplicate samples and three different experiments are shown as ± SD in 




3.4.2.2 Effect of FGF in conjunction with LIF  
 
Once the selection of the LIF concentrations were established, their effect in conjunction 
with 8 different concentrations of FGF2 or FGF4 titrated from 0 to 250ng/ml was tested.  
The data presented in Figure 3.6 represents the means of four independent experiments 
for both FGF2 and FGF4.  Each experiment consisted of duplicate determinations of β-
galactosidase activity from triplicate samples.  The mean results of the absorbance 
determinations were normalised against the total protein concentration of the sample.  
The final result is presented normalised against to the response in the absence of FGF at 
100U/ml.  The ONPG assays confirmed a direct relationship between LIF concentration 
and the level of β-galactosidase expressed by the cells and, as expected, self-renewal 
was reduced at the lower concentrations of LIF.  The addition of FGF did not increase 
the levels of β-galactosidase activity.  In fact, it resulted in a slight reduction at high LIF 
concentrations, indicating that FGFs do not enhance the self-renewal of mouse ES cells 
(Figure 3.6).  Intriguingly, β-galactosidase was reduced after the addition of high 
concentrations of FGF, at 100 and 500 U/ml LIF, which are concentrations used to 
inhibit differentiation in mES cells (Smith et al., 1992).  Figure 3.7 shows the slight 
decrease in the β-galactosidase at 100U/ml of LIF in the presence of 25ng/ml of FGF.  In 
conclusion, there was not an increase in β-galactosidase activity, and consequently ES 
































































Figure 3.6 Effect of different concentrations of FGF and LIF on the normalised β-








































































Figure 3.6 Effect of different concentrations of FGF and LIF on the normalised β-
galactosidase activity in IOUD2 (A) and Y118F (B) mES cells.  Six days after plating 
the cells in the different concentrations of LIF and FGFs, β-galactosidase activity was 
measured by an ONPG assay and normalised against the protein concentration in cell 
lysates.  The concentrations 0, 4, 100 and 500 U/ml, were used as negative control, 
minimal, optimal and semi-saturating LIF concentrations for mES self-renewal 
respectively.  The data presented has been normalised against 100% β-galactosidase 
activity at 100 Units of LIF and 0ng/ml of FGF.  The mean of four independent 
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experiments is shown.  The error bars denote the standard error mean (S.E.M) between 

























Figure 3.7.  Percentage of β-galactosidase activity in IOUD2 cells treated with 
25ng/ml of FGF in the presence of 100U/ml of LIF.  Results from the ONPG assay 
were normalised and presented as an effect of 25ng/ml of FGF in the presence of 




















3.4.2.3 Statistical analysis 
 
With the intention of determining whether the reduction in the β-galactosidase activity 
by FGF (Figures 3.6 and 3.7) was statistically significant, an ANOVA test was carried 
out (Figure 3.8).  To isolate any change in the β-galactosidase’s activity of FGFs, the 
effect of exogenous LIF and any possible noise were excluded for this analysis.   
 
Results from the ANOVA test confirmed an overall decrease in the β-galactosidase 
levels by FGF2 and FGF4 (Figure 3.8).  This effect was more pronounced for FGF4, 
which induced the reduction of the enzyme activity at all the concentrations tested.  In 
the case of FGF2, the results showed a slight increase in the β-galactosidase levels at 
250ng/ml.  This was not a consistent effect; it was caused by the results from one of the 
experiments. 
 
In conclusion, FGF addition seemed to induce the decrease in the levels of the OCT4 
reporter in a proportional manner to the concentration of growth factor added.  The 
ANOVA test seemed to indicate a greater effect than previous data presented in Figures 
3.6 and 3.7, which may be caused by the exclusion of the concentrations of protein from 
the analysis. Normalisation of β-galactosidase levels to the protein concentration is 
standardising the results in the culture.  In this case the decrease in enzyme activity 
(Figure 3.6) could be caused by either differentiation or by a decline in cell growth.   
Since a less significant effect was observed when the results were normalised, it was 
 116
indicated that the levels of protein were not reduced, suggesting a reduction in the self-
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Figure 3.8. ANOVA analysis into the effect of different concentrations of FGF in 
mES cell self-renewal when LIF and protein levels were excluded.  The points in the 
plot are the means for the responses at the various levels of each factor plotted against 
the β-galactosidase value.  The S.E.D. shows the standard error of a difference between 
the means.  There was a decrease in β-galactosidase activity when the concentration of 
FGF was increased.  FGF4 produced a higher decrease than FGF2.  Data is presented as 









3.4.3 Determination of the specificity of FGF on mES cells 
 
Previous results indicate a positive effect of FGF in mES cell differentiation.  This could 
occur by either proliferation of the already differentiated cells or, as suggested by the 
effect of FGF and at high concentrations of LIF, by promoting differentiation.  To 
further examine the possibility of FGF producing a specific induction of mES cell 
differentiation, the effects of FGF were examined at the cellular level.  For this purpose 
the FDG assay was used, which allows the relative quantification of β-galactosidase 
enzymatic activity per cell. 
 
3.4.3.1 Conditions for the Fluorescein di-β-D-galactopyranoside (FDG) assay   
 
FDG was used to sensitively distinguish LacZ positive and negative cells, allowing time-
dependent fluorescence activated cell analysis.  FDG is cleaved by β-galactosidase in 
LacZ positive cells to yield fluorescein along with galactose (Nolan et al., 1988).  The 
emission of light by fluorescein can be detected and measured by fluorescence activated 
cell sorter (FACS) and the activity of the enzyme is directly proportional to the rate of 
fluorescence accumulation (Nolan et al., 1988). 
 
Before performing this assay, some key issues needed to be taken into account.  Firstly, 
the number of cells should be sufficient to provide enough enzymatic activity to cleave 
the substrate supplied and to provide the cells with a sufficient concentration of substrate 
for the enzyme.  This issue was addressed by performing titrations of the substrate on a 
standard number of cells.  Secondly, the fluorochrome produced by the cleavage of the 
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FDG must be retained within the cells, avoiding any transfer from the positive to the 
negative cells.  With the purpose of preventing FDG leakage, following the loading of 
the FDG substrate by hypotonic shock at 37oC, the samples were rapidly cooled with 
ice-cold PBS, which sealed the cells.  This was followed by incubation at 4oC to allow 
accumulation of the fluorescent product at the same time that cell leakage was 
prevented.   
 
3.4.3.2 Titration of the substrate (FDG) 
 
A titration was carried out with the aim of selecting the optimal concentration of FDG to 
use in the experiment.  To facilitate the examination of the fluorescence emission, the 
LacZ+ cell line (IOUD2) was mixed 50:50 with a LacZ- line (HM1).  This procedure had 
the advantage of allowing the assessment of any transfer of the fluorochrome from the 
positive to the negative cells.  The volume of FDG and cells loaded was adjusted from 
100µl (which was the amount used in the protocol described by Nolan et al, (1988) to 
40µl.  It was reasoned that loading a lower volume of FDG, the variability between 
samples, would be minimised by decreasing the time in manipulation of the samples.  
Different concentrations of FDG (2-0.1mM) were loaded into 40µl of cells at 107cells 
per ml for 2 minutes under hypotonic conditions at 37oC to improve the uptake of 
substrate through the membrane.  FDG loaded cells were incubated for 60 minutes at 
4oC at standard osmolarity.  The rate of fluorescence increment, at that temperature, is 
linear and directly proportional to β-galactosidase activity.  Fluorescence reaches a 
plateau when the hydrolysis of the substrate is completed.   
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Results presented in Figure 3.9 indicate that the concentrations 2-0.25 mM gave a peak 
ratio of 50:50 indicative of an accurate generation of fluochrome.  At these 
concentrations and cell number (107/ml), the intracellular enzyme seems to have enough 
substrate.  Moreover, the negative peaks have shifted to the right at 2 and 1mM.  At the 
concentrations of 0.25mM and 0.1mM the resolution of the peaks were unsatisfactory, 
indicating sub-optimal concentrations of FDG since they did not provide sufficient 
substrate for the enzymatic reaction.  As a result of this titration, the concentration of 
0.5mM FDG was selected in the subsequent experiments.   
 
 120
Figure 3.9. Specific staining of LacZ+ and LacZ- cells with a titration of FDG.  All 
cells were uniformly loaded at 37oC and allowed to generate fluorescein at 4oC for 60 
minutes.  A: LacZ- cells stained alone did not develop appreciable fluorescence above 
the auto-fluorescence background. B: LacZ+ cells developed considerable fluorescence 
with a minor population of cells, which have lost LacZ expression.  C: The 50:50 
mixtures treated with concentrations of FDG (2-0.1 mM) showed two discrete peaks, 
LacZ+ clearly resolved from LacZ- cells.  FDG concentrations below 0.5mM were 
suboptimal and at 0.5 mM and above there was sufficient substratum for the 107 
cells/ml.   
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3.4.3.3 Cell number  
 
The protocol developed by Nolan and et al, (1988) suggested 107cells/ml to be used with 
2mM FDG.  The results in Figure 3.9 show that 0.5mM provides a sufficient 
concentration of substratum to saturate the enzyme present at that cell number.    
 
3.4.3.4 Validation of the FDG assay 
 
To asses the efficiency of the FDG assay, the 4 concentrations of LIF (0, 4, 100 and 500 
U/ml) used in the previous experiments were tested.   After 6 days of growth in the 
different concentrations of LIF, the plates were harvested and 107cells/ml FDG stained.  
Flow cytometry results were equivalent to the results obtained by the ONPG assay.  
Accordingly, flow cytometry analysis showed an increase in the fluorescence emission 
relative to concentrations of LIF (Figure 3.10).  The fluorescence emission corresponds 












































Figure 3.10. Effect of LIF concentration on the fluorescence emission.  Six days after 
plating, β-galactosidase activity was measured by flow cytometry.  0.5µM of FDG was 
added to the mixture and incubated for 1 hour at 4oC.  A: The histograms show duplicate 
samples representing the fluorescence distribution of LacZ-cells (control, grey) and 
LacZ+ that have been maintained in 0 (red), 4 (purple), 100 (blue) and 500 (green) 
Units/ml of LIF.  B: Plotted values for the median of three independent experiments 
show that increasing concentrations of LIF are associated with a significant increased in 
fluorescence emission (p<0.001).  Two way analysis of variance used for generation of p 
value. 
    
    
    
    














3.4.3.5 Effect of FGF addition on FDG conversion 
 
To determine the specificity of the effect of FGF, FDG assays were carried out since 
they can report the effect of FGF at the cellular level.  The cells were maintained for 6 
days in the following conditions:  LIF alone, FGF2 or FGF4 with LIF or in absence of 
factors.  LIF was used at a concentration of 100U/ml because it was reasoned that if FGF 
induced a decrease in β-galactosidase levels at 100U/ml of LIF (concentration used to 
grow undifferentiated mES cell) then the undifferentiated ES cells could be the target of 
FGF.  The concentration of FGF was 25ng/ml, since at this intermediate concentration a 
decrease in enzyme activity by the ONPG assay was observed and it is the concentration 
used to induce ERK activity.  Figure 3.11 is representative of the results obtained in the 
FDG assay.   
 
Four independent experiments consistently showed a decrease in the fluorescence 
emission when FGF2 was added and more noticeably with FGF4 (Appendix 1).  The 
loss of brightness was concomitant with a decrease in the number of bright cells, which 
suggests that the reduction in the reporter occurs in the whole population.  In conclusion, 
FGF produced a decrease in enzymatic activity, and the shift of the whole population 
indicates that also the undifferentiated cells are targeted. 
 
To allow a comparison with data from hES cells grown in a defined medium, the 
analysis of FGF effects in mES cells was also carried out in the N2B27 medium (Ying et 
al., 2003b).  The FDG experiment was repeated in triplicate in independent wells four 
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times in the standard mES cells medium GMEM (Figure 3.12, A) and twice in a serum 
free medium, N2B27 (Figure 3.12, B).  Results from the FDG analysis were statistically 
analysed and the values for the medians were presented as a percentage of FDG 
conversion.  The values were normalised, taking the FDG conversion obtained in the 
absence of FGFs and in the presence of 100U/ml of LIF as 100% of substrate 
conversion. 
 
Averaged results showed a decrease in the percentage of the FDG conversion in 
response to FGF supplementation.  This decrease of β-galactosidase activity was more 
pronounced in the normal culture conditions for mES cells (Figure 3.12A) than when the 
defined medium was used (Figure 3.12B).  The fact that in the absence of LIF the 
enzyme levels were not dramatically reduced could suggest that N2B27 sustained 
enzyme activity and may mitigate the effect of FGF.  In conclusion, the effect of FGF 
was independent of the culture conditions and was promoting a reduction in the β-
galactosidase activity.  The decrease in the value of the medians indicates that FGF 






Figure 3.11. Effect of FGF addition on FDG conversion.  The LacZ+, cell line 
IOUD2, was maintained for 6 days in the presence of LIF alone (blue), LIF and FGF2 
(green) or FGF4 (red) or LIF absence (light blue).  The HM1, a LacZ- cell line (grey), 
did not convert the FDG substratum.  A decrease in the fluorescence emission was 
observed in the presence of FGF2 and more evidently in the presence of FGF4.  As 
expected the reduction was major in the absence of LIF.  The histogram is formed with 
data from one experiment and is representive of the results obtained in 4 independent 
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Figure 3.12. Normalised percentage of the FDG conversion in GMEM (A) and 
N2B27 (B) in the presence of FGF and LIF.   The values were normalised at 100% 
with the cells in the presence of LIF alone.  Error bars represent the S.D. of 3 replicates 
in 4 different experiments (A) and 3 replicates in 2 experiments (B).   Both cases showed 
a more distinct decrease in the FDG conversion in the cells treated with FGF4, which in 
the case of the standard conditions was significantly lower (p<0.001) than in the other 












































3.4.4 Validation of the LacZ as reporter of OCT4 
 
3.4.4.1 Western Blotting 
 
In order to verify that LacZ was reliably reporting the changes occurred in Oct4 levels, 
the expression of the OCT4 protein was tested directly by immunoblotting (Figure 3.14).  
As a control of the sensitivity of this assay, series dilutions of the lysate protein of the 
samples corresponding to 100U/ml of LIF, in the absence of FGF, was firstly 
immunoblotted (Figure 3.13A).  This showed that the limit of detection of OCT4 was 
about 20% of normal levels.  The quantification by densitrometry of the level of protein 
(Figure 3.13B) showed a direct proportional increase of protein to the increase amount 
of cell lysate.   
 
Once the conditions were established, to directly assess the levels of the OCT4 protein, a 
western blot was carried out.  The cells were maintained in the following conditions: LIF 
alone (100U/ml), LIF and FGF (25ng/ml) and in the absence of FGF and LIF.  In 
addition to this, a sample of fibroblast lysate was added as a negative control of OCT4 
expression.  After 6 days in culture the cells were lysed with Ripa buffer and the protein 
quantified and normalised.  The immunoblot was probed with OCT4 antibody and 
reprobed with SHP2 antibody as a loading control (Figure 3.14A). 
 
The western blot showed a reduction in OCT4 in response to FGF, which confirms the 
decrease of the reporter shown in the ONPG and FDG assays.  OCT4 as expected was 
not detected in mouse fibroblasts.  The levels of protein were quantified by densitometry 
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and the results normalised to SHP2 levels (Figure 3.14B).  The results were normalised 
against the control cells (LIF alone).  FGF2 treatment produced a decrease of 20% and 
FGF4 a reduction of 44% in the OCT4 levels.  The OCT4 protein expression in the cells 
in the absence of LIF dropped 85.5%.   
 
These results were comparable to the ONPG and FDG assays in terms of relative levels 
between treatments.  However, the lower decrease in the ONPG assay reflects a 
reduction in the effect by the protein normalisation.  Therefore, the cell population 
presents high protein levels implying that FGF is not reducing cell growth.  In 
conclusion, the western blotting shows that FGF4 and to a lesser extent FGF2, caused 
the reduction in the levels of OCT4 protein correlating with the results in the reporter 
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Figure 3.13 Immunoblotting and densitometric quantification of series dilution of 
mES cell lysate grown in 100U/ml LIF and without FGF.  A: The series dilutions of 
the samples were immunoblotted and probed with an antibody that recognises OCT4 
protein.  Fibroblast lysate was included as a negative control.  B: The levels of protein 
were quantified by densitometry showing a directly proportional increase in the levels of 
protein to the percentage of cell lysate loaded. This was linear for the concentrations 

























           
Figure 3.14. Effect of FGF on the levels of OCT4 protein assessed by 
immunoblotting (A) and quantification and normalisation of the adjusted volume 
of OCT4 to SHP2 levels (B).  Cells were maintained in LIF alone (No FGF), with 
FGF2, FGF4 and LIF in the absence of growth factors.  Fibroblast lysate (Fib) was used 
as a negative control of OCT4 expression.  After 6 days in these conditions, the cells 
were lysed and the protein levels normalised.  A: The immunoblots were probed with a 
specific antibody for OCT4 and after stripping, the membrane was reprobed with an 
antibody that recognises the total SHP2 protein, as a control of an equivalent amount of 
loaded protein.  The triplicate samples correspond to 3 independent wells with the 
treatment specified above. B: After scanning the film, the levels of OCT4 and SHP2 
were quantified by densitometry and normalised.  The results shown here are mean 
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3.4.5 Effect of FGF on the morphology of mES cells 
 
Preceding results demonstrated a suppressive effect of the FGFs on the OCT4 levels of 
mES cells.  To establish the effect of OCT4 reduction in mES cell morphology, FGF at 
25ng/ml and LIF at 100U/ml were added to the cells and after 6 days, the cells were 
fixed and X-gal stained (Figure 3.15A).  Cell staining showed that colonies of mES cells 
looked more compact and darker stained in the presence of LIF alone.  FGF 
supplemented cultures produced flattened and more diffuse colonies with a paler 
staining, principally in the presence of FGF4.  In confirmation of the previous assays, 
these effects were evident at two high concentrations (100U/ml) of LIF, a routinely used 
and a near saturating concentration of LIF respectively.   
 
In addition to this, cells maintained in the absence of LIF with or without FGF4 
supplement were X-gal stained (Figure 3.15B).   In the absence of factors a few dark 
small colonies of ES cells remained, whereas in the presence of FGF4 the staining 
appeared lighter and in a diffuse manner.  This could be indicative of the fact that even 
in the absence of LIF some ES colonies still remained, whereas FGF4 addition induced 
an overall differentiation.  A larger number of pale stained colonies in the presence of 
FGF4 could indicate the presence of intermediate cells in the process of differentiation.  
These X-gal results are in agreement with the findings of ONPG, FDG, and western 
blotting and could be indicative of a direct effect of FGF on the mES cells. 
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In all the experiments, FGF was supplemented with heparin (1µg/ml), which has been 
reported to support oligomerisation of the growth factors and stabilisation of the 
complexes with FGFRs (Plotnikov et al., 1999).  To exclude heparin as the reason in the 
morphological changes and decrease of OCT4, the effect of FGF4 was assessed in the 
presence or absence of heparin by X-gal staining (Figure 3.16).   
 
The addition of heparin alone did not decrease the activity of the enzyme, which 
contrasts with the inhibitory effect of the FGFs alone.  X-gal staining showed that 
heparin addition seems to have an effect on the compactness of the colonies but the 











        
 
 
Figure 3.15 The effect of FGF on LacZ+ mES cells in the presence/absence of LIF.  
A: IOUD2 cells were X-gal stained following 6 days incubation of the cells with 




















































Figure 3.15 The effect of FGF on LacZ+ mES cells in the presence/absence of LIF.  
B: Cells were grown for 6 days in the absence of LIF with or without FGF4 (25ng/ml) 


























Figure 3.16 Effect of FGF on LacZ+ mES cells in the presence/absence of heparin.  
IOUD2 cells were X-gal stained following 6 days incubation of the cells with or without 
heparin in the presence of LIF (100U/ml), in the absence of growth factor or in 
conjunction with FGF2 and FGF4.  The decrease in the β-galactosidase activity was 
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3.4.6 Effect of FGFR inhibition by SU5402 
 
It has been shown that SU5402 inhibitor decreased activated phospho ERK1/2 in mES 
cells (Kunath et al., 2007).  Furthermore, another inhibitor of the FGFRs, PD173074 has 
been shown to block the effect of the addition of FGF to FGF4-/- cells, therefore 
preventing differentiation of these cells (Kunath et al., 2007).  To confirm the 
differentiating role of FGF on mES cells, the inhibitor SU5402, was used.  This 
specifically interacts with intracellular catalytic domain of FGFRs (Mohammadi et al., 
1997).  Cells grown in GMEM supplemented with LIF (100U/ml) and in the presence of 
FGF (25ng/ml) were exposed to the inhibitor SU5402 (20µM).  Cells cultured in 
standard GMEM medium with LIF and the equivalent maximum concentration of the 
diluent, dimethylsulfoxide (DMSO) served as a control (Figure 3.17).  
 
After six days of continuous exposure to SU5402 the colonies appeared compact and 
rounded with well defined boundaries contrasting with the more disperse and flattened 
morphology of those maintained with only the FGFs.  This effect was observed from 
early stages of the treatment.  Interestingly, the phenotype of the cells in presence of the 
inhibitor was different than that of the cells without exogenous FGF.  This indicated the 
action of autocrine FGF in spite of the daily media change.   The effect of DMSO is 
shown by the presence of some loose cells, which suggested that the diluent is opposing 
the effect of the inhibitor.  In conclusion, inhibition of FGF signal prevented the 
emergence of the typical morphology of differentiating cells in mES cells and confirmed 
the activity of autocrine FGF4 on mES cells (Rathjen et al., 1999). 
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Figure 3.17 Effect of the inhibition of FGFR by SU5402 (SU) on mES cell 
morphology.  IOUD2 cells were cultured in a standard medium with LIF (except “No 
factor”) and 25ng/ml of FGF2 or FGF4 were added (except to “DMSO”).  After six days 
of cell exposure to 20µM of the FGFR inhibitor SU5402, the colonies were tight and 
well defined contrasting with the flattened morphology in the presence of FGF.  Cells in 
the absence of LIF, as expected, appeared differentiated (scale bar = 200μm).   
 
    No  













    FGF2                                                                         SU5402 











    FGF4                                                         SU5402 











    No  
    Factor                                        DMSO  
     
 138
3.4.6.1 Is FGF signalling required for mES cell differentiation? 
 
To establish whether FGF was a required signal for mES cell differentiation, the 
inhibitor of the FGFR, SU5402 was used on IOUD2 cells maintained in the absence of 
LIF.  In addition to this, cells were also grown in the absence of factor, with SU5402 and 
LIF, and LIF and FGF4 at the concentrations described above.  The cells were 
maintained in these conditions for three days with a daily media change. 
 
Inhibition of FGF signal, in the absence of LIF, resulted in a compact colony 
morphology, which contrasted with the stretched and flattened colonies that formed 
when the cells were starved of LIF and the FGF signal was not blocked (Figure 3.18).  
The morphology associated with differentiation observed in the absence of LIF was 
more noticeably induced when FGF4 was added to the LIF starved cells. In the presence 
of LIF, FGF4 seemed to loosen the colonies.  In conclusion, FGF signalling seemed to 
be required for mES cell differentiation and therefore, it might have a role in early 
differentiation in the murine system. 
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Figure 3.18. Effect of inhibition of FGF signal in the absence of LIF.  IOUD2 cells 
were supplemented with SU5402 in the absence of LIF (No factor+SU5402) and in the 
presence of LIF (LIF+SU5402).  Cells were also maintained in the absence of factor, in 
only the presence of FGF4 (No LIF+FGF4), only LIF and in the presence of LIF and 
FGF4 (LIF+FGF4). Cells without FGF signal seem to lose the capacity for 
differentiation in the absence of LIF (scale bar = 200μm).   
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3.4.7 Characterisation of the cells treated with FGF 
 
To establish whether the FGF associated reduction of OCT4 observed in the previous 
experiments, resulted in the differentiation of the IOUD2 cells into a particular cell 
lineage, the expression of specific genes to the three different lineages was analysed.  In 
addition to this, the expression of genes related to pluripotent stem cells was also 
examined.  Clathrin was the housekeeping gene used as a loading control and a minus 
RT control was used to test genomic DNA contamination.  The results shown in Figures 
3.18 and 3.19 are representative of repeated experiments. 
 
3.4.7.1 Expression of differentiation-associated genes 
 
To examine changes in gene expression, cDNA from mES cells maintained for six days 
in the previously reported conditions (100U/ml LIF, LIF and FGF2 or FGF4 (25 ng/ml) 
or no factors) were analysed by PCR.  All the conditions were analysed in duplicate 
samples from independent wells.  In addition to this, a cDNA sample from day nine 
embryoid body (EB) cultures was added as a control for differentiation.  The expression 
of the genes Fgf5 and Pax6 (ectoderm), Brachyury (mesoderm), Afp and Gata6 
(endoderm) were evaluated (Figure 3.19).   
 
Fgf5 (primitive ectoderm marker) expression was detected in all the conditions and there 
was a slight increase in its expression in the samples cultured in the presence of FGF4 or 
in the absence of LIF.  The other ectoderm marker, Pax6 was up regulated in the 
presence of FGF4, which suggested an induction towards the ectoderm lineage by FGF4.   
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Expression of these two genes, Fgf5 and Pax6 was also detected in the control cells (LIF 
alone).  Up regulation of these ectodermal markers could be a consequence of the 
expontaneous differentiation caused by the plating of the cells at low density.  The 
expression of the other genes, Brachyury, Afp and Gata6 was not affected by the action 
of the FGFs.  LIF withdrawal induced the up regulation of Gata6, Brachyury and Fgf5.   
In the EB sample, up regulation of four of the five genes analysed was detected: Fgf5, 
Brachyury, AFP and Gata6.  By contrast, Pax6 appeared to be expressed at a lower 
degree in the EB and the samples without any factor than in the controls.  This could be 
due to an earlier temporal expression of Pax6 in differentiation.  AFP was exclusively 
expressed in the EBs, as it has been shown that AFP is not expressed until day 7 of 
differentiation (Cai et al., 2006).  In conclusion, the addition of FGF4 to mES cells 
seemed to induce markers of the ectodermal lineage, even in the presence of LIF.  




Figure 3.19. RT-PCR analysis of gene expression in IOUD2 cells.  RNA was 
extracted from IOUD2 cells following 6 days of culture treatment.  cDNA was prepared 
and amplified with primer pairs specific for the genes shown.  PCR products for the 
same marker were all run on the same gel.  Cells were maintained for 6 days with LIF 
alone (100U/ml), with LIF and FGF2 or FGF4 (25ng/ml) and in the absence of factors.  
Sample EB corresponds to the control amplification with day 9 embryoid body.  The 
housekeeping gene Clathrin was used as a loading control.  Samples were obtained in 





























































3.4.7.2 Expression of ES-associated genes 
 
In addition to the differentiation-associated genes (Figure 3.19) the expression of genes 
related with pluripotency such as Oct4, Nanog and Rex1 and the gene for the adhesion 
molecule E-Cadherin were assessed using the samples as above (Figure 3.20). 
 
The RT-PCR results in Figure 3.20 show the reduction in expression of Oct4, Nanog and 
Rex1 in the samples without any factor and in the EBs, but not when FGF was added.  
The regulation of E-Cadherin did not seem to be significantly altered by the addition of 





Figure 3.20. RT-PCR analysis of gene expression in IOUD2 cells.  Following 6 days 
of treatment of the IOUD2 with the FGFs, the RNA was extracted; the cDNA was 
prepared and amplified with primer pairs specific for the genes shown.  Sample EB 
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3.5 DISCUSSION 
The findings reported here suggested that FGF4 promoted the reduction of OCT4 in 
mES cells; more specifically, treatment with FGF4 seemed to lead to up regulation of 
the marker of ectodermal differentiation Pax6, although this would have to be confirmed 
by quantitative RT-PCR.  The role of FGF as a promoter of differentiation in mES cells 
differed from previous reports suggesting that FGF supported the growth and survival of 
the differentiated progeny without affecting the undifferentiated mES cells (Rappolee et 
al., 1994; Wilder et al., 1997; Rizzino et al., 1988).  Wilder et al, (1997) based this 
argument on the results obtained by comparing the differentiating capacity of mES cells 
with the Fgf4 inactivated (Fgf4-/-) against the wild type.  Experiments in vivo showed 
that Fgf4-/- and Fgf4+/+ gave rise to a similar mixture of differentiated tissues, indicating 
that the host animal could provide the necessary FGF.  However, in vitro, the survival 
and proliferation of the differentiated cells was severely compromised by the 
inactivation of the Fgf4 gene.  Additionally, the data presented by Wilder et al, (1997) 
may imply a lack of the appropriate signals for differentiation in Fgf4-/- cells.  The Fgf4-/- 
colonies presented a compact homogeneous undifferentiated morphology, even when the 
cells had been plated at clonal density.  Furthermore, Fgf4-/- cells were only capable of 
differentiation when FGF4 or retinoic acid was added to the medium.  This is in line 
with the necessity for FGF signals to induce the differentiation reported in this chapter.  
The maintenance of tight colonies in the absence of LIF when FGFR was blocked by the 
chemical inhibitor SU5402, suggested the requirement of FGF signal for mES cell 
differentiation.  This contrasted with the stretched colonies associated with 
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differentiation when the inhibitor and LIF were not added.  The flattening of the colonies 
and loose cells could also be observed when FGF4 was added in the presence of LIF.  A 
quantitative RT-PCR analysis of these cells treated with the FGFR inhibitor, along with 
the samples to which FGF had been supplemented, would have highlighted the 
specificity of the effect of FGF on differentiation, such as was the case with the up 
regulation of Pax6. 
 
X-Gal staininig showed that FGF produced a flattened morphology of the colonies in 
association with a decrease in the levels of the stem cell reporter OCT4.  Interestingly, 
this reduction also happened in the presence of the inhibitor of differentiation LIF, 
which could be indicative of the direct role of FGF4 as a promoter of differentiation of 
mES cells.  Mouse ES cells express FGF and LIF receptors implying that these two 
signals can happen simultaneously.  Further support for this direct role, was in the loss 
of strong LacZ-expressing colonies when FGF4 was supplemented to a LIF free 
medium.  Conversely, some of those strong LacZ colonies were observed in the absence 
of LIF when FGF4 was not added.  It would be of interest to further analyse whether the 
morphological changes observed were the cause or the consequence of the 
differentiating process that the cells were undergoing.  For example, further studies 
would clarify whether the observed flattening of the cells induced by FGF have a role in 
the process of differentiation.  Among the adhesion molecules, which could be involved 
in this process (fibronectin, laminin and heparins), only E-Cadherin levels were assessed 
and the morphological changes observed in the presence of FGF could not be related to 
changes in the levels of E-Cadherin.  Furthermore, FGF4 stimulation of the secretion of 
 147
specific enzymes (gelatinase and plasminogen activator) (Rappappolee et al.,1994) 
associated with the differentiation of embryonic stem cells (Behrendtsen et al., 1992) 
could have a role in the observations reported in this chapter.   
 
The levels of the Oct4-LacZ reporter were further analysed by chromogenic and 
fluorogenic methods of quantification, ONPG and FDG respectively.  Using a reporter 
of the stem cell marker OCT4 was a powerful tool to quantify self-renewal and therefore 
they were chosen to the alkaline phosphatase staining.  Moreover, ONPG and FDG are 
standard methods used for assessing the levels of mES cell self-renewal by measuring 
the levels of β-galactosidase activity.  The ONPG assay has been used to establish that 
inhibition of ERK and SHP-2 signalling promoted mES cell self-renewal (Burdon et al., 
1999b).  In the case of FDG, this assay has been applied recently to determine the 
differentiation and self-renewal properties of subpopulations of mES cells with a 
heterogeneous expression pattern of NANOG (Singh et al., 2007).  The validity of the 
reporter was confirmed by direct measurement of the levels of the OCT4 protein by 
western blotting.  Western blotting was preferred to the analysis of OCT4 by flow 
cytometry because when this method was applied, unspecific staining of the negative 
control fibroblast was detected.  Further stainings were performed on the mES cell line 
ZHBtc4.1 cells that carry two null Oct4 alleles modulated by a doxycycline-responsive 
Oct4 transgene (Niwa et al., 2000).  In this case, both the treated and untreated cells 
showed similar levels of OCT4 staining although western blotting established that only 
the cells that had not been treated with the drug expressed OCT4.    
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In this thesis, ONPG and FDG methods confirmed that β-galactosidase activity in ES 
cells was dependent on the dose of LIF, which is consistent with a previous report by 
Smith et al, (1988).  More significantly was the reduction in the expression of the OCT4 
reporter when FGF was added.  This was consistently quantified by the ONPG and FDG 
assays.  In fact, the FDG assay indicated that the decrease in the levels of β-
galactosidase occurred in the entire population rather that in a more differentiated 
fraction of the cells.  This result suggested a direct effect on the ES cells, which is 
consistent with the reduction in enzymatic activity observed at high concentrations of 
LIF.   Therefore, ONPG and FDG assays confirmed the morphological studies and 
contrasted with previous reports (Rappolee et al., 1994; Wilder el al., 1997; Rizzino et 
al.,1998; Viswanathan et al.,2003).  It should be noted, results from the FDG assay 
revealed that a reduction in the OCT4 reporter was caused by a decrease in self-renewal 
rather than a reduction in cell proliferation, since an equal number of cells were used in 
all the FDG experiments.  FGF induced reduction of OCT4 protein is consistent with the 
decrease in the OCT4 reporter activity.  Densitometry quantification verified a 
significant decrease of 30% between the FGF4 samples and the controls.   
 
This reduction in protein levels, however, was not reflected by the Oct4 gene expression, 
which indicates the limited sensitivity of the non quantitative RT-PCR.  Down-
regulation of Oct4 and the other ES cell associated genes analysed Nanog and Rex1, was 
only detected when LIF was withdrawn.  On the other hand, the effect of FGF in the 
morphological changes and in the reduction of OCT4 did correlate with a slight increase 
in Pax6.  The up regulation of Pax6, a marker associated with ectoderm lineage, 
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contrasts with reports of FGF4 promoting primitive endoderm (Wilder et al.,1997; Esner 
et al.,2002) and mesoderm (Ciruna and Rossant, 2001) differentiation in mES cells.  
This discrepancy in the reports could be a consequence of the different approaches used, 
that is exogenous FGF was added in this thesis, instead of the inhibition of endogenous 
FGF signal performed in the reports above.  However, more recently other groups have 
revealed the association of FGF and the ectodermal lineage in mES cell differentiation.  
It has been reported that FGF4 promoted mES cell neuroectodermal differentiation when 
the inductive signals for alternative fates were removed (Kunath et al., 2007).  
Furthermore, a gene identified in the chicken embryo induced by FGF, Churchill (chch), 
has been found to inhibit the expression of the mesoderm marker Brachyury and to 
facilitate the ectoderm induction to neural fate (Sheng et al., 2003).   
 
The control cells also expressed the two ectodermal markers, Fgf5 and Pax6, which 
could be a response to the low density at which the cells were seeded at the beginning of 
the experiment.  Cell exposure to autocrine differentiating signals, as a consequence of 
their maintainance for 6 days in the same medium, could also induce the expression of 
these markers.  Expression of Fgf5 is used as an early marker of ES cell differentiation 
since it is up regulated by LIF withdrawal, and is associated with the formation of a 
population corresponding to the egg cylinder in the epiblast (Rathjen et al., 1999).  Fgf5 
expression has been shown in pluripotent cells of the primitive ectoderm from 4.75 d.p.c 
(Pelton et al., 2002) and also low levels have been found in ES cell cultures (Kunath et 
al., 2007).  This could be due to the progressive appearance of different pluripotent 
populations in the transition from ICM to primitive ectoderm (Pelton et al., 2001).   
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In contrast to the up-regulation of Pax6, the addition of FGF had no effect on Brachyury, 
AFP and Gata6 expression.  This indicates the restriction in the choice to the ectoderm 
lineage when the mES cells were supplemented with FGF4.  As mentioned above, the 
addition of FGF could have different outcomes than just the inhibition of FGF.  For 
example, the absence of FGF signalling reduces the expression of Afp (Esner et al., 
2002), but supplementation of FGFs did not promote the expression of this endoderm 
specific gene.  Furthermore, the differentiation method used in this chapter could have 
an impact on differentiation.  For example, FGF was added in the presence of LIF, 
which by activating STAT3 resulted in the suppression of neurodermal differentiation.  
In addition to this, the adherent culture used in this report may be limiting the 
differentiation capacity to only one lineage, since it does not fully reflect embryonic 
differentiation.  In addition to this, an adherent model perhaps results in the slower 
regulation of the genes and therefore, a wide range of different points in time would 
need to be assessed.  Furthermore, it needs to be taken into account that maintained in 
culture, some active factors may be altering or promoting certain markers and/or 
restricting others.   
 
The results of the PCRs seem to be in line with previous reports suggesting that Oct4 
and Nanog regulate differentiation by transcriptional repression of genes that promote 
differentiation (Mitsui et al., 2003).  However, this appears to occur only for certain 
lineages since down regulation of Oct4 and Nanog correlated with the increased 
expression of Gata6 and Brachyury.  However, also within the pluripotent Oct4 positive 
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cells, distinct genes associated with differentiation were detected.  Cells with a strong 
expression of Oct4 and Rex1 also expressed Pax6 and Fgf5 and in lower level expressed 
Gata6, but did not express Brachyrury and Afp.  This co-expression of typical ES cells 
and differentiation markers may be denoting a state of transition in the pluripotent cell 
population. A model for the transition from ICM to primitive ectoderm would be in 
agreement with the regulation of peri-implantation in pluripotent cell development by 
FGF signalling (Feldman et al., 1995, Armand el al., 1998).  However, the resultant 
alteration of Rex1 expression in vivo was not confirmed in this project. 
 
The expression of the Fgf4 gene in ES is controlled by OCT4 and SOX2 activation of its 
enhancer (Curatola and Basilico, 1990) and all the three factors are expressed 
simultaneously in pluripotent cells.  It has been established that the maintenance of ES 
cells depends on the tight regulation of the levels of OCT4 (Niwa et al., 2000).  FGF4 
has an essential role in the development of the mouse embryo and thus it should be also 
closely regulated. Therefore, when differentiating signals such as FGF4 are stronger than 
those promoting self-renewal such as STAT3, differentiation would occur.  As shown by 
immunoblotting in this chapter, FGF induced ERK activation but did not activate 
STAT3.  This contrasts with LIF, which activated both STAT3 and ERK.  Activation of 
STAT3 is essential in the self-renewal of mES by possibly blocking ERK signalling 
(Burdon et al., 1999b).  Therefore, when both LIF and FGF act simultaneously, this 
balance is lost.  This hypothesis could also be associated with the differentiation caused 
by OCT4 over expression, which is a similar differentiation to LIF withdrawal (Niwa et 
al., 2000) or NANOG deletion (Chambers et al., 2003; Mitsui et al., 2003).  This could 
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be caused by the over stimulation of FGF4 by high levels of OCT4, which in turn could 
increase FGF autocrine signalling, promoting differentiation.  Furthermore, this could be 
related to a recent report which attributes to FGF a role in NANOG regulation 
(Hamazaki et al., 2006).  FGF through the activation of MAPK/ERK pathway repressed 
NANOG expression, resulting in endoderm differentiation (Hamazaki et al., 2006).   
The divergence in the lineages up-regulated by FGF in the report by Hamazaki et al, 
(2006) and this thesis could be caused by the different culture conditions.  The high 
concentrations of LIF used here could be repressing an endodermal differentiation.  It 
would have been of interest to assess whether the down-regulation of OCT4 by FGF was 
through the modulation in NANOG expression.  In particular, assessment of different 
points in time in Gata6 expression may clarify the involvement of NANOG in the 
process.  
 
At the time of writing this thesis, two reports (Stavridis et al., 2007; Kunath et al., 2007) 
regarding the functions of FGF in mES cells were published.  Both reports confirm the 
role of FGF4 and to a lesser extent FGF2 in the induction of mES cell differentiation 
into ectoderm lineage.  More specifically, Kunath et al., and Stavridis et al., (both 2007) 
established that FGF4 is the initiator of neuroectodermal commitment, indicating the 
role of FGF4 in earlier stages of differentiation.  In addition to this, and in agreement 
with this thesis, Kunath et al, (2007) established the differentiative role of FGF.  Fgf4-/- 
mES cells remained in an undifferentiated state, even upon LIF withdrawal, instead of 
selecting an alternative commitment program when FGF4 was not added (Kunath et al., 
2007).  Kunath et al, (2007) also demonstrated that the requirement for FGF was 
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selective, since the addition of FGF5 failed to restore the neural differentiation of Fgf4-/- 
mES cells.  Among the three pathways activated during neural specification (PI3K, 
phospholipase C gamma (PLCγ) and MAPK/ERK) (Stavridis et al., 2007), it was 
established that it is the FGF/ERK pathway that initiates neural specification in mES 
cells (Kunath et al., 2007) and in the embryo (Stavridis et al.,2007).  In addition to ERK, 
it would be interesting to get further insight into the role of PI3K in the process of 
differentiation.  FGF/PI3K pathway has been shown to be necessary for differentiation 
of EBs (Chen et al., 2000).  In addition to this, PI3K/AKT regulates numerous cellular 
processes such as cytoskeletal rearrangement that could also be associated to 
differentiation.  Finally, Kunath et al, (2007) proposed that FGF activation of ERK 
induced a transitory state in the mES cells in which pro differentiating signals could 
specify the cell commitment.  This implied the necessity for controlling FGF signals in 
order to sustain pluripotency.  The transcription factors OCT4, SOX2 and NANOG are 
the suppressors of those inductive signals (Silva and Smith, 2008).  The results from this 
chapter are in line with this model, in that a FGF4 reduction of OCT4 caused a decrease 
in resistance to differentiation and those cells with reduced OCT4 were “open” to signal 







































Figure 3.21 Regulation of mES cell self-renewal.  OCT4 is maintained during LIF 
activation of STAT3.  OCT4 in these conditions maintains self-renewal by suppressing 
differentiative signals.  FGF increased ERK activity, causes the reduction in OCT4 
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Human (Thomson et al., 1998) and mouse (Evans and Kuffman, 1981) ES cells were 
initially isolated and propagated on irradiated mouse embryo fibroblast (MEFs) feeder 
cells, in a medium that contained serum.  In mouse ES cell propagation the principal 
function of the feeder layer was to supply the cytokine LIF.  LIF signalling activates the 
transcription factor STAT3, which is the key event to sustain mES cell self-renewal 
(Niwa et al., 1998; Matsuda et al., 1999).  The identification of LIF as the required 
cytokine in mES cell self renewal was a significant development in mES cell knowledge 
(Smith et al., 1988).  Consequently, mES cells could be propagated and maintained in a 
serum containing media to which the appropriate amount of LIF is added (Williams et 
al., 1988).  However, the requirements for hES cells propagation are more complex and 
although LIF can also activate the gp130/STAT3-signalling pathway, this mechanism 
cannot support the growth of the hES cells (Thomson et al., 1998; Daheron et al., 2004).  
The different signalling requirements for the self-renewal of mouse and human ES cells 
imply the existence of alternative factors to LIF released by the mouse embryonic 
fibroblasts (MEFs) and/or present in the serum to support hES cells self-renewal.   
 
MEFs provide the substratum and the microenvironment for the maintenance and growth 
of undifferentiated hES cells.  However, MEFs also add unknown factors to the culture 
system (Lim and Bodnar, 2002).  This is a critical issue for the studies of this thesis, 
since the complexity of the system could cause confusion in the analysis of the effects of 
individual factors.  Furthermore, the large amount of factors in this system, all 
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potentially highly variable, complicates the consistency of the growth conditions.  In 
addition to this, the heterogeneity of the culture complicates the study of hES cells 
biology and biochemistry at the same time that contact with the MEFs can increase the 
risk of hES cells contamination with pathogens.  Therefore, to minimise the effects of 
undefined factors in the growth of the hES cells, different culture systems have been 
developed.  In the first feeder free method elaborated, hES cells were maintained on 
Matrigel coated plates with a culture medium that had been conditioned from mitotically 
inactivated MEFS and supplemented with FGF2 (Xu et al., 2001).  This system 
eliminated direct contact of hES cells with MEFs but still required the use of 
conditioned medium (CM) from MEFs.  Therefore, the possibility of pathogen 
transmission caused by the mouse feeders when generating MEF-CM remained.  
Furthermore, it did not provide a solution to the complexity and variability.    
 
Human feeders including human foreskin fibroblasts (Amit et al., 2003) and human 
adult marrow cells (Chen et al., 1999) were demonstrated to support hES cell growth.  
However, human serum also contained undefined components and it is variable in 
quality.  Consequently, a serum free medium (SFM) medium produced by conditioning 
with human feeder cells and containing recombinant proteins has also been used to 
culture hES cells in a feeder free system (Li et al., 2005).  However, the use of an 
additional cell line still implied variability in performance.  For these reasons it was 
necessary to develop a culture medium that was defined, contained only recombinant 
proteins and did not require conditioning with feeder cells. 
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The objective when developing a serum-feeder free medium is to replicate the 
conditions in which hES cells are propagated when maintained on the feeder cells 
through the addition of growth factors to a basal medium.  Feeder cells are believed to 
support hES proliferation because they release factors that promote the growth and/or 
remove toxic or differentiating components from the medium.  However, at the time of 
preparing this thesis, with the exception of FGF2, the active/s factor and specific 
mechanisms that sustained hES cells growth had not yet been identified.  Feeder cells 
also secrete either protease inhibitors or binding proteins that adjust FGF2 stability, as 
suggested by the enhanced stability of FGF2 in CM (Levenstein et al., 2005).  Finally, 
another essential function of the feeders is the promotion of the extracellular matrix 
formation (Lim and Bodnar, 2002).   
 
Culture systems have been developed to reproduce the culture conditions attained in 
conditioned media.   The first serum free media containing only human sourced or 
recombinant proteins were developed for culturing human progenitor cells, mainly 
hematopoietic stem cells (Lam et al., 2001).  One of the earliest feeder and serum free 
culture system for hES cells made use of serum replacement (SR) supplemented with 
FGF2 and TGFβ1 on plates coated with fibronectin (Amit et al., 2004).  This system did 
not require the conditioning of the medium, but undefined bovine sourced materials 
were still included.  More recently another feeder free and defined system has been 
reported in which the growth of the hES cells was achieved by adding high 
concentrations of hFGF2 (80ng/ml).  However, the total composition of the medium was 
not published (Li et al., 2005).  During the preparation of this thesis, other groups have 
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reported increasingly refined feeder free culture systems for hES cells.  All these 
systems included FGF2 or/and growth factors from the TGFβ family in order to achieve 
hES cell self-renewal (Wang et al., 2005; Beattie et al., 2005; Xu et al., 2005a; Xu et al., 
2005b).  However, in these systems the serum has been substituted by knockout serum 
replacement (KSR) which is still undefined and of animal origin.  More recently further 
developed chemical defined and animal free culture mediums have been reported 
(Beattie et al., 2005; Yao et al., 2006; Lu et al., 2006; Liu et al., 2006; Ludwig et al., 
2006b)  These newly described systems have been demonstrated to support the growth 
of undifferentiated hES cells but still are not used routinely for hES cell culture.  
Nevertheless, they can help to clarify the requirements for hES cell self-renewal, 
pointing towards the significant factors and signalling pathways involved in the 
propagation of hES cells.  For example, the medium developed by Ludwig et al, (2006), 
is a combination of FGF2, LiCl, GABA, pipecolic acid and TGFβ.  LiCl (lithium 
chloride) activates the Wnt pathway and together with the presence of FGF2 and TGFβ, 
highlights the importance of activation of this three signalling pathways in hES cells 
(Amit et al., 2004; Sato et al., 2004; Xu et al., 2005b; Yao et al., 2006).  In addition to 
this, GABA (γ-aminobutiric acid) was used because microarray assays indicated that 
GABA receptor is highly expressed in hES cells (Sperger et al., 2003; Sato et al., 2004) 
and stimulates proliferation of different tissues (Watanabe et al., 2006).  Pipecolic acid 
was included as it has been reported to enhance the response to GABA (Takahama et al., 
1986).  Therefore, the use of these or similar factors can serve as a starting point for 
further optimisation of the culture conditions of hES.  
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4.1.1 Limitations of conditioned medium  
 
The standard conditions for hES cells culture make use of conditioned medium (CM), 
which is highly complex due to the secretion of multiple growth factors by the 
fibroblasts (Wei et al., 2005).  In addition to the factors secreted by the fibroblasts, hES 
cells highly expressed and released many factors including FGF2 (Dvorak et al., 2005) 
and FGF4 (Mayshar et al., 2008).  The broad expression of FGFRs in hES cells strongly 
suggested that there was an autocrine activity of these factors occurring (Dvorak et al., 
2005).  The complexity of the CM is aggravated by multitude of proteins and soluble 
factors contained in the serum which can be both beneficial and detrimental to hES cells 
culture.  The effects of CM complexity on hES cell culture is indicated by the difficulty 
in showing an unambiguous differentiated phenotype upon FGF2 withdrawal.  This 
suggests FGF2 presence in the medium and is illustrated by the tight colonies indicative 
of hES cells after twelve days in FGF2 withdrawal (Figure 4.1).  FGF2 presence in CM 
is not sufficient to maintain the proliferation of hES cells and routinely 4-8 ng/ml needs 
to be added to the CM.  However, in spite of FGF2 supplement, hES cell cultures appear 
heterogeneous with great amount of stromal cells surrounding the hES cells (Figure 4.1).   
This suggests the presence of factors inducer of differentiation in the CM implying that 
the growth conditions in the CM are not ideal.  A further consequence of the use of CM 
is the high variability in the ability to support hES cell proliferation throughout the 
different batches of serum and MEFs.  The quality of the MEFs is also highly variable 
throughout the days when the medium is collected implying a high variability in the 
quality of CM.  For these reasons and in particular because the presence of FGF2 in the 
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CM, any results obtained in a system including CM and serum could be questionable in 
the study of FGF2.   
 
To be able to define the contribution of FGF signalling to hES cell self-renewal in short-
term experiments using a define culture media was crucial. Such a medium would 
reduce any inconsistency in experiments associated with serum or MEF variability 
would allow defined and reproducible differentiation studies.  This chapter reports the 
use of a semi defined culture system for hES cells composed of a serum free medium, 
which did not require conditioning with feeder cells and Matrigel.  The use of this 
medium permitted preliminary studies characterising the effect of FGF2 on hES cells.  It 
should be noted that there is a high expression of endogenous FGF2 in undifferentiated 
and differentiated hES cells.  This endogenous FGF2 signal acts in an autocrine and 
intracrine fashion in undifferentiated hES cells and its inhibition results in differentiation 
(Dvorak et al., 2005).  In addition to FGF2, it has recently been reported that FGF4 and 
a new splice isoform (FGF4si) are secreted from undifferentiated hES cells as well as 
from mES cells but not from MEFs (Mayshar et al., 2008).   Mayshar et al, (2008) 
proposed that FGF4 promoted the undifferentiated growth of the hES cells, whilst 
FGF4si opposed its effect.  This agrees with the pattern of expression, that is, whilst 





Figure 4.1. Human ES cells growing on Matrigel and CM.  Morphology of the cell 
line H1 grown in CM in the presence or absence of FGF2.  The withdrawal of FGF2 did 
not result in a complete differentiation after 12 days in culture, which indicates the 
presence of factors that support hES cell self-renewal.  Asterisks highlight the colonies 
with a tight morphology associated with undifferentiated hES cells.  Even when FGF2 is 
added to the culture there is a great amount of flat stromal cells (highlighted by arrows) 
surrounding the compact colonies of the hES cells, suggesting the inadequacy of the 





















4.2 Hypothesis A 
That human ES cells could be propagated in semi-defined conditions and in this 
environment, hES cells still depend on FGF2 for their growth in an undifferentiated 
state.   
 
4.3 Objectives 
I To define the contribution of FGF signalling on hES cell self-renewal 
II To develop a defined medium suitable for the study of FGF signalling on hES 
cells 









4.4 Experimental design 
 
            
 
Figure 4.2. Diagram of the experimental steps followed in this chapter.  Two cell 
lines T5 and H1 were transferred from CM to a defined culture condition where the 
effects of FGF in morphology, cell growth and self-renewal were studied. 
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4.4.1 The dissociation methods 
 
In this study the hES cells were not grown on feeders but, because they require adhesion 
to an extracellular matrix for survival and growth, the hES cells were seeded on 
Matrigel.  The cell culture was initially carried out in CM, using collagenase as method 
of harvesting.  However, this typical method for the dissociation of hES cells produced 
low number of cells over long time.  Because the experiments planned for this thesis 
depended largely on routine availability of moderate to large number of cells, the 
harvesting system was changed from collagenase to PBS-EDTA.  PBS-EDTA has being 
used previously to transfections (Gerrard et al., 2005) and is chemically defined.  PBS-
EDTA is used prior to transfection because this method produces flattened colonies in a 
monolayer, which makes easier the direct visualisation of any morphological change 
result of the treatments studied.  Observation of the morphology is also improved by the 
clearer appearance of the colonies (Figure 4.3).  Collagenase harvesting requires the 
manual scraping of the cells from the plate surface, generating big clumps of cells, 
whereas PBS-EDTA dissociaton is in smaller groups of 4-8 cells.  This provided enough 
cells to prevent the differentiation caused by single cell dissociation that occurs when 
trypsin is used (Draper et al., 2004).  Furthermore, the use of PBS-EDTA improved the 
plating efficiency, enhancing the growth rate from the start and therefore larger number 






Figure 4.3. Morphology differences between hES cells harvested by collagenase and 
PBS-EDTA.  The method of harvesting the hES cell line H1 was changed from the 
standard collagenase to PBS EDTA, in order to facilitate the visualisation of any 
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4.4.2 Cell lines 
 
The experiments described here were performed on two hES cell lines, H1 (Thomson et 
al., 1998) and the transgenic T5 (Gerrard et al., 2005) cell lines.  T5 cells had been 
derived from the H1 cell line by the transfection of an enhanced green fluorescence 
protein (EGFP) vector under the control of the Oct4 promoter (Gerrard et al., 2005).  
The insertion of the Oct4 promoter upstream of EGFP strongly drives its expression and 
therefore the levels of the reporter provide a measurement of stem cell self-renewal in 
the T5 cells (Gerrard et al., 2005).   The system of the OCT4-EGFP reporter is 
equivalent tool to the OCT4-LacZ in the IOUD2 and Y118F cell lines but it has the 
advantage over OCT4-LacZ in that allows direct checking of OCT4-EGFP in living 
cells.  Expression of the autofluorescent protein can be directly observed by confocal 
microscopy and quantified by flow cytometry, and fluorimetric assays.  Therefore, T5 
cell line was a powerful tool to study the effects of the culture conditions on the hES 


































Figure 4.4. OCT4-EGFP clonal cell line T5 derived by (Gerrard et al., 2005) A: 
EGFP image and corresponding phase-contrasting image of T5 (taken from Gerrard et 
al.,2005).  Only the hES cell colony expressed OCT4-EGFP.  B: Experimental system.  
T5 cell line carries the EGFP reporter of the stem cell specific marker, OCT4.  
Expression of the OCT4-EGFP reporter in hES cells is restricted to undifferentiated ES 
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4.5.1 Cell growth in un-pre-treated CM  
 
The routine maintenance of hES cells involved a conditioned medium (CM) prepared by 
incubating the basal medium (Xu et al., 2001) on MEFs to which 4 ng/ml of FGF2 is 
added.  To the CM an extra 8ng/ml of FGF2 is added at the time of feeding the hES cells 
(CM+FGF2).   To reduce FGF2 from the culture medium, CM to which FGF2 had not 
been added at any point was intended to be used in early experiments.  H1 cells were 
plated in medium (untreated), in untreated medium with FGF2 added to the hES cells 
(untreated+FGF2), medium treated with 4g/ml of FGF2 alone (CM) and the medium 
routinely used (CM+FGF2).  A diagram of the conditions is shown in Figure 4.5.A.      
 
Within 5 days of culture in the conditions described above, the morphological 
differences became evident.  The cells growing in CM+FGF2 presented the typical 
morphology of hES cells cultured in CM.  This contrasted with the less compact 
colonies growing in the untreated medium +FGF2, which were surrounded by cells with 
a differentiated morphology.  As expected, the growth of the cells in CM alone was 
slower and highly differentiated.  This contrasted with the complete cell loss in the 
untreated medium alone (Figure 4.5B). 
 
These results highlighted the necessity for a medium independent of the conditioning 
process.  They also suggested the importance of the addition of FGF2 as early as the 
conditioning step to perhaps stimulate the secretion of other factor/s.  
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Figure 4.5.  A: Process of media conditioning (for more details see 2.1.3.1) B: 
Morphology of hES cells in CM in presence/absence of FGF2.  H1 cells grown in 
treated conditioned medium with FGF2 addition before and after the conditioning step 
(CM+FGF2), in CM supplemented with 8ng/ml after conditioning (untreated+FGF2), in 
CM supplemented with 4ng/ml FGF2 before the conditioning (CM) and in CM without 
FGF2 (untreated).  Adequate hES cell proliferation was attained only with CM produced 
by MEFs to which FGF2 had been added.   
4ng/ml FGF2 




CM+FGF2                               Untreated+FGF2 
CM                  Untreated   
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4.5.2 Transition from CM to serum free medium 
 
The chemical defined medium N2B27 has been shown to sustain mES cells (Ying et al., 
2003b).  At the outset, it was intended to use the N2B27 medium, supplemented with 
FGF2 and in conjunction with Matrigel, only to analyse the short term effects of FGF on 
hES cells.  However, surprisingly, hES cells (T5 and the parental H1 cell lines) could 
also be maintained in the N2B27 for several passages. 
 
4.5.2.1 Morphological changes  
 
The fact that there was not an increase in death during the transition of H1 and T5 hES 
cell lines to the new serum free conditions suggested that the signalling activated by the 
N2B27 were not significantly different from CM.  However, some changes were noted 
in the morphology of the cells during the first hours of the transition into the serum free 
medium N2B27 (illustrated by H1 cell line in Figure 4.5).  N2B27 seemed to induce a 
rapid increase in cell size accompanied by a flattened morphology.  This morphology 
reversed in the next few hours and during the next day in N2B27 the cells proliferated 
rapidly.  Once the cells have reached confluence (80-85% of the surface area covered) 
the hES cells were harvested and plated at a 1:3 dilution.  After a few hours following 
cell plating, the hES cells in N2B27 had attached to the Matrigel and after 24 hours, the 
cells were spreading, maintaining dense and compact cell morphology (Figure 4.7).  
This was observed in H1 and T5 cell lines, which became confluent after two days in 
N2B27, contrasting with the slower cell attachment and proliferation in CM.  
Furthermore, both cell lines presented clear defined boundaries, unlike the cells in 
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conditioned medium, (Figures 4.1 and 4.3,A) with a dramatic decrease in the stromal 
differentiated cells that normally surround the hES cells colonies (Figures 4.7 and 4.8).  
T5 cells grown in N2B27 maintained the expression of OCT4-EGFP reporter (Figure 
4.8).  This expression was associated specifically with colonies of undifferentiated hES 






























Figure 4.6. H1 transition from CM to N2B27 defined medium.  H1 cells maintained 
in CM were passaged into N2B27.  Initially, N2B27 induced flattening and enlargement 
of the cells.  After 12 hours the cells formed a compact monolayer, in a similar manner 




































Figure 4.7. Cell morphology of H1s following first passage in N2B27 and how it 
compares to the CM conditions.   Following an effective cell attachment in the new 
conditions, H1s showed neat and compact colonies after 24 hours from the first passage 
in N2B27.  The morphology of H1p66 1EDTA colonies in CM appeared flatter and less 
compact and defined (scale bar = 200μm). 
 
 
    N2B27   CM 
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Figure 4.8. Live OCT4-EGFP clonal cell line T5 in serum free conditions and CM.  
EGFP image and corresponding phase contrast image of T5 in N2B27 and CM (PBS-
EDTA) show sharper and better defined colonies in serum-free medium compared to 
CM.  Live images show that the hES OCT4-EGFP clonal cell line T5 growing in N2B27 
for several passages maintained the OCT4 EGFP reporter.  EGFP is expressed uniquely 
and specifically in the undifferentiated hES colonies.  The arrows highlight 
differentiated cells that have lost their EGFP expression.  Note that in the EGFP image 
(N2B27) there are some cells in the centre of the colony not expressing EGFP.  These 
cells do not present the morphology of differentiated cells but have possibly silenced the 
reporter, which could be due to epigenetic changes resulting from the integration site 
(scale bar = 200μm).   
 
 
N2B27                                 CM 
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4.5.2.2 Expression of OCT4  
 
To determine whether hES cells growing in N2B27 maintained the expression of the 
internal standard marker for pluripotent cells a Western Blot was carried out.  Samples 
containing equivalent numbers of cells were prepared from H1 and T5 cell lines cultured 
in serum free conditions for over 10 passages.  The immunoblots were probed using an 
antibody against OCT4 and the membranes stripped and probed for SHP2 to ensure 
equality in loading. 
 
High levels of OCT4 protein were detected in both cell lines after several passages in the 
defined conditions when analysed by immunoblotting (Figure 4.9).  The levels of OCT4 
in the serum free medium were comparable to those of the cells maintained in CM, 
establishing the maintenance of the stem cell marker OCT4.  In addition to this, the 
OCT4-EGFP (Figure 4.8) was validated as an effective reporter of the endogenous 












Figure 4.9. Expression of OCT4 in H1s and in the subclone T5. After harvesting, an 
equivalent number of cells were lysed and the immunoblots probed using an antibody 
against OCT4.  After stripping the membranes, they were reprobed with an antibody 
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4.5.2.3 Expression of surface markers  
 
H1 and T5 cell lines propagated in serum free conditions maintained the expression of 
the marker of pluripotency OCT4.  To get an independent confirmation that hES cells 
growing in N2B27 retained qualities of cells in CM, the expression of cell surface 
markers was compared by flow cytometry.  Expression of SSEA3 and 4 and TRA1-81 as 
markers of undifferentiated hES cells and SSEA1 as a marker of early differentiation 
was assessed.  It is widely reported that human ES and EC cells typically express 
SSEA3 and SSEA4 but not SSEA1 whilst their differentiation is characterised by down-
regulation of SSEA3 and SSEA4 and an up-regulation of SSEA1 (Andrews et al., 1984). 
 
Regular assessment of surface markers was carried out in hES cells and Figure 4.10 
shows a representative outline of the expression of surface markers on the H1 cell line.  
In N2B27 and CM conditions the surface markers associated with undifferentiated hES 
cells SSEA4, SSEA3 and TRA1-81 were highly expressed.   This expression was 
slightly higher on the cells maintained in N2B27, whilst the expression of early 
differentiation marker: SSEA1 was lower than on those cells in CM.  This could be 
reflecting the decrease in the amount of cells with differentiated morphology observed in 
N2B27. 
 
The expression of surface marker was also assessed on the T5s growing in CM (Figure 
4.11 A) and after 12 passages in N2B27 (Figure 4.11.B) by flow cytometry.  TRA1-81 
and SSEA3 expression were analysed as markers of undifferentiated hES cells and 
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SSEA1 as a marker for differentiation.  T5s in CM showed a high expression of TRA1-
81 (97%) with a high percentage of cells co-expressing this hES cell marker with EGFP 
(62.4%).  SSEA1 expression was low (6.7%) with a small percentage of cells co-
expressing EGFP and this early marker of differentiation (3.8%).  This could be 
reflecting cells in transition to differentiation that still retained EGFP expression (24 
hours half-life).  The high percentage of unstained cells (US) may give account of cells 
which have silenced the reporter and are negative for SSEA1 expression.  Analysis of 
surface markers expression on T5s in N2B27 (Figure 4.11B) showed high levels of 
expression of the specific surface marker for undifferentiated hES cells SSEA3 (96.8%) 
simultaneously with a low expression of SSEA1 (2.7%).  SSEA1 expression was lower 
than in CM, confirming the decrease in the differentiated cells in the serum free 
conditions detected by direct observation of the cell morphology.   
 
The maintenance of surface markers on H1s and T5s associated with undifferentiated 
hES cells and a reduction of the expression of the early differentiation marker SSEA1 
was established by flow cytometry.  Surface marker expression was related to the high 
expression of OCT4 protein illustrated in Figure 4.9.   Flow cytometry also confirmed 
the expression of EGFP by ultraviolet microscopy in the T5s maintained in the serum 
free medium (Figure 4.8).   
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Figure 4.10.  Flow cytometry analysis of surface markers expression on H1 
maintained in N2B27 vs CM.  In the defined conditions H1s showed a higher 
expression of surface markers associated with undifferentiated hES cells and a lower 




















































































































Figure 4.11. Flow cytometry analysis of surface markers expression on OCT4-
EGFP cell line T5 maintained in CM (A) and N2B27 (B).  EGFP expression and 
surface antigens, TRA1-81, SSEA3 and SSEA1 were analysed by flow cytomety.  In 
both conditions EGFP and surface markers associated with self-renewal were expressed 
in CM and N2B27.  SSEA1, as early differentiation marker, was also detected at low 
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4.5.3 Effect of FGF2 on hES cells growing in serum free conditions 
 
4.5.3.1 Effect of FGF2 cell growth 
 
After establishing that H1 and T5 cell lines grown in N2B27 maintained the expression 
of internal and cell surface markers associated to hES cells, the effects of FGF2 were 
studied.  To establish the role of FGF2 on cell growth, H1s and T5 cells 
(5x105cells/well) were seeded with and without FGF2 and the media changed daily. 
 
Observation of the plates showed larger colonies in the presence of FGF2, indicative of a 
positive effect of FGF2 on the growth of the H1 (Figure 4.13) and the T5 (Figure 4.15) 
cell lines.  However, in the absence of FGF2 the T5s maintained a strong OCT4-EGFP 
expression as well as a similar morphology to the cells growing in FGF2 (Figure 4.15).  
It could also be observed that in the early stages of the experiment (Figure 4.13 (A), D1) 
there was more debris in the absence of FGF2.  This could be indicative of cell death 
and might suggest a possible role of FGF2 on cell viability or cell adhesion.  The effect 
of FGF2 on H1 cell growth was confirmed by quantification of the cell number.  During 
the 6 days of the experiment, cells from 3 independent wells were counted and the mean 
results used to produce a growth curve (Figure 4.14).  The results showed an increase in 
cell number in the presence of FGF2 and similar results were obtained in two 
independent experiments (appendix 2).  The lower number of cells harvested in day 1 
(D1) was possibly a consequence of the low density plated.  In conclusion, the absence 
of FGF2 from the medium produced a decrease in cell growth in the two cell lines T5 
and the parental H1.   
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            FGF2        No FGF2 
 
Figure 4.13. A. Effect of FGF2 on H1 cell morphology (days 1-3).  The H1 cell line 
was seeded at 5x105 cells/well in 6 well dishes and maintained for 6 days in the 
presence/absence of FGF2 with daily media change.  These images were representative 








































Figure 4.13. B. Effect of FGF2 on H1 cell morphology (days 3-6).  The H1 cell line 
was seeded at 5x105 cells/well in 6 well dishes and maintained for 6 days in the 
presence/absence of FGF2 with daily media change.  These images were representative 



































  FGF2                                                                  No FGF2 
B 
 185





















Figure 4.14. Effect of FGF2 on H1s cell numbers.  The H1cell line was seeded at 
5x105 cells/well in 6 well dishes and maintained for 6 days in the presence/absence of 
FGF2 with daily media change. The cell number from three independent wells was 
counted daily and from the results a growth curve was produced.  Cell numbers 
increased significantly (p<0.001) when FGF2 was present in the cell culture. Data is 
presented as the mean ± S.E.M of 3 counts.  Two way anlysis of variance used for 























   
 
Figure 4.15. Effect of FGF2 on hES OCT4-EGFP.  The T5 cell line was seeded at 
5x105 cells/well in 6 well dishes and maintained for 6 days in the presence/absence of 
FGF2 with daily media change in order to prevent any autocrine effect. These images 
were taken on the 4th day of the experiment and were representative of the wells (Scale 
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4.5.3.1.1 Effect of FGF2 on plate efficiency  
The experiments outlined in section 4.5.3.1 indicated an increased in cell number due to 
the addition of FGF2.  FGF2 could be enhancing cell attachment to the substratum or 
improving the survival and proliferation once the cells got attached.  Studies carried out 
in different cell types have indicated that FGF2 can modulate cell attachment and 
spreading in feeder free conditions by the induction of adhesion molecules (Debiais et 
al., 2001; El-Hariry et al., 2001; Jang and Chung, 2002).  To examine if FGF2 has an 
effect on cell plating efficiency a 34 well dish was seeded with different cell densities in 
the presence or absence of FGF2.  After 24 hours of being plated the fluorescence 
emission of EGFP was measured.  The EGFP was excited (489nm) and the fluorescence 
emission (508nm) was detected and measured in a fluorescence plate reader (Figure 
4.16).   To relate these results to any possible changes in cell morphology, 5x105 cells 
were plated (equivalent cell density to the higher cell number plated for the fluorescence 
emission assessment) with or without FGF2.  The effect of FGF2 to T5s cell 
morphology after 24 hours of seeding is shown in Figure 4.17. 
 
Quantification of the fluorescence emission showed that the presence of FGF2 at the 
time of plating resulted in a slightly higher expression of the EGFP reporter than in its 
absence (Figure 4.16).  This increase in OCT4-EGFP seemed to correlate with an 
increase in the amount of cells in the presence of FGF2 at the time of plating (Figure 
4.17).  FGF2 seems to have a positive effect on the plate efficiency, which could be due 
to an improvement in cell attachment to the Matrigel, although an enhancing in cell 
proliferation and survival might also be involved.    
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Figure 4.16. EGFP fluorescence emissions from T5s plated in the presence/absence 
of FGF2.  T5 cells were plated at different cell densities in the presence/absence of 
FGF2 and the EGFP emission measured in a Multilabel Counter 24 hours after plating.  
The fluorescence emission was slightly higher in the presence of FGF2 than in its 
absence.   H1, the parental line did not produce any fluorescence.  In the control the 
wells were coated with Matrigel and optimem was used for the readings.  Data is 
presented as the mean ± S.E.M.of six replicates from two independent experiments.  The 





      
Figure 4.17. Effect of FGF2 on T5 cell line plating efficiency.  5x105 cells were plated 
in the presence or absence of FGF2 and 24 hours later the effects on their morphology 
was observed.  After 24 hours in the presence of FGF2, the cells seem to be spreading, 
whereas without FGF2 the cell colonies appear tight and rounded.  Floating dead cells 
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4.5.3.1.2 Effect of FGF2 in cell proliferation 
To establish if the reduction of OCT4-EGFP in the presence of FGF2 was due to an 
increase in cell proliferation, the thymidine assay was carried out.  This assay is based 
on the incorporation of the radioactive3H (tritium) into the Hydrogen of the Thymidine 
during DNA synthesis.  The amount of 3H-Thymidine incorporated into the DNA can be 
quantified by measuring the total amount of labelled DNA in a population and this is 
directly proportional to the amount of cell division occurring in the culture.   
 
T5 cells were plated at different cell densities in the presence of FGF2.  Once the cells 
were attached to the matrix (4-5 hours), the medium was changed to + or - FGF2 and 
after 24 hours the thymidine assay was performed.  The results presented in Figure 4.18 
were obtained by measuring cell filtrates in a β-counter after incubating the cells with 
the radioactive tritium for 6 hours.  Thymidine assay showed that FGF2 produced a 





























Figure 4.18. Effect of FGF2 on the 3H-Thymidine incorporation.  T5 cell line 
proliferation in the presence/absence of FGF2 was measured by 3H-Thymidine 
incorporation and read in a β-counter after 6 hour labelling.  The increase in cell 
proliferation was significantly higher (p<0.001) for all the cell densities.  Paired T-test 
analysis of variance was used for the generation of a p value.  Data is presented as the 
mean ± S.E.M.of six replicates.  The results have been normalised relative to the control: 

















4.5.3.1.3 Effect of FGF2 on the cell cycle  
Previous experiments showed that the addition of FGF2 to the culture produced an 
increase in cell proliferation.   A likely mechanism to increase cell proliferation is by 
FGF2 having a positive effect on the cell cycle.   Mouse (Savatier et al., 2002) and 
rhesus monkey (Fluckiger et al., 2006) embryonic ES cells follow an unusual cell cycle 
with a short or non-existent G1 phase in contrast with somatic cells, which remain a 



















Figure 4.19. The cell cycle in mammalian cells.  In the first phase (G1) the cell grows, 
transcribes RNA, synthesises proteins and when a certain size is reached, the cell enters 
the phase of DNA synthesis (S) where the chromosomes duplicate.  In G2 the cell 
prepares for division by duplicating its chromosomes.  During mitosis (M) the 
chromosomes are separated from the daughter cells.  The cycle is completed when the 
cells start again in G1.  The cells that are resting (quiescent) are said to be in the G0 
phase.  Mouse and primate ES cells have a peculiar cell cycle with a short or non 
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To study the role of FGF2 in the cell cycle of hES cells, the pattern of cycling in H1 cell 
line was examined in the presence and absence of FGF2.  5x105 cells were plated in 
N2B27 containing FGF2, and once the cells were attached to the matrix the medium was 
changed to + or - FGF2.   For six days the medium was changed daily and each day 106 
cells were fixed in cold ethanol and PBS.  At the end of the experiment the fixed cells 
were stained with propidium iodide, whose fluorescent emission is proportional to the 
amount of DNA present in the cell and can be detected by flow cytometry.  The results 
obtained by flow cytometry produced a histogram which was used to analyse the cell 
cycle.  This assessment was only performed on single live cells (For details see section 
2.5.2 in materials and methods).  
 
The effect of FGF in the cell cycle in day two of the experiment is shown in Figure 4.20.   
After only one day in the presence of FGF2, a slight increase in the amount of cells 
cycling was observed compared with the cells in the absence of FGF2.  At this early 
point, however, the overall profile was similar in the two conditions.  An overlay for the 
cell cycle in day 1 of cells with/without FGF2 is shown in Appendix 3.  A more striking 
difference between treatments was observed in the second day of treatment (Figure 
4.20).  The addition of FGF2 resulted in a greater amount of cells in the S and G2 
phases.  FGF2 promotion of cell division in the second day of treatment corresponds to 
the first evident effects on cell number shown in Figures 4.13 and 4.14.  Furthermore, a 
high proportion of cells in S phase was consistent with the higher percentage of cells 
incorporating BrdU in FGF2 treated cells following pulse labeling (Figure 4.18).  
However, there was a progressive increase of cells in the G1 phase for both conditions 
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during the experiment, which is perhaps a consequence of the high confluencies reached.  
This produced a similar overall cell cycle profile after day four of plating and it was 
difficult to make further conclusions.  An overlay for the cell cycle in day 5 of cells 
with/without FGF2 is shown in Appendix 3.   
 
In conclusion, the results of the cell cycle analysis (Figure 4.20) indicated that FGF2 
promotes cell division.  This effect may be due to FGF2 acting as a mitogenic factor, 
thereby promoting a rapid synthesis and cell division, which is consistent with FGF2 
enhancement of cell growth and in DNA synthesis as illustrated in Figure 4.13 and 4.18 
















      












       

































Figure 4.20. Effects of FGF2 on hES cell cycle analysed by flow cytometry. 
Following two days with or without FGF2 the cells were stained with Propidium iodide 
and analysed by flow cytometry.  A: Cells without FGF2 displayed a larger G1 than 
those cells maintained in FGF2.  B: Comparison of the ratio of cell percentage between 
G1 and G2 phases in presence/absence of FGF2.  Data here presented was representative 
of two independent experiments and the error bars represent the S.D.  
G1 = 20.9% 
S    = 27.7%  
G2 = 33.4% 
G1 = 15.4% 
S    =36.8%  






4.5.3.2 FGF2 effect on self renewal 
 
4.5.3.2.1 FGF2 effect on the self renewal of the cell line T5 
The absence of FGF2 from the N2B27 medium diminished cell growth in the two cell 
lines, T5 and the parental H1.  However, in the absence of FGF2 the morphology of the 
T5 cells was similar to those growing in FGF2 and a strong OCT4-EGFP was expressed 
(Figure 4.15).  This suggested that T5 cell self-renewal was not dependeding on FGF2, 
which conflicts with the reported role of FGF2 in the maintenance of the hES cells self-
renewal (Levenstein et al., 2005).  To establish whether T5 cell self-renewal responded 
to the effect of FGF2, the surface markers SSEA3 and SSEA1 were analysed by flow 
cytometry.  The expression of these surface markers and EGFP was compared in the 
cells growing in the presence or absence of FGF2 for 6 days (Figure 4.22). 
 
Gerrard et al, (2005) established that the down-regulation of the OCT4-EGFP marker 
during differentiation correlated with endogenous OCT4 and hES cell surface markers.   
However, flow cytometry analysis indicated that T5 cells maintained high co-expression 
of OCT4-EGFP with SSEA3 in absence of FGF2 as well as a low expression of SSEA1 
(Figure 4.22).  This might suggest that the T5 cells may have lost their capacity to 





Figure 4.22. Analysis of OCT4-EGFP and the surface markers SSEA3 and SSEA1 
on T5 cells growing in serum free medium for 6 days in +/- FGF2.   EGFP and 
SSEA3/1 expressions were analysed by flow cytometry.  After 6 days in culture in the 
absence of FGF2, the T5s maintained high levels of SSEA3, which were associated with 
a strong EGFP expression.  Furthermore, an increase in SSEA1 was not noted. 
 
Neg. 2.5% SSEA3 15.2%
                   FGF2        No FGF2 
                   FGF2        No FGF2 
SSEA3/ SSEA3/
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Neg. 16.4% Neg. 21.4%
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     78.8% 
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    74.5% 
GFP/SSEA1 
     2.3% 
GFP/SSEA1 
     4% 
SSEA3 0.2% SSEA3 0.3%
SSEA3 19.4%
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4.5.3.2.2 Has the T5 cell line lost the capacity for differentiation? 
To determine whether the T5 cell line was unable to differentiate as a result of potential 
changes generated by the serum free conditions, BMP4 was added to the N2B27 to 
induce differentiation.  Contrasting with the role of BMP4 in suppressing mES 
differentiation, BMP4 cannot maintain hES cells propagation but can promote hES cells 
differentiation into trophoblasts (Xu et al., 2002).  T5 cells were seeded at 1:3 density in 
N2B27 supplemented with FGF2 (8ng/ml) and BMP4 (5ng/ml) or N2B27 alone or in 
N2B27 with FGF2 alone (8ng/ml) (Figure 4.23).  
 
BMP4 supplement resulted in a rapid onset of a flattened morphology, which corelated 
with the loss of the expression of the OCT4-EGFP reporter.  Therefore, the T5 cell line 
was able to differentiate.  This might indicate that autocrine and/or intracrine 
mechanisms could have been activated and maintained these cells in a constant self-





Figure 4.23. Induced differentiation of T5s in serum free medium.  T5s 
differentiated when the serum free medium was supplemented with BMP4 but not upon 





































4.5.3.2.3 FGF2 effect on the self-renewal of the parental cell line H1 
The expression of surface and internal markers characteristic of hES cells suggested the 
normal behaviour of the H1 and T5 cells lines in the serum free conditions.  However, 
T5 cells failed to differentiate upon FGF2 withdrawal.  To test whether the self-renewal 
of the parental line H1 was dependent on FGF2 in the serum free conditions, the 
expression of cell surface markers was assessed in the presence and absence of FGF2.  
5x105 cells were seeded in the presence of FGF2 and once attached to the substratum the 
medium changed to +/- FGF2.  Following six days in these conditions and a daily media 
change (Figure 4.24) the expression of TRA1-81 and SSEA1 was assessed (Figure 4.25).  
The expression of these markers was also analysed before setting the experiment to 
monitor any possible plating effect. 
 
The effect of the absence of FGF2 (Figure 4.24) could be observed as early as day two 
in the differentiation process.  At this early stage the lack of FGF2 resulted in the 
elongation and flattening of the cells, which correlated with the larger G1 of the cell 
cycle (Figure 4.20C).  Further flattening of the colonies and an increase in the amount of 
loose cells appeared progressively throughout the experiment.  These morphological 
changes associated with differentiation, were concurrent with a decrease in cell 
proliferation as discussed previously. 
 
Flow cytometry results showed a comparable expression of surface markers before and 
after the experiment only in the presence of FGF2 (Figure 4.25).  Strikingly, when FGF2 
was not added the expression of the marker associated with differentiation SSEA1 
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increased from 6.5% to 68.2%.  The up-regulation of SSEA1 was related to a decrease in 
TRA1-81 expression.   The change in TRA1-81 expression was not as dramatic as that 
in SSEA1, possibly because induction of a marker was more readily detected than the 
loss of one already expressed.   Interestingly, the withdrawal of FGF2 resulted not only 
in the decreased expression of TRA1-81 but also in the number of cells expressing this 
surface protein.  This suggested a reduction in the expression of the marker on individual 
cells as well as on the whole population. 
 
Results compiled from the analysis of the expression of surface markers from 3 
independent experiments are presented in Figure 4.25.  These experiments consistently 
showed an increase in SSEA1 and a decrease in TRA1-81 expression in the absence of 
FGF2.  This indicated that H1 cell self-renewal was dependant on an FGF2 supplement 




Figure 4.24. Morphological effect of FGF2 on H1’s self renewal.  The H1 cells were 
maintained in the presence or absence of FGF2 for 6 days with a daily media change.  
Morphology associated with hES cell differentiation was appreciated early (D2-3).  At 
the end of the time course the cells grown with FGF2 had formed a homogeneous layer, 
whereas their counterparts without FGF2 were reduced to small areas of tight colonies 
(highlighted by the asterisk) surrounded by flat cells with differentiated morphology 
(highlighted by the arrow).  (Scale bar = 500µm) 
 
 































                          
 
Figure 4.25. Effect of FGF2 on the expression of H1 surface markers analysed by 
flow cytometry. A: Surface markers expressed on H1 before being plated for the 
differentiation experiment.  B: expression of surface markers with or without FGF2 at 
day 6 of the experiment.  The isotype antibody control appears as an empty histogram 
plot and cells stained with SSEA1 or TRA1-81 antibody as red fill.  Results here 
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Figure 4.26. Effect of FGF2 on the expression of H1 surface markers.  The 
expression of the surface markers SSEA1 or TRA1-81 on H1 was assessed by flow 
cytometry.  SSEA1 expression increased in the absence of FGF2 and TRA1-81 was 
down-regulated.  This effect was highly significant (p<0.001).  A two-way test of 
variance was applied to generate a p value.  The results were represented as an average 


















Typically hES cell proliferation depends on the presence of a mouse (Thomson et al., 
1998) or a human (Amit et al.,2003) fibroblast feeder layer to produce the matrix 
required for adherence of the cells and to secrete factors to maintain their self-renewal 
and pluripotency potential.  Recently the culture techniques are moving from the use of 
feeder cell layers towards more defined systems.  However, hES cell culture still in the 
main involves the use of the ill-defined conditioned media from the feeder cells.  During 
conditioning of the medium, undefined factors are secreted into the culture.  This 
produces a highly variable system, thereby complicating the replication of the culture 
conditions and the quality control.  FGF2 is one of the factors released by the feeder 
cells (Lim and Bodnar, 2002), which creates complications in evaluating the effect of the 
supplemented FGF2.  In addition to this, hES cells tend to spontaneously differentiate in 
CM causing a mixture of cells at different stages of differentiation.  For these reasons a 
defined culture system within which to propagate hES cells was essential for the study 
of FGF2.  However, at the time of preparing this thesis there was not a commercially 
available serum free media specifically produced for hES cells.  Furthermore, there was 
no conclusive data published clarifying the highly complex requirements of hES cells.  
The defined medium N2B27 (Ying et al., 2003b) was chosen to study the short term 
biological and biochemical effects of FGF2 on hES cells.  N2B27 had been developed 
for the study of mES cells, but surprisingly also supported hES cells propagation when 
supplemented with FGF2 and when used in conjunction with Matrigel.  Matrigel is a 
basement membrane preparation extracted from a murine Englebreth-Holm-Swarm 
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sarcoma.  As it is composed of murine proteins and growth factors, Matrigel potentially 
adds some variability to the system.  To minimise this variability a growth factor-
reduced Matrigel at a dilution of 1:100 was used.   
 
This thesis reports the propagation of two cell lines: T5 (Gerrard et al., 2005) which 
carries an EGFP reporter under the control of the OCT4 promoter, and the parental line 
H1 (Thomson et al., 1998) in the N2B27 medium.  After several passages in N2B27, the 
two lines maintained a high expression of the OCT4 protein and of the surface markers 
characteristic of hES cells.  These cells formed aggregates with the characteristics of 
embryoid bodies in a similar manner to the cells in CM (data not shown).  However, the 
expression of the three embryonic markers was not analysed, which would be necessary 
to confirm pluripotency.   Two groups have stablished though the pluripotency of H1 
hES cells maintained in N2B27 by differentiation into the three germ layers.  Yao et al, 
(2006) established pluripotency through the injection of the hES cells into nude mice 
followed by the histological characterisation of the formed teratomas.  In addition to 
this, Liu et al, (2006) demonstrated that the H1s growing in the N2B27 medium readily 
formed embryoid bodies, which when plated differentiated into the three layers and 
trophoblast in a similar manner to those cells in CM. 
 
The addition of FGF2 to the hES cells growing in these semi-defined conditions 
produced an enhancement in the cell number and a lower amount of floating cells.  
Therefore, FGF2 seemed to have a positive effect on cell proliferation and a role in 
plating efficiency.  However, it needs to be noted that FGF2 might also be supressing 
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cell death.  FGF2 improvement in plating efficiency might be achieved by inducing the 
expression of cell adhesion molecules (Debiais et al., 2001) or forming complexes with 
FGFR along with Matrigel associated heparin sulfates (Richard et al., 2000).  Analysis 
of the effect of FGF in the expression of cell adhesion molecules (e-cadherin, integrins 
α4 and α5, ICAM 1 and 3) would give an indication of their interactions and their role 
on cell attachment and plate efficiency.  The enhancement in cell proliferation in the 
presence of FGF2 seemed to be related to the increase in cell synthesis and mitosis as 
indicated by the BrdU incorportation and the cell cycle analysis.  This is consistent with 
the reported role of FGF2 in the regulation of genes associated with hES cell 
proliferation (Greber, 2006).   FGF2 seems to up- regulate more than 30 genes involved 
in cell cycling as well as inducing the expression of oncogenes such as Fos, Jun, Myc, 
Ets2 (Greber, 2006).  In addition to the mitogenic effect, cell cycle analysis also might 
suggest that FGF induced a more rapid transit of the hES cells through the G1 phase.  
However, a synchronisation of the cells should be carried out to confirm if the short G1 
phase was enhanced by the effect of FGF2.   A short G1 phase would concur with the 
reduced time of this phase that has been reported to be characteristic of ES cells 
(Savatier et al., 2002; Fluckiger et al., 2006; Becker et al., 2006).  This brief G1 phase is 
the cause of the shortened cell cycle in hES cells (15.8h against 24-32h in proliferating 
somatic cells) as determined by the proliferative index (Becker et al., 2006).  The report 
presented by Becker et al, (2006) also strongly suggested that high levels of cyclin 
D2/CDK4 complexes were to account for this rapid proliferation of hES cells.  Another 
possible candidate in the stimulation of entry in the S phase is the protooncogene c-Myc.  
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It has been reported that c-Myc collaborates with the retinoblastoma pathway in the 
activation of Cyclin genes required to entry in the S phase (Bartek and Lukas, 2001).  In 
addition to this role in the cell cycle, it has been suggested that c-Myc is a key regulator 
of mES self-renewal since it is a common target of LIF/STAT3 and/or Wnt (Cartwright 
et al., 2005).  Therefore expression levels of the c-Myc gene in the presence/absence of 
FGF2 could demonstrate whether this gene is activated by FGF2 and maybe identify 
possible connections between the cell cycle and self-renewal.   
 
The negative effect in cell proliferation when FGF2 was not supplemented was bypassed 
in T5s by maintaining the medium in which the cells were plated (Appendix 4).  This 
suggested the presence of FGF2 and/or other autocrine factor/s were able to maintain T5 
cell proliferation in the absence of exogenous FGF2.  It was believed that autocrine 
signalling could also account for the unexpected maintenance of T5’s self-renewal when 
FGF2 was not added to the medium.  However, addition of BMP4 resulted in the rapid 
differentiation of the T5 cells.  This indicated that these cells have not lost the capacity 
for differentiation and suggested there could be activity of FGF and/or others signals.  A 
noticeable differentiation in the absence of FGF2 was by contrast suggested in the 
parental line H1.  Withdrawal of FGF2 resulted in the emergence of the flattened cell 
morphology and of the surface marker SSEA1 as well as the down regulation of TRA1-
81, which are changes associated with hES differentiation.  
 
 In conclusion, although intended to be used only for the short term experiments, hES 
cells could be propagated in the N2B27 defined medium for several passages and 
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provided a consistent tool for the study of FGF2 on hES cells.  However, it needs to be 
taken into account that this is a semi defined system since the Matrigel used can be 
variable and it also includes growth factors and proteins.  This implies that a cooperation 
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It was shown in the previous chapter that FGF2 could sustain the proliferation of the 
hES cells.  However, in later batches of medium it was seen an increase in the 
background differentiation.  Matrigel is a variable component in the N2B27 culture 
system, which implies that other elements might be involved in the regulation of self-
renewal besides FGF2.  This chapter dealt with the possible factors included in Matrigel, 
which could collaborate with FGF2.  In addition to this, the principal pathways down-
stream of FGFR were studied. 
 
Self-renewal of hES cells is sustained when the cells get the appropriate signals to 
prevent spontaneous differentiation.  In conventional culture systems, these signals are 
provided by the feeder cells, either by direct contact of hES cells with the feeder layer 
and/or by soluble factor/s secreted by the feeders and present in the CM (Brivanlou et 
al., 2003).  Recent systems have tried to replicate these signals by adding specific 
growth factors to basal medium and several groups have reported the growth of hES 
cells in feeder free conditions (Amit et al., 2004; Sato et al., 2004; James et al., 2005; 
Dravid et al., 2005; Xu et al., 2005a; Xu et al., 2005b).  However, at the time of these 
publications the numerous signals from the feeders were mostly yet undefined.  FGF2 
was the exception, since it has been identified early as the key factor that is necessary for 
hES cell propagation.  Accordingly, FGF2 has been used consistently to derive and 
maintain hES cell lines (Amit et al., 2000) and has been shown to support hES cell 
growth in the absence of CM (Amit et al., 2004; Wang et al., 2005; Xu et al., 2005a; Xu 
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et al., 2005b).  Therefore, substantial evidence indicates the significance of FGF 
signalling in hES cell proliferation.  However, this conclusion has been reached through 
the use of complex culture conditions in which other factors may be acting.   
 
Recent transcriptional profiling has confirmed the significance of the FGF pathway, but 
it has also been suggested that Wnt and TGFβ pathways may play relevant roles in the 
regulation of hES cells (Sato et al., 2003; Levenstein et al., 2005; Wei et al., 2005).  It 
has been shown that the sustained activation of Wnt by the GSK-3 specific inhibitor BIO 
was sufficient to maintain hES cell self-renewal (Sato et al., 2004).  Conflicting with this 
report, (Dravid et al., 2005) demonstrated, by using Wnt antagonists, that Wnt activation 
is not sufficient to maintain undifferentiated and pluripotent hES cells in the long-term.  
Dravid et al, (2005) suggested that Wnt signalling promotes hES cell proliferation only 
when other self-renewal signals, both intrinsic and extrinsic are present.  As discussed 
above, significant evidence indicates that FGF2 is a promoter signal for hES cell self-
renewal, but other factors could also be co-operating in this role.   It has been proposed 
that Activin and TGFβ, two factors produced by MEFs (Beattie et al., 2005) could be 
involved in sustaining the undifferentiated state of hES cells.  More specifically (James 
et al., 2005) suggested that Activin was the factor, which collaborated with Wnt in the 
maintenance of pluripotency.  In this model the TGFβ/Activin/Nodal branch of the 
pathway through Smad2/3 needed to be activated and the BMP4/GDF branch repressed 
to prevent differentiation of hES cells (James et al., 2005).   It has been shown that 
BMP4 activation of Smad 1/5 induces trophoblast differentiation in hES cells (Xu et al., 
2002), which can be prevented by the antagonic effect of FGF2 (Pera et al., 2003).  
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Consistent with this, it has been suggested that inhibition of BMP4 activity (Wang et al., 
2005; Xu et al., 2005b) is the mechanism by which significantly high concentrations of 
FGF2 (100ng/ml) (Levenstein et al., 2005; Xu et al., 2005b; Liu et al., 2006) sustain the 
undifferentiated state in hES cells.   
 
FGF2 autocrine and possibly intracrine signalling have to be added to the complex 
extrinsic factors acting on hES cells (Dvorak et al., 2005; Xu et al., 2005b; Liu et al., 
2006).  Autocrine/intracrine mechanisms was hypothesised in Chapter 4 might be 
sustaining T5 cell proliferation and self-renewal in the absence of exogenous FGF2.  
The high expression of FGF2 by hES cells (Brandenberger et al., 2004; Xu et al., 2005b; 
Liu et al., 2006) suggests the potential role of this factor in autocrine and paracrine 
signalling.  This is consistent with the difficulty of clonal growth of hES cells, which 
indicates the necessity for FGF2 autocrine signalling.  However, this could also suggest 
the involvement of other autocrine factors, such as Nodal, which are also produced by 
hES cells, (Xu et al., 2001).   
 
In conclusion, FGF2 is the common key component of the many different systems used 
to grow hES cells.  FGF2 as shown in Chapter 4 is required for proliferation and self-
renewal of hES cells in serum free conditions.  However, the presence of Matrigel 
includes critical factors to the system suggesting co-operating activity.  The activity of 
co-operating factors with FGF2 was also suggested by the observation that CM which 
had not been produced in presence of FGF2 could not sustain the hES cells.  This would 
be in line with recent, increasingly popular, suggestions that signals, principally those 
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activators of SMAD2/3 might be involved in hES cells self-renewal.  Therefore, to 
identify the key signalling pathways downstream of FGF2 and to establish whether these 
signals are sufficient in sustaining self-renewal it is necessary to understand the 
regulation of hES cells. 
 
5.2 Hypothesis 
That FGF2 signalling plays the key role in maintaining hES cell self-renewal and that 
other signalling pathways may contribute to this outcome. 
 
5.3 Aims 
I. To establish the biochemical activation of the MAPK/ERK signalling pathway in 
hES cells when treated with FGF. 
II.  To identify the key signalling pathways downstream of FGF2 involved in hES 
cell self-renewal. 
III.  To describe the possible interactions between the FGF pathway and other 






5.4 Experimental design 
 
 
Figure 5.1. Diagram of the experimental steps followed in this chapter.  Western 
Blotting (WB) was used to asses the induction of H1 cell line with FGF2 or FGF4.  Also 
WB was used to assess the biochemical effect of blocking FGFR, and the signalling 
pathways downstream of the receptor PI3K and MAPK.  These inhibitions would be 
performed by the use of the inhibitors SU5402, LY29400 and UO126 respectively.  The 
effect of these inhibitions was monitored by observation of the morphological changes 
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5.5.1 Activation of hES cells by FGF 
 
To determine whether hES cells maintained in N2B27 are activated by FGF, the 
phosphorylation of the extracellular signal-regulated kinase (ERK) was evaluated by 
western blotting after stimulating the cells with 25ng/ml of FGF2 or FGF4.  LIF, which 
has been shown to activate ERK in mES cells (Burdon et al., 1999b; Kang et al., 2005) 
was used to stimulate hES cells at a concentration of 10ng/ml.  STAT3 as well as ERK 
phosphorylation was analysed in the cells treated.  FGF2 and 4 strongly activated ERK1 
and 2 (ERK-P) in the hES cells (Figure 5.2).  Immunoblotting of the samples with anti-
ERK2 antibody, revealed an additional band above the inactive ERK2 indicative of a 
motility shift.  When compared with FGF activation of ERK on mES cells (Figure 3.2), 
this “mobility shift” suggested that FGF activation of ERK in the hES cells was stronger.  
This strong activation is likely to be consequence of the higher expression on the hES 
cells of all four FGF receptors (Brandenberg et al.,2004) compared with the mES cells 
(Esner et al., 2002). 
   
On the other hand, FGF did not activate STAT3 on hES cells, although it was strongly 
phosphorylated by LIF.  This contrasts with LIF activation of ERK in mES cells, which 










Figure 5.2. Western Blotting of ERK and STAT3 activation on hES cells.  Human 
ES cell stimulation by FGF or LIF (10 minutes) was analysed by examining the 
activation of ERK or STAT3 proteins.  Cell lysates from cells that have been starved of 
signal were used as controls.  The immunoblots of the cell lysates were probed with an 
antibody specific for the active phosphorylated forms of ERK1/2-P or STAT3-P.  After 
stripping, the membranes were re-probed with antibodies that recognise ERK2 or 
STAT3 protein as controls for protein loading.  This pattern of activation was consistent 



























  Controls                       FGF2                           FGF4                       LIF 
 219
5.5.1.1 FGF2 titration 
 
To determine a range of concentrations that activate hES cells, different doses (0, 2, 4, 8, 
16 and 32ng/ml) of FGF2 were used in a 10 minutes induction.  Following the blotting, 
the nitrocellulose membrane was probed with a specific antibody for the phosphorylated 
form of ERK and re-probed with an antibody against the total ERK2 protein as a control 
(Figure 5.3).  ERK was activated in hES cells even at the lowest concentration tested of 


















Figure 5.3. Western Blotting of ERK activation by FGF2 titration. Stimulation of 
hES cells with titrated concentrations of FGF2 were analysed by examining the 
activation of ERK protein.  Cell lysates from cells that have been starved of signal were 
used as controls.  The immunoblots of the cell lysates were probed with an antibody 
specific for the active phosphorylated forms of ERK1/2-P.  After stripping, the 
membranes were re-probed with antibodies that recognise ERK2 protein as controls for 



































5.5.2 Effect of FGF2  
 
To establish the effect of the different concentrations of FGF2 on the cell biology, 
duplicated wells with 5x105 cells were plated and different concentrations of FGF2 
(from 0 to 32ng/ml) were added into the N2B27media (Figure 5.4).  To prevent major 
autocrine effect, the media was changed daily.  After 6 days of treatment the expression 
of SSEA1 and TRA1-81 was assessed by flow cytometry (Figure 5.5). 
 
Cell morphology (Figure 5.4) indicated that the effect of FGF2 on hES cells was dose 
dependent.  In the absence of FGF2 the colonies appeared flattened with large cells, a 
morphology associated with differentiation.  At only 2ng/ml of FGF2 the effect of the 
factor could be observed by a few tight colonies indicative of perhaps remaining ES 
cells.  This change in cell morphology was associated with the increased 
phosphorylation of ERK shown in the western blotting (Figure 5.3).   
 
After 6 days of continuous exposure to the different doses of FGF2, the expression of 
cell surface markers was assessed by flow cytometry (Figure 5.5).  As expected by the 
flattened cell morphology (Figure 5.4) observed in the absence of FGF2, the marker of 
differentiation SSEA1 was highly expressed in contrast to the low expression of TRA1-
81.  Coinciding with the few remaining tight colonies at the lowest concentration of 
FGF2 (2ng/ml), TRA1-81 levels increased and SSEA1 decreased in relation to 0ng/ml of 





Figure 5.4. Effect of FGF2 titration on hES cells morphology.  Increased 
concentrations of FGF2 (0-32ng/ml) were added to the hES cells.  The lower doses of 
FGF2 (2 and 4 ng/ml) were unable to support the undifferentiated state of the cells, 
which is shown by the flattened, spicky morphology of the colonies.  At higher 
concentrations, the colonies appeared progressively more compact with more defined 
edges (scale bar = 200μm).  FGF2 titration has been repeated on cell morphology with 
matching results. 
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Figure 5.5. Effect of FGF2 titration on hES expression of surface markers Increased 
concentrations of FGF2 (0-32ng/ml) were added to the hES cells. After 6 days in those 
conditions, the expression of the surface markers SSEA1 and TRA1-81 were analysed 
by flow cytometry.  The compact colony morphology at increased FGF2 concentration 
was associated with a stronger TRA1-81 and a decrease in SSEA1 expression. FGF2 
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5.5.3 Effect of FGF4 on hES cells 
 
FGF4 significantly activated hES cells at a similar level than FGF2 (Figure 5.2).  In 
addition to this, a recent report attributes an important role to FGF4 in hES cell 
signalling with the consequences of growth and differentiation (Mayshar et al., 2008).  
To determine whether the effect of FGF2 on hES cells is specific, the effect of FGF4 on 
the morphology of hES cells was assessed.  105 cells were plated in N2B27 and FGF4 
(8ng/ml) was added into the media daily.  After 6 days of treatment, morphological 
observation suggested that FGF4 was not compensating for FGF2 (Figure 5.6). 
However, a positive effect of this factor on cell growth could be indicated by the larger 
colonies formed in the presence of FGF4 compared with N2B27 alone.  This could mean 
that the effect of FGF2 on hES cells is specific and even when hES cells clearly respond 




Figure 5.6. Effect of FGF4 on the morphology of hES cells.   FGF4 supplement 
seemed to enhance cell growth but it could not sustain hES cell self-renewal indicating 
the specificity of the FGF2 effect.  However, this should be repeated to confirm. Scale 







































5.5.4 Effect of FGFR inhibition by SU5402 
 
To confirm the promotion of FGF2 on hES cell self-renewal and to test whether 
autocrine FGF signalling is playing any role in the proliferation of undifferentiated hES 
cells, FGFR signalling was inhibited.  SU5402 selectively inhibits the tyrosine kinase 
activity of FGFR1 by interacting with the catalytic domain of this receptor without 
inhibiting PDGF, EGF or insulin receptors (Mohammadi et al., 1997).   
 
To determine the concentration of inhibitor to use in the biological assessment, 106  
cells/well were plated on N2B27 containing FGF2.  After 24 hours the medium was 
changed to a control medium (N2 without B27, insulin and FGF2).  Following 4 hours 
incubation, the medium was changed to the control medium with the inhibitor.  After 
incubating for 1 hour the cells were stimulated with 25ng/ml of FGF2. 
   
High levels of phosphor-ERK were observed in the absence of SU5402 following FGF2 
simulation (Figure 5.7).  ERK phosphorylation was potently inhibited when SU5402 was 
present.  ERK phosphorylation was observed at low levels in 20µM SU5402 and was 
detectable in 30 µM SU5402.  The membrane was stripped and re-probed with antibody 
that recognises ERK2 protein as a control.  This indicated that total ERK was unaffected 




To assess the biological effects of inhibiting FGFR, 5x105 cells/well were plated in a 6 
well dish with FGF2 and 20µM of SU5402.  This concentration was chosen as the 
increased concentration of 30µM resulted in too high a cell death to analyse.  As 
controls, the cells were treated with a concentration of DMSO, which is equivalent to the 
maximum used with the inhibitors.  Cells with or without FGF2 were also included.  
  
After 2 days of continuous exposure to SU5402, the cells acquired a differentiated 
morphology in the centres of the colonies, in addition to slower proliferation.  After 6 
days, very few small flattened colonies remained in the presence of the inhibitor.  
(Figure 5.8).  This morphology characteristic of differentiation of H1 cells in N2B27 
was associated with an increase in SSEA1 and a decrease in TRA1-81 expression 
(Figure 5.9).  In conclusion, morphology and surface marker expression indicated that 
H1 hES cell self-renewal is attained by activation of FGFRs.  Interestingly, a more 
dramatic effect was observed by the use of the inhibitor than when FGF2 was 


















               
 
 
20µM Su5402   FGF2+D 
Figure 5.7. Inhibition of FGFR signal by SU5402 on H1s.  Cells were cultured in a 
control medium (medium without FGF, insulin or B27) for 4 hours before changing to a 
medium with the inhibitor SU5402 at different concentrations (30 to 5 µM).  After 1 
hour of treatment with the inhibitor, the cells were stimulated with FGF2 and lysates 
were blotted and probed with an antibody specific to phosphorylated ERK (ERK-P).  SU 
inhibited FGF2 mediated phosphorylation of ERK1 and 2 in H1s hES cells.  SU5402 
had no effect on the overall level of ERK2 as revealed by re-probing with an antibody 
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Figure 5.8.  Effect of SU5402 on cell morphology.  Duplicate wells were plated with 
105 cells/well in the absence of FGF2, FGF2 and the FGFR inhibitor Su5402 (20ng/ml), 
FGF2 alone and FGF2 and DMSO as a control.  After 6 days in these conditions, cells in 
the absence of FGF2 presented a differentiated morphology in addition to a lower 
number of cells when compared with the controls. The inactivation of FGFR resulted in 
a similar morphology to that produced by FGF2 withdrawal, which indicated that FGFR 
activation was key in hES cell self-renewal. The more striking morphology in the 
presence of the inhibitor than in the absence of FGF2 could be indicative of FGF 
autocrine signalling (scale bar = 200μm).  The results shown here are representative of 
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Figure 5.9.  Effect of SU5402 on the expression of cell surface markers.  Duplicate 
wells were plated with 105 cells/well in the absence of FGF2, FGF2 and the FGFR 
inhibitor SU5402 (20ng/ml), FGF2 alone and FGF2 and DMSO as control.  After 6 days 
in these conditions, the cells exposed to the inhibitor dramatically up-regulated SSEA1 
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5.5.5 Signalling pathways downstream of FGF, which may contribute 
to self-renewal of hES cells     
 
The previous section confirmed that FGF2 is a key factor in the propagation of hES cells 
in serum free conditions.  The question is which pathways downstream of FGF2 
contribute to hES cell self-renewal.  Two important signals activated by FGF in hES 
cells are the ERK/MAPK (Kouhara et al., 1997; Hadari et al., 2001; Armstrong et al., 
2006) and PI3K/AKT (Hadary et al.,2001; Armstrong et al,. 2006) pathways.  To assess 
their functional relevance, H1 cells were treated with the drugs UO126 and LY294002, 
inhibitors of the MAPK and PI3K pathways respectively.   
 
To determine the minimum effective dose of inhibitor, a titration was carried out and 
assessed by immunoblotting.  Duplicated wells with 106 cells were treated with different 
concentrations (5, 10, 20µM) of the inhibitor.  Following one hour incubation, the cells 
were stimulated with 25ng/ml of FGF2 for 10 minutes and the cell lysates analysed by 
western blotting (Figure 5.10).  Immunoblots from lysates treated with UO126 were 
probed with an antibody specific for the active phosphorylated forms of ERK1 and 2.  
Immunoblots from lysates treated with LY294002 were probed with an antibody specific 
for the active phosphorylated forms of AKT, downstream in the PI3 Kinase pathway.   
 
5.5.5.1 Effect of MAPK and PI3K inhibition in hES cell biochemistry 
 
The inhibitor UO126 was used to block the MAPK signalling pathway.  UO126 inhibits 
the kinase activity of MAP Kinase I and II (MAPKK or MEK) by directly inhibiting the 
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action of phosphorylated MEKs (Kouhara et al., 1997; Favata et al., 1998) thereby 
preventing phosphorylation of ERK1 and 2.  The inhibitor LY294002 was used to 
inhibit the PI3K pathway.  This is a cell permeable, potent PI3K inhibitor, which acts on 
the ATP binding site of the enzyme and in the catalytic subunit of DNA-activated 
protein kinase.    LY294002 is specific in its function and does not affect the activity of 
EGF receptor kinase, MAP kinase, PKC, S6 kinase, PI 4-kinase and C-SRC (Baumann 
and West, 1998). 
 
High levels of activated ERK1 were observed in the absence of UO126 following FGF2 
simulation.  ERK phosphorylation was potently inhibited when UO126 was present.  
ERK phosphorylation was observed at low levels in 5µM UO126 and was detectable in 
10µM UO126 at a similar intensity than the basal level of activation.  This basal level of 
ERK could be due to the activity of intrinsic FGF2, which has been previously reported 
to activate ERK (Dvrorak et al., 2005).  The membrane was stripped and re-probed with 
antibody that recognises ERK2 protein as control.  In conclusion, UO126 inhibited 
FGF2 mediated phophorylation of the H1 cells in serum free conditions. 
 
AKT phosphorylation was observed in the absence of LY294002 following FGF2 
simulation.  AKT phosphorylation was potently inhibited at all the doses tested of 
LY294002.  The membrane was stripped and re-probed with antibody that recognises 
SHP2 protein, confirming that wells were evenly loaded.  In conclusion, LY294002 




             
 
Figure 5.10. MAPK and PI3K inhibition by UO126 and LY294002 in hES cells.  
Cells were cultured in control medium (medium without FGF, insulin or B27) for 4 
hours before changing to medium with the inhibitors (10 to 2.5µM).  After 1 hour of 
treatment with the inhibitor, the cells were stimulated with FGF2 and lysates were 
blotted and probed with an antibody specific to phosphorylated ERK (ERK-P) or 
phosphorylated AKT (AKT-P).  UO126 inhibited FGF2 mediated phosphorylation of 
ERK1 and 2 in H1s hES cells.  LY294002 inhibited FGF2 mediated phosphorylation of 
AKT at all the doses.  The membranes were stripped and re-probed with antibodies that 
recognise ERK2 and SHP2 proteins respectively.  The results shown here are 









FGF2                          -                         +                           +                        +                         +     
µM UO126                 -                         10                          5                      2.5                         -             
FGF2                         -                          +                         +                        +                         +     
µM LY294002           -                         10                        5                      2.5                         -              
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5.5.5.2 Effect of MAPK and PI3K inhibition on hES cell biology  
 
To asses the biological effects of the inhibition of a specific pathway, 5x105 cells were 
plated in N2B27+FGF2 (8ng/ml) + inhibitor.  The inhibitors were added at a 
concentration of 5µM (UO126) and 2.5µM (LY294002) and 20 µM for SU5402, which 
was included as control. In addition to this, early passage cells with FGF2 were 
included.  After 5 days of continuous exposure to the inhibitor, the morphological effects 
(Figure 5.11) and the expression of surface markers (Figure 5.12) were examined.  
 
The effect of MAPK inhibition on cell morphology was noticed after 2 days in culture 
by the appearance of flattening cells in the centre of some colonies.  After 5 days the 
colonies appeared completely flattened.  The effect of PI3K pathway inhibition was 
more rapidly revealed.  From the first day of treatment it could be observed by the 
flattening in the middle of the colonies and the stretched and detached cells. This effect 
increased progressively, and in the 5th day of treatment PI3K inhibition resulted in a 
general morphology of “star-shaped” colonies.  This experiment has been repeated three 
times with similar results and Figure 5.11 shows a representation of these.  
 
To asses the effects of the inhibition of MAPK and PI3K pathways in self-renewal, the 
expression of SSEA1 and TRA1-81 were analysed (Figure 5.12).  TRA1-81 expression 
decreased and SSEA1 levels increased when MAPK and PI3K pathways were inhibited.  
However, these changes were not as pronounced as when FGFR was inhibited, which 
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could indicate the role of both pathways MAPK and PI3K in self-renwal, or the 
contribution of a complementary pathway.     
 
Figure 5.11. Effect of inhibition of MAPK and PI3K pathways on H1s morphology.  
Cells were supplemented continuously for 5 days with UO126 (5µM) or LY294002 (2.5 
µM).  SU5402 (20 µM) and cells with and without FGF2, and cells supplemented with 
DMSO were included as controls. Scale bar = 200µm. The results shown here are 
representative of three independent experiments. 
           FGF2                                                              UO126 
               FGF2+                                                                LY294002 
               DMSO                                                                                 
             No                                                                       SU5402 




Figure 5.12. Effect of inhibition of MAPK and PI3K pathways on H1s surface 
markers.  Cells were supplemented continuously for 5 days with UO126 (5µM) or 
LY294002 (2.5 µM).  SU5402 (20 µM) and cells with FGF2 and cells supplemented 
with DMSO were included as controls.  MAPK and PI3K inhibition resulted in the 
increase in SSEA1 and decrease of TRA1-81.  This effect was not produced by the 
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5.5.5.3 Is FGF2 sufficient for hES cell self-renewal? 
 
Two observations have suggested the participation of additional factors to FGF2 in the 
maintenance of hES cell self-renewal.  Firstly, the requirement of FGF2 addition to the 
MEFs to produce effective CM indicated the induction of paracrine factors.  Secondly, 
the observation that although initially FGF2 sustained hES cell proliferation in N2B27, 
in later batches of the components of the system, an increase in the background 
differentiation appeared (Figure 5.13).  This was accompanied by the progressive 
increase in SSEA1 and loss of TRA1-81 (Figure 5.14).  Matrigel is an undefined 
component of the system and therefore any change in its composition may account for 
FGF2 no longer being sufficient and other signals might be necessary for self-renewal.  
Even in the presence of the growth factor-reduced form of Matrigel used in this thesis, 
heparan sulphate proteoglycan, laminin, collagen IV and entactin are all present.  In 
addition to this, a large number of growth factors including TGFβ (1.7ng/ml), FGF2 (0-
0.1pg/ml), EGF (<0.5ng/ml), IGF1 (5ng/ml), PDGF (<5pg/ml) and NGF (<0.2ng/ml) are 
included.   This may suggest that any inbalance in the Matrigel composition, either by 
the increased presence of a pro-differentiating factor or alternatively the reduction of a 









Figure 5.13. Spontaneous differentiation of H1 cells.  Cell morphology indicated the 
progressive onset of differentiation with every passage. Shown above are passages 3, 5 





























































Figure 5.14. Spontaneous differentiation of H1s.  Flow cytometry assessment of 
surface markers showed an increase in expression of SSEA1 along the passages.  This 
related to the down-regulation of TRA1-81 expression from 90% of expression in the 
first passages to under the 10% of expression.  The results shown here are representative 























5.5.5.4 Can high doses of FGF2 sustain H1 self-renewal? 
  
To determine whether FGF2 could compensate for any deficiency and/or excess in 
Matrigel, high concentrations of FGF2 were added to the cultures of the H1 cells. 
 
Cell morphology observation (Figure 5.15) and flow cytometry analysis (Figure 5.16) 
suggested that a high dose of FGF2 is sufficient in sustaining the self-renewal of the H1 
cells.  The mechanism could be the inhibition of promoter signals of differentiation or 
compensating for a missing factor. However, the costs limit the experimental design and 







Figure 5.15. Effect of high doses of FGF2 on the morphology of H1 cells that are 
spontaneously differentiating.  Increased concentration of FGF2 to 40ng/ml sustained 
the cell morphology associated with self-renewal (scale bar = 200μm).  The results 
shown here are representative of two independent experiments. 
 



































Figure 5.16. Effect of FGF2 on the expression of cell surface markers of 
spontaneously differentiating H1 cells.  Increased concentration of FGF2 to 40ng/ml 
sustained the expression of surface cell markers associated with self-renewal. The results 
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5.5.6 Possible factors co-operating with FGF2  
 
High doses of FGF2 were sufficient to sustain the proliferation of H1 cells; however this 
did not exclude the potential requirement for other factor/s.  Two components of 
Matrigel are heparin and TGFβ and they could have a role as regulators of hES cells. 
 
5.5.6.1 Heparin  
 
Heparin is a significant component of Matrigel and as discussed in the introduction, this 
is a co-factor in FGF signalling.  Consequently, it was thought that heparin could have a 
role in the enhancement of FGF activity, indicating that a decrease in its levels in 
Matrigel would result in cell differentiation.   
 
To establish whether heparin addition could enhance the effect of FGF2 on H1 cell self-
renewal, 1µg/ml of heparin was supplemented with FGF2 to the N2B27 medium. Cell 
morphology (Figure 5.17) and surface marker expression (Figure 5.18) indicated that the 
addition of heparin to the cell culture resulted in an increase in differentiation. This 
suggested that a decreased amount in the heparin content of Matrigel was not causing 






Figure 5.17. Effect of heparin on the morphology of spontaneously differentiating 
H1 cells.  Supplement of 1µg/ml of heparin induced the flattened morphology associated 
with differentiation.  The results shown here are representative of three independent 





































Figure 5.18. Effect of heparin on the morphology of spontaneously differentiating 
H1 cells.  Supplement of 1µg/ml of heparin induced the increase in SSEA1 and the 














































































































5.5.6.2 TGFβ  
 
TGFβ is included in growth factor-reduced Matrigel at the significant concentration of 
1.7ng/ml.  It has been reported that hES cells with TGFβ alone remained 
undifferentiated, although their proliferation was poor (Amit et al., 2004). Furthermore, 
TGFβ1 has been included in defined culture systems for the growth of hES cells 
(Ludwig et al., 2006a).  To determine whether TGFβ was the “missing” factor, 5ng/ml 
of TGFβ was added in addition to FGF2 to the N2B27 medium.  TGFβ was added from 
the 5th passage, when the spontaneous differentiation started.   
 
TGFβ supplement maintained the compact colony morphology and prevented the 
flattening of the cells, which occurred when FGF2 alone was added (Figure 5.19).  This 
suggested a positive effect of TGFβ on the cell self-renewal, which was confirmed by 
flow cytometry analysis of the surface markers (Figure 5.20).  Expression of SSEA1 
rapidly increased in FGF2 alone, but it decreased when TGFβ was added.  Equivalent 
effects were observed on TRA1-81, whose expression was recovered by TGFβ addition 
to the medium.  In conclusion, adding TGFβ rescued cell morphology and surface 
marker expression of undifferentiated hES cells.  These results indicated that TGFβ co-
operated with FGF2 in the maintenance of hES cell self-renewal.  The effect of TGFβ in 
conjunction with FGF2 was also assessed from the early passages, and the effect on 
surface marker expression was analysed at passages 3, 5, 7 and 9 (Figure 5.21).  This 






Figure 5.19. Effect of adding TGFβ on the morphology of spontaneously 
differentiating H1 cells.  Cells were maintained for 8 passages with FGF2 alone or 
FGF2 and TGFβ (5ng/ml).  Addition of 5ng/ml of TGFβ prevented the flattening of the 
colonies, which is associated with ES cell differentiation.  The results shown here are 
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Figure 5.20. Effect of adding TGFβ on the surface markers of spontaneously 
differentiating H1 cells.  Cells were maintained for 8 passages with FGF2 alone or 
FGF2 and TGFβ (5ng/ml).  Addition of TGFβ prevented the increase of SSEA1 and loss 
of TRA1-81.  The results shown here are representative of three independent 
experiments. 
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Figure 5.22 Effect of adding TGFβ to the surface markers of early passages of 
spontaneously differentiating H1 cells.  Cells were maintained from passages 3 to 9 
passages with FGF2 alone or FGF2 and TGFβ (5ng/ml).  Addition of TGFβ prevented 





5.5.6.2.1 TGFβ role in hES cell self-renewal 
The results above indicated that the morphology and surface marker expression was 
recovered when TGFβ was added in conjunction with FGF2.  However, this did not 
exclude the possible support of self-renewal by TGFβ alone.  To establish whether 
TGFβ co-operated with FGF2 or could sustain self-renewal alone, the H1 cells were 
plated in the presence of FGF (8ng/ml) and TGFβ (5ng/ml) and TGFβ alone.  The cells 
plated in TGFβ alone have been maintained with the two factors: FGF2 and TGFβ for 
eight passages. 
 
After five days, the cell morphology indicated that TGFβ was not sufficient to maintain 
the growth of undifferentiated hES cells (Figure 5.22).  It was only when the 
combination of the two factors was used that a compact cell morphology was adopted.  
Interestingly, some tight colonies with ES morphology remained in the absence of 
FGF2, contrasting with the complete differentiation observed with TGFβ alone.  TGFβ 
could not compensate for FGF2 and in fact in the absence of FGF2 the effect of TGFβ 
seemed to promote differentiation. 
 
To further assess the effect of TGFβ signalling, SB431542 inhibitor of the TGFβ type I 
receptor-like kinase ALK5 (Inman et al., 2002) was used.  SB31542 also inhibits ALK 4 
and 7 receptors for Activin and Nodal respectively, therefore the inhibition of the 
TGFβ/Activin/Nodal signalling pathway was expected to occur.   Firstly, a titration of 
the inhibitor was carried out and 10ng/ml of TGFβ used to stimulate the cells.  The 
activation of SMAD proteins downstream of TGFR were examined by western blotting 
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(Figure 5.23A).  20μM of inhibitor was chosen in subsequent experiments despite 
detectable SMAD activation.  SMAD basal level of phosphorylation suggested 
TGFβ/Activin/Nodal activity either from the Matrigel or in an autocrine fashion.   
 
To examine the cell morphology, 5x105 cells were plated in the presence of 20μM of the 
SB431542 inhibitor.  As controls the following were included: first passage of cells in 
FGF2, cells treated with SU5402 (20µM) and cells with FGF2 and DMSO.  After 5 days 
of continuous exposure, the effect of the inhibition was shown by the spreading of the 
cells (Figure 5.23B) and the maintenance of low levels of SSEA1 (Figure 5.24).  
Although high levels of TRA1-81 were detected, the amount of cells expressing this 
marker had decreased in comparison with the controls in FGF2.  In conclusion, TGFβ 














Figure 5.22. Effect of TGFβ alone on the cell morphology of spontaneously 
differentiating H1 cells.  H1 cells were maintained for 8 passages in FGF2 and TGFβ 
were plated in TGFβ alone and in the absence of factors.  Cells in FGF2 and FGF+ 
TGFβ (as passaged) were also included.  The addition of TGFβ alone was not capable of 
compensating for FGF in the self-renewal of the hES cells.  The results shown here are 
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Figure 5.23.  Inhibition of TGFβ/Activin/Nodal signal by SB431542.  A: Titration of 
the inhibitor.   After 1 hour of incubation with the inhibitor the cells were stimulated 
with 10ng/ml of TGFβ and the lysates were blotted and probed with an antibody specific 
to phosphorylated Smad (Smad-P).  B: Effect of TGFβ inhibition on cell morphology.  
5x105 cells were plated in the presence of 20μM of inhibitor.  Scale bar = 500µm. 
TGFβ                         -                   +                    +                  +                    +                    +     
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Figure 5.24. Effect of SB31542 on the expression of cell surface markers.  After 5 
days of continuous exposure to the inhibitor SB431542, low levels of SSEA1 and high 
levels of TRA1-81 were observed showing a maintenance of the markers when TGFβ 
signalling was inhibited.  This contrasted with the effect of SU5402, which increased 
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In addition to the different roles of FGF in the biology of human and mouse ES cells, the 
biochemistry of FGF in these two cell types also seemed to differ.  In chapter 5 has been 
shown that FGF can sustain hES cell self-renewal and highly activated the MAPK/ERK 
pathway. This contrasts with FGF activation of MAPK/ERK, which is an initiator of 
lineage commitment (Kunath et al., 2007).  On the other hand, LIF addition to the hES 
cells did not result in the phosphorylation of ERK, although LIF activated STAT3.  FGF 
activation of STAT3 had been reported (Schlessinger, 2000), however, this was not 
observed in the repeated inductions performed in this study and neither has it been 
confirmed by Dvorak et al, (2005).  LIF phosphorylation of STAT3 is consistent with an 
intact LIF/STAT3 signalling pathway suggested by Daheron et al, (2004).  Despite its 
phosphorylation, it is recognised that STAT3 activation is not sufficient in maintaining 
hES cells in an undifferentiated state (Humphrey et al., 2004; Daheron et al., 2004).  
Data presented in this chapter indicated that it is through the activation of FGFRs that 
hES cell self-renewal is sustained.  This was supported by the chemical inhibition of 
FGFR, which resulted in a very dramatic loss of proliferation and self-renewal.  FGF2 
maintained self-renewal in a dose dependent manner.  Comparison of cell morphology 
and surface markers of cells treated with FGFR inhibitor and FGF withdrawal suggested 
the activity of autocrine FGF signalling.   Furthermore, the requirement for FGF2 seems 
to be specific since FGF4, which also highly activates ERK, did not sustain hES cell 
self-renewal.  Inhibition of the MAPK and PI3K pathways by UO126 and LY294002 
respectively result in the loss of morphology and surface markers associated with hES 
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cells.  This indicated that both pathways may be involved in hES cell self-renewal and 
perhaps proliferation.  In addition to these, other signals could be activated downstream 
of FGF2, for example, the SRC pathway could also be involved in hES cell self-renewal.  
These results are supported by a recent report indicating the key function of MAPK and 
PI3K in maintaining the pluripotency and viability of hES cells (Armstrong et al., 2006). 
 
Furthermore, FGF2 may be also co-operating with other factors, either in an autocrine 
manner or provided by Matrigel, which is an undefined component of the system.  The 
effects of two significant factors included in Matrigel, heparin and TGFβ were tested.  
Heparin has an important role in FGF signalling by stabilising the FGF:FGFR binding 
complexes (Pantoliano et al., 1994),  which could suggest a positive effect on self-
renewal.  However, heparin did not improve the cell self-renewal in the presence of 
FGF2 and in fact, cell morphology and surface markers indicated an increase in 
differentiation.  The explanation could be associated with the reported ability of heparin 
in activating the FGFR independently from the growth factors (Roghani et al., 1994).   
Absence of the high affinity ligand would result in a weaker FGFR activation and 
consequently a reduction in transmembrane signalling. This could also result in a 
dominant negative effect, increasing differentiation.  In addition to engaging with the 
receptors, an excess of heparin could occupy all the binding sites on the FGF molecule, 
restricting the effect of FGF on receptor activation.  A differentiating role of heparin in 
conjunction with FGF2 has been indicated by the induction of differentiation of neural 
stem cells into functional neurons (Ren et al., 2006).  On the other hand, a  recent 
publication attributes heparan sulphates (HSs) a significant role in the maintenance of 
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mES cell self-renewal (Sasaki et al., 2008).  Sasaki et al, (2008) reported that a reduction 
in the levels of HS chains resulted in a decrease of mES cell proliferation and 
differentiation into extraembryonic lineages.  One of the mechanisms responsible for 
this outcome was the HS regulation of BMP/Smad signalling and consequently the 
blocking of neural differentiation (Sasaki et al., 2008).  As discussed previously, an 
increase in BMP signalling could result in hES cell differentiation.  In contrast with 
heparin, TGFβ addition to the medium in conjunction with FGF2 had a positive effect on 
hES cell proliferation.  When an increase in spontaneous differentiation occurred in the 
cultures, TGFβ supplement with FGF2 restored the undifferentiated cell proliferation.  
This suggested that the variation in the TGFβ concentration in Matrigel could affect 
differentiation and more importantly, it indicated the collaboration of FGF2 and TGFβ in 
sustaining self-renewal.  A co-operation between these two signalling pathways in hES 
cells was reported at the time of printing this thesis.  The report by Wu et al, (2008) 
implied that the TGFβ/Activin/Nodal pathway was necessary to determine pluripotency 
in early human development.  They showed by RT-PCR and western blotting that the 
expression of FGF2, FGF4 and FGF8 was highly repressed when TGFβ/Activin/Nodal 
pathway was inhibited (Wu et al., 2008).  Based on the observations that both, inhibiton 
of TGFβ/Activin/Nodal and activation of BMP were required for trophoblast 
differentiation they proposed that trophoblast separation from the ICM is controlled by 
TGFβ/Activin/Nodal signalling in human embryonic development.  In this way, in the 
morula, the cells that did not receive sufficient TGFβ/Activin/Nodal signal form the 
trophoblast, and only those that receive the signal develop into ICM.  Significantly, 
when they inhbited TGFβ/Activin/Nodal pathway in the 8-cell stage mouse embryo, the 
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ICM and trophoblast formed normally, demonstrating that this pathway was not 
involved in the regualation of pluripotency in mouse (Wu et al., 2008).  Nevertheless, it 
should be noted that although abnormalities were not detected at d.p.c. 4.5 they may 
have appeared later in development.  A later effect would be consistent with the 
requirement for Activin and FGF signalling by the cells in the mouse epiblast (Camus et 
al., 2006).  This dependency on these two signalling pathways is also maintained by the 
epiblast stem cells from post implantation epiblast (5.75 d.p.c) (Brons et al.,2007 and 
Tesar et al.,2007).  In other animal models such as Xenopus, it was demonstrated that 
when FGF signalling was blocked the levels of many Activin-responsive genes (Cornell 
and Kimelman, 1994a) decreased implying the co-operation of TGFβ/Activin/Nodal and 
FGF signalling pathways. 
 
Therefore, the results reported in this chapter 5 indicated that TGFβ and FGF2 must 
operate together.  However, whilst FGF inhibition resulted in differentiation, the 
blockage of TGFβ/Activin/Nodal pathway did not result in differentiation.  This was 
consistent with the inability of TGFβ to sustain self-renewal alone.  Taken together, 
these results indicated that FGF2 is the principal factor in maintaining hES cell self-
renewal.  This was supported by the restoration of self-renewal when high 
concentrations of FGF2 were applied to differentiating hES cells.  It is believed that high 
concentrations of FGF2 can inhibit the differentiating effect of BMP4 (Wang et al., 
2005) in unconditioned medium (Xu et al., 2005b).  BMP activity could be suggested by 
the trophoblast-like morphology presented in spontaneous differentiating cells.   
Therefore, high doses of FGF2 or activation of the TGFβ/Smad2/3 branch of the 
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pathway might be compensating for these pro-differentiating signals and therefore 
prevent differentiation.  It would be of great interest to assess the signalling pathways 
activated in the cells that were spontaneously differentiating.   In the case of activation 
of the Smad1/5 proteins it would demonstrate that BMP-like signals were active and 
inducing differentiation.  Once it was established whether FGF2 alone or in conjunction 
with TGFβ could inhibit Smad1/5 activation, the mechanisms for restoring self-renewal 
would be demonstrated.  Furthermore, the analysis of gene expression in the 
differentiated cells would indicate whether the cells were differentiating into a specific 
cell lineage.   
 
In CM, inhibitors of BMP4 activity such as Gremlin and Cerberus are provided by the 
MEFs when stimulated by FGF2 (Greber et al., 2006).  In addition to these, several other 
members of the TGFβ family including TGFβ and Activin are released in response to 
FGF2 at a concentration dependent manner.  The secretion of these factors is not only 
induced from the MEFs but also from the hES cells themselves, suggesting the activity 
of autocrine signalling (Greber et al., 2006).  Other components of the TGFβ pathway 
activators of Smad2/3 found specifically expressed in hES cells are Nodal 
(Brandenberger et al., 2004; James et al., 2005) and Cripto (Sato et al., 2003; James et 
al., 2005).  Amongst all of them, special significance has been given to Nodal and 
Activin, to which some groups attribute the central role in maintaining hES cells (Xiao 
et al., 2005; Vallier et al., 2005; Beattie et al.,2005).   However, this conclusion has 
been based on the activation of the downstream effectors of the branch SMAD 2/3, 
which can also be activated by TGFβ1.  TGFβ1 has recently been shown to contribute 
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with a combination of growth factors, which included FGF2 to maintain hES cells in a 
feeder free culture (Ludwig et al., 2006a).  TGFβ mechanism is suggested to be the 
direct repression of differentiation since its addition resulted in reduced cell-specific 
transcripts in hES cells (Schuldiner et al., 2000).    
 
In conclusion, data from this chapter indicates that FGF2 is an upstream factor in human 
ES cell self-renewal and that FGF2 can sustain hES cells through the activation of the 
MAPK/ERK and PI3K/AKT pathways.  In addition to FGF2, TGFβ seems to contribute 
to the maintenance of hES cell self-renewal, possibly by compensating for BMP4-like 
signalling in unconditioned medium.  The presence of TGFβ in Matrigel is likely to be 
critical for hES cell growth since in serum and feeder free conditions this is the main 
source of the factor.  Therefore, any variance in TGFβ concentrations could unbalance 
the signalling and consequently the undifferentiated proliferation will be lost.  On the 
whole, these conclusions were reached using flow cytometry.  Other methods such as 
immunocytochemistry, immunoblotting and RT-PCR could be used to confirm the 
results for the assessment of markers of pluripotency.  A model of the co-operating cell 









Figure 5.25. Human ES cell regulation.  Activation of FGFR by FGF binding resulting 
in the phosphorylation of MAPK/ERK and PI3K/AKT signalling pathways, which 
resulted in the regulation of hES cell self-renewal.  TGFβ activates the TGFβR and 
subsequently activates the SMAD2/3 transcription factors.  SMAD2/3 bind to a co-
transcription factor SMAD4 and together they translocate into the nucleus.  FGF2 and 
























 PI3K MAPK 








































6.1 General discussion 
Mouse and human ES cells propagate on inactivated murine embryonic fibroblast (MEF) 
feeders or in conditioned medium (CM) derived from MEFs.  In these conditions, both 
populations of cells express markers characteristic of pluripotent cells, such as OCT4, 
and retain the potential to differentiate into the three germ layers (Brook and Gardner, 
1997; Thomson et al., 1998; Amit et al., 2000).  However, the signals required to 
maintain self-renewal and pluripotency are different in these two cell types: LIF and 
BMP4 signalling sustain mES cells self-renewal (Smith, et al.,1988; Ying et al.,2003a), 
whereas LIF cannot maintain hES cells (Daheron et al., 2004) and BMP4 induces their 
differentiation (Xu et al., 2002).  FGF2 is the factor used routinely to grow hES cells 
whereas the media to grow mES cells is not supplemented with FGF.  Furthermore, 
significant levels of Fgf2 transcripts have been detected in hES cells, whilst FGF2 is 
undetected in mES cells.  Mouse ES cells express significant levels of FGF4, whereas in 
hES cells this had not been detected (Wei et al., 2005) until a recent study claiming that 
FGF4 was also expressed by hES cells  (Mayshar et al.,2008).  This difference in the 
expression of FGF4 have been attributed to different stages in the early embryonic 
development from which mouse and human ES cells are derived (Wei et al., 2005).  
However, divergence in the factors for propagation and the distinct phenotypes of these 
two cell populations, such as expression of surface markers and specific gene 
expression, have also been thought to be characteristic of the human and mouse species.  
Therefore, pluripotent stem cells derived from mouse and human embryos appear to be 
markedly different and this has been attributed either to species specificity, or to 
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different developmental properties or to a combination of both.  In addition to this, a 
different role of FGF signalling seemed to be suggested.  Consequently one of the 
principal aims of this study was to determine the role of FGF signalling in human and 
mouse ES cells.   
 
Data presented within this thesis suggested that in mES cells the effect of FGF2 and 
principally FGF4 resulted in the down regulation of OCT4.  OCT4 down regulation may 
indicate that FGF4 is a pro-differentiative signal for mES cells.  This result contrasts 
with previous literature suggesting that FGF function was limited to regulating the 
differentiated progeny (Rappolee et al., 1994; Wilder et al.,1997; Rizzino et al.,1998).  
However, recent evidence indicates a requirement for FGF4 signalling in 
neuroectodermal differentiation in mES cells and in the chick embryo (Stavridis et al., 
2007; Kunath et al., 2007).  More specifically, these groups established that FGF4 is the 
auto inductive stimulus initiator of neural commitment, thus indicating an autocrine role 
of FGF4 in earlier stages of differentiation.  FGF autocrine induction of differentiation 
in mES cells contrasts with the FGF autocrine induction of self renewal reported in hES 
cells (Dvorak et al., 2005 and own observations).   Kunath et al, (2007) proposed that 
FGF activation of ERK is necessary to induce ES cells into a receptive state towards 
pro-differentiating signals, rather than directly specifying a lineage.  It is when the 
FGF/ERK signal switches the pro-self-renewal function of BMP4 (Ying et al., 2003b) to 
a non-neural differentiation that lineage commitment could occur (Kunath et al., 2007).  
Results presented within this thesis are in line with the argument that blocking extrinsic 
signals such as FGF4 is necessary to sustain the pluripotency of mES cells (Silva and 
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Smith, 2008).  Therefore, FGF4 reduction of OCT4 levels, discussed in chapter 3, would 
result in a decrease in the resistance to differentiation.  Consequently, cells with reduced 
levels of OCT4 change into a competent state in which they can accept signals that are 
the inducers of lineage commitment.   
 
In addition to studying the effects of FGF signalling on mES cells, the effect of FGF was 
assessed on hES cells.  At the start of this project, the basis for the use of FGF2 in hES 
cell culture had not been fully established, despite its presence in all reported hES cell 
culture systems.  Over the course of this study the positive role of FGF2 in maintaining 
the self-renewal of hES cells has been reported by several groups and is now widely 
recognised (Levenstein et al., 2005; Xu et al., 2005a and b; Ludwig et al., 2006).  
However, another factors than FGF2 also have been attributed with the main anti-
differentiation and/or pro-self-renewal role in hES cells (Sato et al., 2004; Beattie et al., 
2005; James et al., 2005).  Consequently, it was a key aim of this project to establish 
whether FGF2 signalling is sufficient in sustaining hES cell self-renewal and to 
determine the principal signalling pathways downstream of FGF2.  In addition to this, 
while this thesis was carried out, any possible collaborating signals with the FGF 
pathway were still to be determined.  The standard culture system for hES cells involves 
the use of the highly variable CM medium, which also contained FGF2 making it very 
difficult to distinguish the role of specific growth factors in self-renewal.  Therefore, to 
define the role of FGF2 and other specific factors during hES cell self-renewal the 
simplified N2B27 system was established and used. 
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Data presented within this thesis demonstrated that FGF2 increased proliferation and 
decreased differentiation of hES cells.  This suggested that the effect of FGF2 on hES 
cells is not the equivalent to that of LIF on mES cells as might be expected.  The role of 
LIF is primarily to prevent differentiation with little effect on stimulation of proliferation 
(Raz et al., 1999).  The results presented in Chapter 4 indicate that FGF2 is not only an 
anti-differentiation factor but it also induced proliferation of hES cells.  In addition to 
this, results from this thesis indicate that FGF2 acted directly on hES cells, which differs 
with the indirect role of FGF2 on the maintenance of hES cell self-renewal recently 
reported by Bendall et al, (2007).  In their model, FGF2 induced the secretion of pro-
self-renewal factors from the differentiated progeny of the hES cells (Bendall et al., 
2007).  Among these factors, a significant role was attributed to insulin growth factor II 
(IGF-II) and TGFβ (Bendall et al., 2007).  This agrees with FGF2 induction of soluble 
members of the TGFβ family from fibroblasts, which has been described by Greber et 
al. (2006).   However, a direct effect of FGF2 on hES cells cannot be excluded.  FGF2 
also enhanced the expression of promoters of self-renewal in the hES cells themselves 
(Greber et al., 2006; Nguyen et al., 2007).  Furthermore, this thesis has demonstrated 
FGF2 activation of hES cells, in addition to their proliferation in cultures deficient in 
surrounding differentiation as a result of the serum-free conditions.  In fact, the report of 
IGF-II as a factor in the regulation of hES cells (Bendall et al., 2007) supports the 
importance of Matrigel in hES cell culture.  IGF-II activates the IGF1 receptors (IGF-
1R), which are also activated by the other member of the insulin like family of growth 
factors, IGF-I (Bendall et al., 2007; Nguyen et al., 2007).  IGF-I is present in growth 
factor reduced Matrigel at a concentration of 5ng/ml.  In addition to IGF-I and II, insulin 
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has been shown to activate the same IGF-1 receptors in mES cells (Nguyen et al., 2007).  
Since insulin is one of the principal components of the N2B27 medium, this could 
indicate the cooperating role of FGF2 and the signals activated by IGF-1 receptors.  
FGFs have been previously described as priming factors for other signalling pathways 
(Cornell and Kimelman, 1994b), therefore, it was proposed that FGF2 signalling 
increased the competency of hES cells in receiving other signals directly involved in 
self-renewal in addition to directly sustaining hES cell proliferation. 
 
Results from chapter 5 indicate that TGFβ was a cooperating factor with FGF2 in 
maintaining hES cells and that in feeder-free systems, TGFβ is usually provided by 
Matrigel.  These results were in line with the suggested collaboration of FGF and TGFβ 
signalling pathways in sustaining the undifferentiated state of hES cells (Vallier et al., 
2005).  However, it has been proposed that the TGFβ/Activin/Nodal is the principal 
signal for maintenance of hES cell self-renewal (Amit el al., 2004; Vallier et al., 2005; 
James et al.,2005).  In contrast, results within this thesis indicated that TGFβ was not 
sufficient to sustain the undifferentiated state of hES.  A cooperation between FGF and 
TGFβ/activn/Nodal signalling pathway is also required for mouse and rat EpiES cells 
propagation (Tesar et al., 2007; Brons et al., 2007) and mouse trophoblast stem (TS) 
cells (Guzman-Ayala et al., 2004). 
 
Further signalling studies within this thesis indicated that activation of MAPK/ERK and 
PI3K are pathways possibly involved in the maintenance of hES cell self-renewal.  
There is still somewhat limited literature about the signalling pathways responsible of 
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hES cell self-renewal.  Data from chapter 5 agrees with the dependence of hES cells on 
active MAPK/ERK and PI3K/AKT downstream of FGF2 demonstrated by 
transcriptional profiling and functional analysis (Armstrong et al., 2006).  FGF 
activation of the MAPK/ERK pathway may be fundamental to the differences between 
mouse and human ES cell regulation.  FGF/ERK seems to be involved in hES cell self-
renewal, which contrasts with the inductive role in the differentiation of mES cells.  In 
addition to this, the relationship between FGF and BMP signalling might be related to 
the conflicting function of FGF on mouse and human ES cells, in that  BMP4 expression 
in hES cells is down-regulated by FGF signalling (Greber et al., 2006) and BMP4 
inhibits ERK and thereby supports mES cell self-renewal (Qi et al., 2004).  Therefore, it 
might be possible that FGF and BMP signals block each other with opposite effects in 
both cell populations.  However, this argument is contradicted somewhat by FGF/ERK 
acting upstream of BMP4, rather than directly blocking BMP4 signal in mES cells 
(Kunath et al., 2007). 
 
6.2 Conclusions  
The key finding in this thesis was the contrasting effect of FGF signalling on mouse and 
human ES cells.  FGF signalling promoted the undifferentiated proliferation of hES cells 
and produced a destabilizing effect on mES cell self-renewal.  This denoted fundamental 
differences in the regulation of ES cells propagation and differentiation, which have 
been attributed to different developmental properties but also to species specificity.  
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Arguments claiming that differences were associated to different developmental origins 
in mouse and human ES cells were challenged by the recent induced pluripotent stem 
(iPS) cells from mouse (Takahashi and Yamanaka, 2006) and human embryonic 
fibroblasts (Yu et al., 2007; Takahashi et al., 2007).  Both types of iPS cells were 
induced by the same cocktail of transcription factors, OCT4, SOX2, KLF4 and c-MYC.  
However, each cell population needed to be maintained in their specific conditions: hES 
cells in FGF2 and mES cells in LIF.  Therefore, specific requirements in the regulation 
of mouse and human iPS cells might be attributed to species divergence.   
 
However, the hypothesis of species specificity disagrees with the finding that hES cells 
resembled the recent isolated mouse and rat EpiSCs.  Similarities included gene 
expression and a requirement for FGF2 and the activator of Smad2/3 proteins, Activin.  
This gene expression in EpiSCs represents the post implantation epiblast from which 
these cells originate.  FGF and Activin are involved in both, proliferation and 
differentiation of the mouse post implantation epiblast in vivo (Xu et al., 2002; Camus et 
al., 2006).  These characteristics could suggest a similar epiblast origin in hES cells and 
EpiES cells, which would imply a difference in the pluripotent stages of the cells of 
origin for mouse and human ES cells.  The different roles of FGF on the two ES cell 
types therefore, might be denoting the different developmental origin.  Therefore, ES 
cells would be reflecting the in vivo roles of FGF signalling in early development.   An 
equivalent epiblast stage of hES cells and EpiSCs also indicates that hES cells originate 
at a later stage of development than previously thought.  However, the differentiation of 
hES and EpiES cells into extraembryonic trophoblast when treated with BMP4 (Xu et 
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al., 2002; Brons et al., 2007) seemed to indicate otherwise.  Significantly, trophoblast 
stem (TS) cells derived from the trophectoderm also depend on FGF and Activin 
signalling for self-renewal.  It could be reasoned that perhaps the combination of activity 
of FGF and TGFβ pathways can prime hES and EpiES cells to respond to BMP4 signal 
by differentiating into the trophoblast lineage.  Furthermore, previous views of ES 
cultures as homogeneous populations have been challenged by showing an inconsistent 
expression in the levels of Nanog (Chambers et al., 2007) and Rex1 (Toyooka et al., 
2008) in ES cells.  Supporting this, is the transcriptional activity of many genes related 
to lineage commitment found in ES cells (Ye et al., 2003).  A heterogeneous population 
of cells implies that there will be different responses to signals for self-renewal and 
differentiation.  The same signals that promote self-renewal in hES cells could induce 
the differentiation of cells at distinct pluripotent states.   For example, expression of 
trophoblast markers in cultures of hES and Epi cells may be caused by the increased 
presence of TS cells, since all of them proliferate by the same signal activation (Rossant, 
2008).  Another possibility is that these particular cell types in culture gain the capacity 
for this atypical differentiation.   It has became apparent that prolonged culture of hES 
cells may result in genetic changes as the cells adapt to the growth under in vitro 
conditions (Draper et al., 2004).  The cells in the embryo from which the immortal ES 
originate disappear after a few days.   It is therefore logical to think that some signalling 
pathways in ES cells might not have relevance in vivo.  Moreover, hES cells use several 
intracrine or autocrine signalling pathways to retain their capacity to proliferate.  Such 
autonomous signalling mechanisms might not have relevance in vivo but it may be 
necessary to adapt to in vitro conditions.   
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At present the causes for the differences between mouse and human ES cells are still 
uncertain.  In support of the argument for the different developmental properties it can 
be said that LIF is an inhibitor of differentiation towards the post implantation epiblast 
(Smith et al., 1988) in ICM.  Therefore, cells which are in a post implantation state, such 
as EpiSC-like cells do not need LIF, as they are dependent on FGF and Activin in 
accordance with their developmental origin.  However, and in support of the hypothesis 
of species specificity is that only murine embryos have been reported to be able to delay 
implantation by using LIF (Nichols et al., 2001).  Therefore, the requirement for LIF to 
sustain pluripotency seems to be exclusive of mice, indicating species specificity. 
 
6.3 Future work 
The results described within this thesis indicated the contrasting effects that activation of 
FGF signalling has on mouse and human ES cells.  However, it is difficult to determine 
whether this difference could be attributed to species specificity or different timing in 
development.  Further insight into this should be obtained by examining if mouse iPS 
cells could produce EpiSC-like cells in the presence of FGF and Activin. 
 
This thesis has demonstrated the key role of FGF2 in hES cell propagation in addition to 
indicating the positive role of ERK and PI3K activation in the self-renewal of hES cells.  
However, further analysis of the exclusive role of FGF2 in the activation of these 
signalling pathways and the involvement of other factors would be of interest for future 
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research, for example, studying the role of IGF-I and II in PI3K activation.  
Furthermore, collaboration between FGF2 and TGFβ has been suggested here, in 
addition to the significant role of Matrigel as a provider of TGFβ and other potential 
factors in hES cell growth.  The development of standardised and more favorable culture 
conditions for hES cells would reduce the tendency of ES cells toward spontaneous 
differentiation and consequently would reduce the selection pressure for mutations that 
inhibit those processes.   Therefore, the study of the relationship between FGF2 and 
other factors included in Matrigel, and the effect of the combination of signals in hES 
cells would help to clarify the mechanisms controlling pluripotency in hES cells.  This 
knowledge could be translated to early human development and more specifically, to the 
understanding of the mechanisms controlling cell fate commitment during the first 
events of differentiation.  A combination of human and mouse ES cells thus provides a 
powerful approach for studying the molecular mechanisms controlling pluripotency 




Abraham JA, Mergia A, Whang JL, et al. Nucleotide sequence of a bovine clone 
encoding the angiogenic protein, basic fibroblast growth factor. Science 1986; 233 
(4763):545-8. 
Adnane J, Gaudray P, Dionne CA, et al. BEK and FLG, two receptors to members of the 
FGF family, are amplified in subsets of human breast cancers. Oncogene 1991; 6 
(4):659-63. 
Alanko T, Tienari J, Lehtonen E, Saksela O. FGF-2 inhibits apoptosis in human 
teratocarcinoma cells during differentiation on collagen substratum. Exp Cell Res 1996; 
228 (2):306-12. 
Amit M, Carpenter MK, Inokuma MS, et al. Clonally derived human embryonic stem 
cell lines maintain pluripotency and proliferative potential for prolonged periods of 
culture. Dev Biol 2000; 227 (2):271-8. 
Amit M, Margulets V, Segev H, et al. Human feeder layers for human embryonic stem 
cells. Biol Reprod 2003; 68 (6):2150-6. 
Amit M, Shariki C, Margulets V, Itskovitz-Eldor J. Feeder layer- and serum-free culture 
of human embryonic stem cells. Biol Reprod 2004; 70 (3):837-45. 
Andrews PW. Human teratocarcinomas. Biochim Biophys Acta 1988; 948 (1):17-36. 
Andrews PW. From teratocarcinomas to embryonic stem cells. Philos Trans R Soc Lond 
B Biol Sci 2002; 357 (1420):405-17. 
Andrews PW, Damjanov I, Simon D, et al. Pluripotent embryonal carcinoma clones 
derived from the human teratocarcinoma cell line Tera-2. Differentiation in vivo and in 
vitro. Lab Invest 1984; 50 (2):147-62. 
Anneren C, Cowan CA, Melton DA. The Src family of tyrosine kinases is important for 
embryonic stem cell self-renewal. J Biol Chem 2004; 279 (30):31590-8. 
Arman E, Haffner-Krausz R, Chen Y, Heath JK, Lonai P. Targeted disruption of 
fibroblast growth factor (FGF) receptor 2 suggests a role for FGF signaling in 
pregastrulation mammalian development. Proc Natl Acad Sci U S A 1998; 95 (9):5082-
7. 
Armstrong L, Hughes O, Yung S, et al. The role of PI3K/AKT, MAPK/ERK and 
NFkappabeta signalling in the maintenance of human embryonic stem cell pluripotency 
 274
and viability highlighted by transcriptional profiling and functional analysis. Hum Mol 
Genet 2006; 15 (11):1894-913. 
Bartek J, Lukas J. Cell cycle. Order from destruction. Science 2001; 294 (5540):66-7. 
Baumann P, West SC. DNA end-joining catalyzed by human cell-free extracts. Proc 
Natl Acad Sci U S A 1998; 95 (24):14066-70. 
Beattie GM, Lopez AD, Bucay N, et al. Activin A maintains pluripotency of human 
embryonic stem cells in the absence of feeder layers. Stem Cells 2005; 23 (4):489-95. 
Becker KA, Ghule PN, Therrien JA, et al. Self-renewal of human embryonic stem cells 
is supported by a shortened G1 cell cycle phase. J Cell Physiol 2006; 209 (3):883-93. 
Beckwith J. Industrial genetic screening. Sci People 1980; 12 (2):20-1. 
Beddington RS, Robertson EJ. An assessment of the developmental potential of 
embryonic stem cells in the midgestation mouse embryo. Development 1989; 105 
(4):733-7. 
Behrendtsen O, Alexander CM, Werb Z. Metalloproteinases mediate extracellular 
matrix degradation by cells from mouse blastocyst outgrowths. Development 1992; 114 
(2):447-56. 
Bellacosa A, Chan TO, Ahmed NN, et al. Akt activation by growth factors is a multiple-
step process: the role of the PH domain. Oncogene 1998; 17 (3):313-25. 
Bellot F, Crumley G, Kaplow JM, et al. Ligand-induced transphosphorylation between 
different FGF receptors. EMBO J 1991; 10 (10):2849-54. 
Bendall SC, Stewart MH, Menendez P, et al. IGF and FGF cooperatively establish the 
regulatory stem cell niche of pluripotent human cells in vitro. Nature 2007; 448 
(7157):1015-21. 
Bolland S, Pearse RN, Kurosaki T, Ravetch JV. SHIP modulates immune receptor 
responses by regulating membrane association of Btk. Immunity 1998; 8 (4):509-16. 
Boulton TG, Stahl N, Yancopoulos GD. Ciliary neurotrophic factor/leukemia inhibitory 
factor/interleukin 6/oncostatin M family of cytokines induces tyrosine phosphorylation 
of a common set of proteins overlapping those induced by other cytokines and growth 
factors. J Biol Chem 1994; 269 (15):11648-55. 
Boyer LA, Lee TI, Cole MF, et al. Core transcriptional regulatory circuitry in human 
embryonic stem cells. Cell 2005; 122 (6):947-56. 
 275
Bradley A, Evans M, Kaufman MH, Robertson E. Formation of germ-line chimaeras 
from embryo-derived teratocarcinoma cell lines. Nature 1984; 309 (5965):255-6. 
Brandenberger R, Wei H, Zhang S, et al. Transcriptome characterization elucidates 
signaling networks that control human ES cell growth and differentiation. Nat 
Biotechnol 2004; 22 (6):707-16. 
Brinster RL. The effect of cells transferred into the mouse blastocyst on subsequent 
development. J Exp Med 1974; 140 (4):1049-56. 
Brivanlou AH, Gage FH, Jaenisch R, et al. Stem cells. Setting standards for human 
embryonic stem cells. Science 2003; 300 (5621):913-6. 
Brons IG, Smithers LE, Trotter MW, et al. Derivation of pluripotent epiblast stem cells 
from mammalian embryos. Nature 2007; 448 (7150):191-5. 
Burdon T, Chambers I, Stracey C, Niwa H, Smith A. Signaling mechanisms regulating 
self-renewal and differentiation of pluripotent embryonic stem cells. Cells Tissues 
Organs 1999a; 165 (3-4):131-43. 
Burdon T, Smith A, Savatier P. Signalling, cell cycle and pluripotency in embryonic 
stem cells. Trends Cell Biol 2002; 12 (9):432-8. 
Burdon T, Stracey C, Chambers I, Nichols J, Smith A. Suppression of SHP-2 and ERK 
signalling promotes self-renewal of mouse embryonic stem cells. Dev Biol 1999b; 210 
(1):30-43. 
Burdsal CA, Flannery ML, Pedersen RA. FGF-2 alters the fate of mouse epiblast from 
ectoderm to mesoderm in vitro. Dev Biol 1998; 198 (2):231-44. 
Burke D, Wilkes D, Blundell TL, Malcolm S. Fibroblast growth factor receptors: lessons 
from the genes. Trends Biochem Sci 1998; 23 (2):59-62. 
Cai J, Chen J, Liu Y, et al. Assessing self-renewal and differentiation in human 
embryonic stem cell lines. Stem Cells 2006; 24 (3):516-30. 
Campbell WJ, Miller KA, Anderson TM, Shull JD, Rizzino A. Expression of fibroblast 
growth factor receptors by embryonal carcinoma cells and early mouse embryos. In 
Vitro Cell Dev Biol 1992; 28A (1):61-6. 
Camus A, Perea-Gomez A, Moreau A, Collignon J. Absence of Nodal signaling 
promotes precocious neural differentiation in the mouse embryo. Dev Biol 2006; 295 
(2):743-55. 
Carpenter MK, Inokuma MS, Denham J, et al. Enrichment of neurons and neural 
precursors from human embryonic stem cells. Exp Neurol 2001; 172 (2):383-97. 
 276
Cartwright P, McLean C, Sheppard A, et al. LIF/STAT3 controls ES cell self-renewal 
and pluripotency by a Myc-dependent mechanism. Development 2005. 
Catena R, Tiveron C, Ronchi A, et al. Conserved POU binding DNA sites in the Sox2 
upstream enhancer regulate gene expression in embryonic and neural stem cells. J Biol 
Chem 2004; 279 (40):41846-57. 
Chai N, Patel Y, Jacobson K, et al. FGF is an essential regulator of the fifth cell division 
in preimplantation mouse embryos. Dev Biol 1998; 198 (1):105-15. 
Chambers I, Colby D, Robertson M, et al. Functional expression cloning of Nanog, a 
pluripotency sustaining factor in embryonic stem cells. Cell 2003; 113 (5):643-55. 
Chambers I, Silva J, Colby D, et al. Nanog safeguards pluripotency and mediates 
germline development. Nature 2007; 450 (7173):1230-4. 
Chen QS, Wang ZY, Han ZC. Enhanced growth of megakaryocyte colonies in culture in 
the presence of heparin and fibroblast growth factor. Int J Hematol 1999; 70 (3):155-62. 
Chen Y, Li X, Eswarakumar VP, Seger R, Lonai P. Fibroblast growth factor (FGF) 
signaling through PI 3-kinase and Akt/PKB is required for embryoid body 
differentiation. Oncogene 2000; 19 (33):3750-6. 
Chesi M, Bergsagel PL, Kuehl WM. The enigma of ectopic expression of FGFR3 in 
multiple myeloma: a critical initiating event or just a target for mutational activation 
during tumor progression. Curr Opin Hematol 2002; 9 (4):288-93. 
Ciruna B, Rossant J. FGF signaling regulates mesoderm cell fate specification and 
morphogenetic movement at the primitive streak. Dev Cell 2001; 1 (1):37-49. 
Conrad AH, Reddy P, Conrad GW. Expression of cytoskeletal, membrane transport, and 
transcription factor mRNAs in embryonic and adult Ilyanassa obsoleta. Bull Mt Desert 
Isl Biol Lab Salisb Cove Maine 1998; 37:2-3. 
Cornell RA, Kimelman D. Activin-mediated mesoderm induction requires FGF. 
Development 1994b; 120 (2):453-62. 
Curatola AM, Basilico C. Expression of the K-fgf proto-oncogene is controlled by 3' 
regulatory elements which are specific for embryonal carcinoma cells. Mol Cell Biol 
1990; 10 (6):2475-84. 
Daheron L, Opitz SL, Zaehres H, et al. LIF/STAT3 signaling fails to maintain self-
renewal of human embryonic stem cells. Stem Cells 2004; 22 (5):770-8. 
 277
Damjanov I, Bagasra O, Dominis M, Solter D. Embryo-derived teratocarcinoma. IV. 
The role of immune factors in the regulation of teratocarcinogenesis. Int J Cancer 1982; 
30 (6):759-62. 
Debiais F, Lemonnier J, Hay E, et al. Fibroblast growth factor-2 (FGF-2) increases N-
cadherin expression through protein kinase C and Src-kinase pathways in human 
calvaria osteoblasts. J Cell Biochem 2001; 81 (1):68-81. 
Delaune E, Lemaire P, Kodjabachian L. Neural induction in Xenopus requires early FGF 
signalling in addition to BMP inhibition. Development 2005; 132 (2):299-310. 
Deng CX, Wynshaw-Boris A, Shen MM, et al. Murine FGFR-1 is required for early 
postimplantation growth and axial organization. Genes Dev 1994; 8 (24):3045-57. 
Dono R, Texido G, Dussel R, Ehmke H, Zeller R. Impaired cerebral cortex development 
and blood pressure regulation in FGF-2-deficient mice. EMBO J 1998; 17 (15):4213-25. 
Draper JS, Moore HD, Ruban LN, Gokhale PJ, Andrews PW. Culture and 
characterization of human embryonic stem cells. Stem Cells Dev 2004; 13 (4):325-36. 
Dravid G, Ye Z, Hammond H, et al. Defining the role of Wnt/beta-catenin signaling in 
the survival, proliferation, and self-renewal of human embryonic stem cells. Stem Cells 
2005; 23 (10):1489-501. 
Dvorak P, Dvorakova D, Koskova S, et al. Expression and potential role of fibroblast 
growth factor 2 and its receptors in human embryonic stem cells. Stem Cells 2005; 23 
(8):1200-11. 
El-Hariry I, Pignatelli M, Lemoine NR. FGF-1 and FGF-2 modulate the E-
cadherin/catenin system in pancreatic adenocarcinoma cell lines. Br J Cancer 2001; 84 
(12):1656-63. 
Erlich HA. Polymerase chain reaction. J Clin Immunol 1989; 9 (6):437-47. 
Ernst M, Oates A, Dunn AR. Gp130-mediated signal transduction in embryonic stem 
cells involves activation of Jak and Ras/mitogen-activated protein kinase pathways. J 
Biol Chem 1996; 271 (47):30136-43. 
Esner M, Pachernik J, Hampl A, Dvorak P. Targeted disruption of fibroblast growth 
factor receptor-1 blocks maturation of visceral endoderm and cavitation in mouse 
embryoid bodies. Int J Dev Biol 2002; 46 (6):817-25. 
Eswarakumar VP, Lax I, Schlessinger J. Cellular signaling by fibroblast growth factor 
receptors. Cytokine Growth Factor Rev 2005; 16 (2):139-49. 
 278
Evans MJ, Kaufman MH. Establishment in culture of pluripotential cells from mouse 
embryos. Nature 1981; 292 (5819):154-6. 
Favata MF, Horiuchi KY, Manos EJ, et al. Identification of a novel inhibitor of mitogen-
activated protein kinase kinase. J Biol Chem 1998; 273 (29):18623-32. 
Feldman B, Poueymirou W, Papaioannou VE, DeChiara TM, Goldfarb M. Requirement 
of FGF-4 for postimplantation mouse development. Science 1995; 267 (5195):246-9. 
Finch BW, Ephrussi B. RETENTION OF MULTIPLE DEVELOPMENTAL 
POTENTIALITIES BY CELLS OF A MOUSE TESTICULAR 
TERATOCARCINOMA DURING PROLONGED CULTURE in vitro AND THEIR 
EXTINCTION UPON HYBRIDIZATION WITH CELLS OF PERMANENT LINES. 
Proc Natl Acad Sci U S A 1967; 57 (3):615-21. 
Fluckiger AC, Marcy G, Marchand M, et al. Cell cycle features of primate embryonic 
stem cells. Stem Cells 2006; 24 (3):547-56. 
Folkman J, Klagsbrun M, Sasse J, et al. A heparin-binding angiogenic protein--basic 
fibroblast growth factor--is stored within basement membrane. Am J Pathol 1988; 130 
(2):393-400. 
Garcia-Maya M, Anderson AA, Kendal CE, et al. Ligand concentration is a driver of 
divergent signaling and pleiotropic cellular responses to FGF. J Cell Physiol 2006; 206 
(2):386-93. 
Gardner RL. The relationship between cell lineage and differentiation in the early mouse 
embryo. Results Probl Cell Differ 1978; 9:205-41. 
Gaubert F, Escaffit F, Bertrand C, et al. Expression of the high molecular weight 
fibroblast growth factor-2 isoform of 210 amino acids is associated with modulation of 
protein kinases C delta and epsilon and ERK activation. J Biol Chem 2001; 276 
(2):1545-54. 
Gerrard L, Zhao D, Clark AJ, Cui W. Stably transfected human embryonic stem cell 
clones express OCT4-specific green fluorescent protein and maintain self-renewal and 
pluripotency. Stem Cells 2005; 23 (1):124-33. 
Ginis I, Luo Y, Miura T, et al. Differences between human and mouse embryonic stem 
cells. Dev Biol 2004; 269 (2):360-80. 
Gospodarowicz D, Cheng J. Heparin protects basic and acidic FGF from inactivation. J 
Cell Physiol 1986; 128 (3):475-84. 
 279
Gospodarowicz D, Greene G, Moran J. Fibroblast growth factor can substitute for 
platelet factor to sustain the growth of Balb/3T3 cells in the presence of plasma. 
Biochem Biophys Res Commun 1975; 65 (2):779-87. 
Gotoh N, Laks S, Nakashima M, Lax I, Schlessinger J. FRS2 family docking proteins 
with overlapping roles in activation of MAP kinase have distinct spatial-temporal 
patterns of expression of their transcripts. FEBS Lett 2004; 564 (1-2):14-8. 
Goumans MJ, Ward-van OD, Wianny F, et al. Mouse embryonic stem cells with 
aberrant transforming growth factor beta signalling exhibit impaired differentiation in 
vitro and in vivo. Differentiation 1998; 63 (3):101-13. 
Granerus M, Welin A, Lundh B, et al. Heparin binding growth factors and the control of 
teratoma cell proliferation. Eur Urol 1993; 23 (1):76-81. 
Greber B, Lehrach H, Adjaye J. FGF2 Modulates TGF{beta} Signaling in MEFs and 
Human ES cells to Support hESC Self-renewal. Stem Cells 2006. 
Guzman-Ayala M, Ben-Haim N, Beck S, Constam DB. Nodal protein processing and 
fibroblast growth factor 4 synergize to maintain a trophoblast stem cell 
microenvironment. Proc Natl Acad Sci U S A 2004; 101 (44):15656-60. 
Hadari YR, Gotoh N, Kouhara H, Lax I, Schlessinger J. Critical role for the docking-
protein FRS2 alpha in FGF receptor-mediated signal transduction pathways. Proc Natl 
Acad Sci U S A 2001; 98 (15):8578-83. 
Hamazaki T, Kehoe SM, Nakano T, Terada N. The Grb2/Mek pathway represses Nanog 
in murine embryonic stem cells. Mol Cell Biol 2006; 26 (20):7539-49. 
Hart AH, Hartley L, Ibrahim M, Robb L. Identification, cloning and expression analysis 
of the pluripotency promoting Nanog genes in mouse and human. Dev Dyn 2004; 230 
(1):187-98. 
Hay DC, Sutherland L, Clark J, Burdon T. Oct-4 knockdown induces similar patterns of 
endoderm and trophoblast differentiation markers in human and mouse embryonic stem 
cells. Stem Cells 2004; 22 (2):225-35. 
Heinrich PC, Behrmann I, Muller-Newen G, Schaper F, Graeve L. Interleukin-6-type 
cytokine signalling through the gp130/Jak/STAT pathway. Biochem J 1998; 334 ( Pt 
2):297-314. 
Henderson JK, Draper JS, Baillie HS, et al. Preimplantation human embryos and 
embryonic stem cells show comparable expression of stage-specific embryonic antigens. 
Stem Cells 2002; 20 (4):329-37. 
 280
Hoch RV, Soriano P. Context-specific requirements for Fgfr1 signaling through Frs2 
and Frs3 during mouse development. Development 2006; 133 (4):663-73. 
Hooper M, Hardy K, Handyside A, Hunter S, Monk M. HPRT-deficient (Lesch-Nyhan) 
mouse embryos derived from germline colonization by cultured cells. Nature 1987; 326 
(6110):292-5. 
Hubbard SR, Mohammadi M, Schlessinger J. Autoregulatory mechanisms in protein-
tyrosine kinases. J Biol Chem 1998; 273 (20):11987-90. 
Humphrey RK, Beattie GM, Lopez AD, et al. Maintenance of pluripotency in human 
embryonic stem cells is STAT3 independent. Stem Cells 2004; 22 (4):522-30. 
Hunter T. The Croonian Lecture 1997. The phosphorylation of proteins on tyrosine: its 
role in cell growth and disease. Philos Trans R Soc Lond B Biol Sci 1998; 353 
(1368):583-605. 
Hyslop L, Stojkovic M, Armstrong L, et al. Downregulation of NANOG induces 
differentiation of human embryonic stem cells to extraembryonic lineages. Stem Cells 
2005; 23 (8):1035-43. 
Ihle JN. STATs: signal transducers and activators of transcription. Cell 1996; 84 
(3):331-4. 
Inman GJ, Nicolas FJ, Callahan JF, et al. SB-431542 is a potent and specific inhibitor of 
transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) 
receptors ALK4, ALK5, and ALK7. Mol Pharmacol 2002; 62 (1):65-74. 
Itskovitz-Eldor J, Schuldiner M, Karsenti D, et al. Differentiation of human embryonic 
stem cells into embryoid bodies compromising the three embryonic germ layers. Mol 
Med 2000; 6 (2):88-95. 
James D, Levine AJ, Besser D, Hemmati-Brivanlou A. TGFbeta/activin/nodal signaling 
is necessary for the maintenance of pluripotency in human embryonic stem cells. 
Development 2005; 132 (6):1273-82. 
Jang JH, Chung CP. A novel splice variant of fibroblast growth factor receptor 2 in 
human leukemia HL-60 cells. Blood Cells Mol Dis 2002; 29 (1):133-7. 
Jirmanova L, Afanassieff M, Gobert-Gosse S, Markossian S, Savatier P. Differential 
contributions of ERK and PI3-kinase to the regulation of cyclin D1 expression and to the 
control of the G1/S transition in mouse embryonic stem cells. Oncogene 2002; 21 
(36):5515-28. 
 281
Jirmanova L, Pacholikova J, Krejci P, Hampl A, Dvorak P. O-linked carbohydrates are 
required for FGF-2-mediated proliferation of mouse embryonic cells. Int J Dev Biol 
1999; 43 (6):555-62. 
Johnson DE, Lu J, Chen H, Werner S, Williams LT. The human fibroblast growth factor 
receptor genes: a common structural arrangement underlies the mechanisms for 
generating receptor forms that differ in their third immunoglobulin domain. Mol Cell 
Biol 1991; 11 (9):4627-34. 
Kang HB, Kim JS, Kwon HJ, et al. Basic fibroblast growth factor activates ERK and 
induces c-fos in human embryonic stem cell line MizhES1. Stem Cells Dev 2005; 14 
(4):395-401. 
Karin M, Hunter T. Transcriptional control by protein phosphorylation: signal 
transmission from the cell surface to the nucleus. Curr Biol 1995; 5 (7):747-57. 
Kilkenny DM, Rocheleau JV, Price J, Reich MB, Miller GG. c-Src regulation of 
fibroblast growth factor-induced proliferation in murine embryonic fibroblasts. J Biol 
Chem 2003; 278 (19):17448-54. 
Klint P, Kanda S, Claesson-Welsh L. Shc and a novel 89-kDa component couple to the 
Grb2-Sos complex in fibroblast growth factor-2-stimulated cells. J Biol Chem 1995; 270 
(40):23337-44. 
Kosako H, Nishida E, Gotoh Y. cDNA cloning of MAP kinase kinase reveals kinase 
cascade pathways in yeasts to vertebrates. EMBO J 1993; 12 (2):787-94. 
Kouhara H, Hadari YR, Spivak-Kroizman T, et al. A lipid-anchored Grb2-binding 
protein that links FGF-receptor activation to the Ras/MAPK signaling pathway. Cell 
1997; 89 (5):693-702. 
Kovalenko D, Yang X, Nadeau RJ, Harkins LK, Friesel R. Sef inhibits fibroblast growth 
factor signaling by inhibiting FGFR1 tyrosine phosphorylation and subsequent ERK 
activation. J Biol Chem 2003; 278 (16):14087-91. 
Kunath T, Saba-El-Leil MK, Almousailleakh M, et al. FGF stimulation of the Erk1/2 
signalling cascade triggers transition of pluripotent embryonic stem cells from self-
renewal to lineage commitment. Development 2007; 134 (16):2895-902. 
Lam AC, Li K, Zhang XB, et al. Preclinical ex vivo expansion of cord blood 
hematopoietic stem and progenitor cells: duration of culture; the media, serum 
supplements, and growth factors used; and engraftment in NOD/SCID mice. Transfusion 
2001; 41 (12):1567-76. 
 282
Larsson H, Klint P, Landgren E, Claesson-Welsh L. Fibroblast growth factor receptor-1-
mediated endothelial cell proliferation is dependent on the Src homology (SH) 2/SH3 
domain-containing adaptor protein Crk. J Biol Chem 1999; 274 (36):25726-34. 
LaVallee TM, Prudovsky IA, McMahon GA, Hu X, Maciag T. Activation of the MAP 
kinase pathway by FGF-1 correlates with cell proliferation induction while activation of 
the Src pathway correlates with migration. J Cell Biol 1998; 141 (7):1647-58. 
Lemmon MA, Schlessinger J. Regulation of signal transduction and signal diversity by 
receptor oligomerization. Trends Biochem Sci 1994; 19 (11):459-63. 
Levenstein ME, Ludwig TE, Xu RH, et al. Basic FGF Support of Human Embryonic 
Stem Cell Self-Renewal. Stem Cells 2005. 
Li Y, Powell S, Brunette E, Lebkowski J, Mandalam R. Expansion of human embryonic 
stem cells in defined serum-free medium devoid of animal-derived products. Biotechnol 
Bioeng 2005; 91 (6):688-98. 
Lim JW, Bodnar A. Proteome analysis of conditioned medium from mouse embryonic 
fibroblast feeder layers which support the growth of human embryonic stem cells. 
Proteomics 2002; 2 (9):1187-203. 
Liu Y, Song Z, Zhao Y, et al. A novel chemical-defined medium with bFGF and N2B27 
supplements supports undifferentiated growth in human embryonic stem cells. Biochem 
Biophys Res Commun 2006; 346 (1):131-9. 
Lu J, Hou R, Booth CJ, Yang SH, Snyder M. Defined culture conditions of human 
embryonic stem cells. Proc Natl Acad Sci U S A 2006; 103 (15):5688-93. 
Ludwig TE, Bergendahl V, Levenstein ME, et al. Feeder-independent culture of human 
embryonic stem cells. Nat Methods 2006a; 3 (8):637-46. 
Ludwig TE, Levenstein ME, Jones JM, et al. Derivation of human embryonic stem cells 
in defined conditions. Nat Biotechnol 2006b; 24 (2):185-7. 
Marshall CJ. Specificity of receptor tyrosine kinase signaling: transient versus sustained 
extracellular signal-regulated kinase activation. Cell 1995; 80 (2):179-85. 
Martin GR. Isolation of a pluripotent cell line from early mouse embryos cultured in 
medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci U S A 1981; 78 
(12):7634-8. 
Martin GR, Evans MJ. Differentiation of clonal lines of teratocarcinoma cells: formation 
of embryoid bodies in vitro. Proc Natl Acad Sci U S A 1975; 72 (4):1441-5. 
 283
Matsuda T, Nakamura T, Nakao K, et al. STAT3 activation is sufficient to maintain an 
undifferentiated state of mouse embryonic stem cells. EMBO J 1999; 18 (15):4261-9. 
Matsui Y, Zsebo K, Hogan BL. Derivation of pluripotential embryonic stem cells from 
murine primordial germ cells in culture. Cell 1992; 70 (5):841-7. 
Mayshar Y, Rom E, Chumakov I, et al. Fibroblast growth factor 4 and its novel splice 
isoform have opposing effects on the maintenance of human embryonic stem cell self-
renewal. Stem Cells 2008; 26 (3):767-74. 
Mitsui K, Tokuzawa Y, Itoh H, et al. The homeoprotein Nanog is required for 
maintenance of pluripotency in mouse epiblast and ES cells. Cell 2003; 113 (5):631-42. 
Mohammadi M, Dikic I, Sorokin A, et al. Identification of six novel 
autophosphorylation sites on fibroblast growth factor receptor 1 and elucidation of their 
importance in receptor activation and signal transduction. Mol Cell Biol 1996; 16 
(3):977-89. 
Mohammadi M, Honegger AM, Rotin D, et al. A tyrosine-phosphorylated carboxy-
terminal peptide of the fibroblast growth factor receptor (Flg) is a binding site for the 
SH2 domain of phospholipase C-gamma 1. Mol Cell Biol 1991; 11 (10):5068-78. 
Mohammadi M, McMahon G, Sun L, et al. Structures of the tyrosine kinase domain of 
fibroblast growth factor receptor in complex with inhibitors. Science 1997; 276 
(5314):955-60. 
Nguyen TT, Sheppard AM, Kaye PL, Noakes PG. IGF-I and insulin activate mitogen-
activated protein kinase via the type 1 IGF receptor in mouse embryonic stem cells. 
Reproduction 2007; 134 (1):41-9. 
Nichols J, Chambers I, Taga T, Smith A. Physiological rationale for responsiveness of 
mouse embryonic stem cells to gp130 cytokines. Development 2001; 128 (12):2333-9. 
Nichols J, Davidson D, Taga T, et al. Complementary tissue-specific expression of LIF 
and LIF-receptor mRNAs in early mouse embryogenesis. Mech Dev 1996; 57 (2):123-
31. 
Nichols J, Zevnik B, Anastassiadis K, et al. Formation of pluripotent stem cells in the 
mammalian embryo depends on the POU transcription factor Oct4. Cell 1998; 95 
(3):379-91. 
Nishimoto M, Fukushima A, Okuda A, Muramatsu M. The gene for the embryonic stem 
cell coactivator UTF1 carries a regulatory element which selectively interacts with a 
complex composed of Oct-3/4 and Sox-2. Mol Cell Biol 1999; 19 (8):5453-65. 
 284
Niswander L, Martin GR. Fgf-4 expression during gastrulation, myogenesis, limb and 
tooth development in the mouse. Development 1992; 114 (3):755-68. 
Niwa H, Burdon T, Chambers I, Smith A. Self-renewal of pluripotent embryonic stem 
cells is mediated via activation of STAT3. Genes Dev 1998; 12 (13):2048-60. 
Niwa H, Miyazaki J, Smith AG. Quantitative expression of Oct-3/4 defines 
differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet 2000; 24 (4):372-
6. 
Nolan GP, Fiering S, Nicolas JF, Herzenberg LA. Fluorescence-activated cell analysis 
and sorting of viable mammalian cells based on beta-D-galactosidase activity after 
transduction of Escherichia coli lacZ. Proc Natl Acad Sci U S A 1988; 85 (8):2603-7. 
Olsen SK, Ibrahimi OA, Raucci A, et al. Insights into the molecular basis for fibroblast 
growth factor receptor autoinhibition and ligand-binding promiscuity. Proc Natl Acad 
Sci U S A 2004; 101 (4):935-40. 
Ong SH, Hadari YR, Gotoh N, et al. Stimulation of phosphatidylinositol 3-kinase by 
fibroblast growth factor receptors is mediated by coordinated recruitment of multiple 
docking proteins. Proc Natl Acad Sci U S A 2001; 98 (11):6074-9. 
Ornitz DM. FGFs, heparan sulfate and FGFRs: complex interactions essential for 
development. Bioessays 2000; 22 (2):108-12. 
Ornitz DM, Itoh N. Fibroblast growth factors. Genome Biol 2001; 2 (3):REVIEWS3005. 
Ornitz DM, Xu J, Colvin JS, et al. Receptor specificity of the fibroblast growth factor 
family. J Biol Chem 1996; 271 (25):15292-7. 
Ornitz DM, Yayon A, Flanagan JG, et al. Heparin is required for cell-free binding of 
basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells. 
Mol Cell Biol 1992; 12 (1):240-7. 
Orr-Urtreger A, Givol D, Yayon A, Yarden Y, Lonai P. Developmental expression of 
two murine fibroblast growth factor receptors, flg and bek. Development 1991; 113 
(4):1419-34. 
Ortega S, Ittmann M, Tsang SH, Ehrlich M, Basilico C. Neuronal defects and delayed 
wound healing in mice lacking fibroblast growth factor 2. Proc Natl Acad Sci U S A 
1998; 95 (10):5672-7. 
Paling NR, Wheadon H, Bone HK, Welham MJ. Regulation of embryonic stem cell self-
renewal by phosphoinositide 3-kinase-dependent signalling. J Biol Chem 2004. 
 285
Palmieri SL, Peter W, Hess H, Scholer HR. Oct-4 transcription factor is differentially 
expressed in the mouse embryo during establishment of the first two extraembryonic cell 
lineages involved in implantation. Dev Biol 1994; 166 (1):259-67. 
Pantoliano MW, Horlick RA, Springer BA, et al. Multivalent ligand-receptor binding 
interactions in the fibroblast growth factor system produce a cooperative growth factor 
and heparin mechanism for receptor dimerization. Biochemistry 1994; 33 (34):10229-
48. 
Pawson T. Protein modules and signalling networks. Nature 1995; 373 (6515):573-80. 
Pelton TA, Sharma S, Schulz TC, Rathjen J, Rathjen PD. Transient pluripotent cell 
populations during primitive ectoderm formation: correlation of in vivo and in vitro 
pluripotent cell development. J Cell Sci 2002; 115 (Pt 2):329-39. 
Pera EM, Ikeda A, Eivers E, De Robertis EM. Integration of IGF, FGF, and anti-BMP 
signals via Smad1 phosphorylation in neural induction. Genes Dev 2003; 17 (24):3023-
8. 
Pera MF, Andrade J, Houssami S, et al. Regulation of human embryonic stem cell 
differentiation by BMP-2 and its antagonist noggin. J Cell Sci 2004; 117 (Pt 7):1269-80. 
Pera MF, Cooper S, Mills J, Parrington JM. Isolation and characterization of a 
multipotent clone of human embryonal carcinoma cells. Differentiation 1989; 42 (1):10-
23. 
Pintucci G, Moscatelli D, Saponara F, et al. Lack of ERK activation and cell migration 
in FGF-2-deficient endothelial cells. FASEB J 2002; 16 (6):598-600. 
Piotrowicz RS, Maher PA, Levin EG. Dual activities of 22-24 kDA basic fibroblast 
growth factor: inhibition of migration and stimulation of proliferation. J Cell Physiol 
1999; 178 (2):144-53. 
Plotnikov AN, Hubbard SR, Schlessinger J, Mohammadi M. Crystal structures of two 
FGF-FGFR complexes reveal the determinants of ligand-receptor specificity. Cell 2000; 
101 (4):413-24. 
Plotnikov AN, Schlessinger J, Hubbard SR, Mohammadi M. Structural basis for FGF 
receptor dimerization and activation. Cell 1999; 98 (5):641-50. 
Poon E, Clermont F, Firpo MT, Akhurst RJ. TGFbeta inhibition of yolk-sac-like 
differentiation of human embryonic stem-cell-derived embryoid bodies illustrates 
differences between early mouse and human development. J Cell Sci 2006; 119 (Pt 
4):759-68. 
 286
Powers CJ, McLeskey SW, Wellstein A. Fibroblast growth factors, their receptors and 
signaling. Endocr Relat Cancer 2000; 7 (3):165-97. 
Qi X, Li TG, Hao J, et al. BMP4 supports self-renewal of embryonic stem cells by 
inhibiting mitogen-activated protein kinase pathways. Proc Natl Acad Sci U S A 2004; 
101 (16):6027-32. 
Rappolee DA, Basilico C, Patel Y, Werb Z. Expression and function of FGF-4 in peri-
implantation development in mouse embryos. Development 1994; 120 (8):2259-69. 
Rathjen J, Lake JA, Bettess MD, et al. Formation of a primitive ectoderm like cell 
population, EPL cells, from ES cells in response to biologically derived factors. J Cell 
Sci 1999; 112 ( Pt 5):601-12. 
Raz R, Lee CK, Cannizzaro LA, d'Eustachio P, Levy DE. Essential role of STAT3 for 
embryonic stem cell pluripotency. Proc Natl Acad Sci U S A 1999; 96 (6):2846-51. 
Resnick JL, Bixler LS, Cheng L, Donovan PJ. Long-term proliferation of mouse 
primordial germ cells in culture. Nature 1992; 359 (6395):550-1. 
Resnick JL, Ortiz M, Keller JR, Donovan PJ. Role of fibroblast growth factors and their 
receptors in mouse primordial germ cell growth. Biol Reprod 1998; 59 (5):1224-9. 
Reubinoff BE, Pera MF, Fong CY, Trounson A, Bongso A. Embryonic stem cell lines 
from human blastocysts: somatic differentiation in vitro. Nat Biotechnol 2000; 18 
(4):399-404. 
Reubinoff BE, Pera MF, Vajta G, Trounson AO. Effective cryopreservation of human 
embryonic stem cells by the open pulled straw vitrification method. Hum Reprod 2001; 
16 (10):2187-94. 
Richard C, Roghani M, Moscatelli D. Fibroblast growth factor (FGF)-2 mediates cell 
attachment through interactions with two FGF receptor-1 isoforms and extracellular 
matrix or cell-associated heparan sulfate proteoglycans. Biochem Biophys Res Commun 
2000; 276 (2):399-405. 
Richards M, Tan S, Fong CY, et al. Comparative evaluation of various human feeders 
for prolonged undifferentiated growth of human embryonic stem cells. Stem Cells 2003; 
21 (5):546-56. 
Rizzino A, Kuszynski C, Ruff E, Tiesman J. Production and utilization of growth factors 
related to fibroblast growth factor by embryonal carcinoma cells and their differentiated 
cells. Dev Biol 1988; 129 (1):61-71. 
 287
Rocchi S, Tartare-Deckert S, Murdaca J, et al. Determination of Gab1 (Grb2-associated 
binder-1) interaction with insulin receptor-signaling molecules. Mol Endocrinol 1998; 
12 (7):914-23. 
Rodda DJ, Chew JL, Lim LH, et al. Transcriptional regulation of nanog by OCT4 and 
SOX2. J Biol Chem 2005; 280 (26):24731-7. 
Roghani M, Mansukhani A, Dell'Era P, et al. Heparin increases the affinity of basic 
fibroblast growth factor for its receptor but is not required for binding. J Biol Chem 
1994; 269 (6):3976-84. 
Rosenthal MD, Wishnow RM, Sato GH. In vitro growth and differetiation of clonal 
populations of multipotential mouse clls derived from a transplantable testicular 
teratocarcinoma. J Natl Cancer Inst 1970; 44 (5):1001-14. 
Rossant J. Stem cells and early lineage development. Cell 2008; 132 (4):527-31. 
Rossant J, Nagy A. Genome engineering: the new mouse genetics. Nat Med 1995; 1 
(6):592-4. 
Sasaki A, Taketomi T, Kato R, et al. Mammalian Sprouty4 suppresses Ras-independent 
ERK activation by binding to Raf1. Nat Cell Biol 2003; 5 (5):427-32. 
Sasaki N, Okishio K, Ui-Tei K, et al. Heparan sulfate regulates self-renewal and 
pluripotency of embryonic stem cells. J Biol Chem 2008; 283 (6):3594-606. 
Sato N, Meijer L, Skaltsounis L, Greengard P, Brivanlou AH. Maintenance of 
pluripotency in human and mouse embryonic stem cells through activation of Wnt 
signaling by a pharmacological GSK-3-specific inhibitor. Nat Med 2004; 10 (1):55-63. 
Sato N, Sanjuan IM, Heke M, et al. Molecular signature of human embryonic stem cells 
and its comparison with the mouse. Dev Biol 2003; 260 (2):404-13. 
Savatier P, Lapillonne H, Jirmanova L, Vitelli L, Samarut J. Analysis of the cell cycle in 
mouse embryonic stem cells. Methods Mol Biol 2002; 185:27-33. 
Schlessinger J. Cell signaling by receptor tyrosine kinases. Cell 2000; 103 (2):211-25. 
Schuldiner M, Yanuka O, Itskovitz-Eldor J, Melton DA, Benvenisty N. Effects of eight 
growth factors on the differentiation of cells derived from human embryonic stem cells. 
Proc Natl Acad Sci U S A 2000; 97 (21):11307-12. 
Shamblott MJ, Axelman J, Littlefield JW, et al. Human embryonic germ cell derivatives 
express a broad range of developmentally distinct markers and proliferate extensively in 
vitro. Proc Natl Acad Sci U S A 2001; 98 (1):113-8. 
 288
Shamblott MJ, Axelman J, Wang S, et al. Derivation of pluripotent stem cells from 
cultured human primordial germ cells. Proc Natl Acad Sci U S A 1998; 95 (23):13726-
31. 
Sheng G, dos RM, Stern CD. Churchill, a zinc finger transcriptional activator, regulates 
the transition between gastrulation and neurulation. Cell 2003; 115 (5):603-13. 
Sheng Z, Lewis JA, Chirico WJ. Nuclear and nucleolar localization of 18-kDa fibroblast 
growth factor-2 is controlled by C-terminal signals. J Biol Chem 2004; 279 (38):40153-
60. 
Singh AM, Hamazaki T, Hankowski KE, Terada N. A heterogeneous expression pattern 
for Nanog in embryonic stem cells. Stem Cells 2007; 25 (10):2534-42. 
Smith AG. Embryo-derived stem cells: of mice and men. Annu Rev Cell Dev Biol 2001; 
17:435-62. 
Smith AG, Heath JK, Donaldson DD, et al. Inhibition of pluripotential embryonic stem 
cell differentiation by purified polypeptides. Nature 1988; 336 (6200):688-90. 
Smith AG, Hooper ML. Buffalo rat liver cells produce a diffusible activity which 
inhibits the differentiation of murine embryonal carcinoma and embryonic stem cells. 
Dev Biol 1987; 121 (1):1-9. 
Smith AG, Nichols J, Robertson M, Rathjen PD. Differentiation inhibiting activity 
(DIA/LIF) and mouse development. Dev Biol 1992; 151 (2):339-51. 
Solter D, Knowles BB. Developmental stage-specific antigens during mouse 
embryogenesis. Curr Top Dev Biol 1979; 13 Pt 1:139-65. 
Sperger JM, Chen X, Draper JS, et al. Gene expression patterns in human embryonic 
stem cells and human pluripotent germ cell tumors. Proc Natl Acad Sci U S A 2003; 100 
(23):13350-5. 
Stavridis MP, Lunn JS, Collins BJ, Storey KG. A discrete period of FGF-induced Erk1/2 
signalling is required for vertebrate neural specification. Development 2007; 134 
(16):2889-94. 
Stokoe D, Stephens LR, Copeland T, et al. Dual role of phosphatidylinositol-3,4,5-
trisphosphate in the activation of protein kinase B. Science 1997; 277 (5325):567-70. 
Suzuki K, Tokue A, Kamiakito T, et al. Predominant expression of fibroblast growth 
factor (FGF) 8, FGF4, and FGF receptor 1 in nonseminomatous and highly proliferative 
components of testicular germ cell tumors. Virchows Arch 2001; 439 (5):616-21. 
 289
Tada M, Tada T, Lefebvre L, Barton SC, Surani MA. Embryonic germ cells induce 
epigenetic reprogramming of somatic nucleus in hybrid cells. EMBO J 1997; 16 
(21):6510-20. 
Taira M, Yoshida T, Miyagawa K, et al. cDNA sequence of human transforming gene 
hst and identification of the coding sequence required for transforming activity. Proc 
Natl Acad Sci U S A 1987; 84 (9):2980-4. 
Takahama K, Hashimoto T, Wang MW, et al. Pipecolic acid enhancement of GABA 
response in single neurons of rat brain. Neuropharmacology 1986; 25 (3):339-42. 
Takahashi K, Mitsui K, Yamanaka S. Role of ERas in promoting tumour-like properties 
in mouse embryonic stem cells. Nature 2003; 423 (6939):541-5. 
Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult 
human fibroblasts by defined factors. Cell 2007; 131 (5):861-72. 
Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic 
and adult fibroblast cultures by defined factors. Cell 2006; 126 (4):663-76. 
Takahashi-Tezuka M, Yoshida Y, Fukada T, et al. Gab1 acts as an adapter molecule 
linking the cytokine receptor gp130 to ERK mitogen-activated protein kinase. Mol Cell 
Biol 1998; 18 (7):4109-17. 
Tanaka S, Kunath T, Hadjantonakis AK, Nagy A, Rossant J. Promotion of trophoblast 
stem cell proliferation by FGF4. Science 1998; 282 (5396):2072-5. 
Thomas SM, Brugge JS. Cellular functions regulated by Src family kinases. Annu Rev 
Cell Dev Biol 1997; 13:513-609. 
Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived 
from human blastocysts. Science 1998; 282 (5391):1145-7. 
Thomson JA, Kalishman J, Golos TG, et al. Isolation of a primate embryonic stem cell 
line. Proc Natl Acad Sci U S A 1995; 92 (17):7844-8. 
Tomioka M, Nishimoto M, Miyagi S, et al. Identification of Sox-2 regulatory region 
which is under the control of Oct-3/4-Sox-2 complex. Nucleic Acids Res 2002; 30 
(14):3202-13. 
Toyooka Y, Shimosato D, Murakami K, Takahashi K, Niwa H. Identification and 
characterization of subpopulations in undifferentiated ES cell culture. Development 
2008; 135 (5):909-18. 
Ullrich A, Schlessinger J. Signal transduction by receptors with tyrosine kinase activity. 
Cell 1990; 61 (2):203-12. 
 290
Vallier L, Alexander M, Pedersen RA.  
Activin/Nodal and FGF pathways cooperate to maintain pluripotency of human 
embryonic stem cells. J Cell Sci 2005; 118 (Pt 19):4495-509. 
Vallier L, Reynolds D, Pedersen RA. Nodal inhibits differentiation of human embryonic 
stem cells along the neuroectodermal default pathway. Dev Biol 2004; 275 (2):403-21. 
Viswanathan S, Benatar T, Mileikovsky M, et al. Supplementation-dependent 
differences in the rates of embryonic stem cell self-renewal, differentiation, and 
apoptosis. Biotechnol Bioeng 2003; 84 (5):505-17. 
Vivanco I, Sawyers CL. The phosphatidylinositol 3-Kinase AKT pathway in human 
cancer. Nat Rev Cancer 2002; 2 (7):489-501. 
Wang F, Kan M, Yan G, Xu J, McKeehan WL. Alternately spliced NH2-terminal 
immunoglobulin-like Loop I in the ectodomain of the fibroblast growth factor (FGF) 
receptor 1 lowers affinity for both heparin and FGF-1. J Biol Chem 1995; 270 
(17):10231-5. 
Wang G, Zhang H, Zhao Y, et al. Noggin and bFGF cooperate to maintain the 
pluripotency of human embryonic stem cells in the absence of feeder layers. Biochem 
Biophys Res Commun 2005; 330 (3):934-42. 
Wang J, Xie LY, Allan S, Beach D, Hannon GJ. Myc activates telomerase. Genes Dev 
1998; 12 (12):1769-74. 
Watanabe S, Umehara H, Murayama K, et al. Activation of Akt signaling is sufficient to 
maintain pluripotency in mouse and primate embryonic stem cells. Oncogene 2006; 25 
(19):2697-707. 
Wei CL, Miura T, Robson P, et al. Transcriptome profiling of human and murine ESCs 
identifies divergent paths required to maintain the stem cell state. Stem Cells 2005; 23 
(2):166-85. 
Wilder PJ, Kelly D, Brigman K, et al. Inactivation of the FGF-4 gene in embryonic stem 
cells alters the growth and/or the survival of their early differentiated progeny. Dev Biol 
1997; 192 (2):614-29. 
Willems E, Leyns L. Patterning of mouse embryonic stem cell-derived pan-mesoderm 
by Activin A/Nodal and Bmp4 signaling requires Fibroblast Growth Factor activity. 
Differentiation 2008. 
Williams RL, Hilton DJ, Pease S, et al. Myeloid leukaemia inhibitory factor maintains 
the developmental potential of embryonic stem cells. Nature 1988; 336 (6200):684-7. 
 291
Wilson SI, Graziano E, Harland R, Jessell TM, Edlund T. An early requirement for FGF 
signalling in the acquisition of neural cell fate in the chick embryo. Curr Biol 2000; 10 
(8):421-9. 
Wu Z, Zhang W, Chen G, et al. Combinatorial signals of activin/nodal and bone 
morphogenic protein regulate the early lineage segregation of human embryonic stem 
cells. J Biol Chem 2008. 
Xu C, Inokuma MS, Denham J, et al. Feeder-free growth of undifferentiated human 
embryonic stem cells. Nat Biotechnol 2001; 19 (10):971-4. 
Xu C, Rosler E, Jiang J, et al. Basic fibroblast growth factor supports undifferentiated 
human embryonic stem cell growth without conditioned medium. Stem Cells 2005a; 23 
(3):315-23. 
Xu RH, Chen X, Li DS, et al. BMP4 initiates human embryonic stem cell differentiation 
to trophoblast. Nat Biotechnol 2002; 20 (12):1261-4. 
Xu RH, Peck RM, Li DS, et al. Basic FGF and suppression of BMP signaling sustain 
undifferentiated proliferation of human ES cells. Nat Methods 2005b; 2 (3):185-90. 
Yamaguchi TP, Conlon RA, Rossant J. Expression of the fibroblast growth factor 
receptor FGFR-1/flg during gastrulation and segmentation in the mouse embryo. Dev 
Biol 1992; 152 (1):75-88. 
Yao S, Chen S, Clark J, et al. Long-term self-renewal and directed differentiation of 
human embryonic stem cells in chemically defined conditions. Proc Natl Acad Sci U S 
A 2006. 
Ye M, Iwasaki H, Laiosa CV, et al. Hematopoietic stem cells expressing the myeloid 
lysozyme gene retain long-term, multilineage repopulation potential. Immunity 2003; 19 
(5):689-99. 
Yeom YI, Fuhrmann G, Ovitt CE, et al. Germline regulatory element of Oct-4 specific 
for the totipotent cycle of embryonal cells. Development 1996; 122 (3):881-94. 
Yin T, Yang YC. Mitogen-activated protein kinases and ribosomal S6 protein kinases 
are involved in signaling pathways shared by interleukin-11, interleukin-6, leukemia 
inhibitory factor, and oncostatin M in mouse 3T3-L1 cells. J Biol Chem 1994; 269 
(5):3731-8. 
Ying QL, Nichols J, Chambers I, Smith A. BMP induction of Id proteins suppresses 
differentiation and sustains embryonic stem cell self-renewal in collaboration with 
STAT3. Cell 2003a; 115 (3):281-92. 
 292
Ying QL, Stavridis M, Griffiths D, Li M, Smith A. Conversion of embryonic stem cells 
into neuroectodermal precursors in adherent monoculture. Nat Biotechnol 2003b; 21 
(2):183-6. 
Yoshida S, Morii K. Brain metastasis from germinal tumors of the testis. Case report. J 
Neurosurg 1998; 88 (4):761-3. 
Yu J, Vodyanik MA, Smuga-Otto K, et al. Induced pluripotent stem cell lines derived 
from human somatic cells. Science 2007; 318 (5858):1917-20. 
Yuan H, Corbi N, Basilico C, Dailey L. Developmental-specific activity of the FGF-4 
enhancer requires the synergistic action of Sox2 and Oct-3. Genes Dev 1995; 9 
(21):2635-45. 
Yusoff P, Lao DH, Ong SH, et al. Sprouty2 inhibits the Ras/MAP kinase pathway by 
inhibiting the activation of Raf. J Biol Chem 2002; 277 (5):3195-201. 
Zhang X, Ibrahimi OA, Olsen SK, et al. Receptor specificity of the fibroblast growth 

































Raw data from the FDG analysis.  These two experiments is part of the four 
independent experiments with triplicate repeats for each condition was used to produce 
the graphs in figure 3.12, A. 
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Raw data from the FDG analysis.  These two experiments is part of the four 
independent experiments with triplicate repeats for each condition was used to produce 
the graphs in figure 3.12, A. 
 



































































































































































































































































































































































Appendix 3: Effect of cell density in cell cycle  
 
A 
            
0 64 128 192 256













          
0 64 128 192 256













Effect of cell density in cell cycle.  A:  Cells plated for one day in presence of FGF2 
showed an increased cycling.  B: Cells plated for 5 days.  Cell confluency caused an 
increase in G1 in the cells maintained with FGF2, which is a similar profile to that from 














            
 
T5 cell growth was sustained by the maintenance of the medium of plating after 5 
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